Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRP,Agouti-related protein,40058,0.296076543840037,0.00466506339346173,0.286933019588852,0.305220068091222,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL27,C-C motif chemokine 27,39868,0.2699827096794,0.00570883454866076,0.258793393964025,0.281172025394775,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN1,CCN family member 1,39758,0.389013725282969,0.00677467447699727,0.375735363308054,0.402292087257884,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,39839,0.107612213630366,0.00268420697793722,0.102351167953609,0.112873259307123,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES1,Liver carboxylesterase 1,39854,0.29966604838084,0.0074023584105252,0.285157425896211,0.314174670865469,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F7,Coagulation factor VII,39899,0.125249326405884,0.00274636307014741,0.119866454788395,0.130632198023373,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FURIN,Furin,39913,0.129651265344216,0.00314206503329631,0.123492817878955,0.135809712809477,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCG,Pro-glucagon,39477,0.481623859963126,0.0113396131160652,0.459398218255638,0.503849501670613,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHR,Growth hormone receptor,37124,0.109133543046305,0.00264934251438064,0.103940831718119,0.114326254374491,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.300499352370559,0.00703029308320422,0.286719977927479,0.31427872681364,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0893698218704035,0.00199326847840265,0.0854630156527343,0.0932766280880727,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLR,Low-density lipoprotein receptor,39882,0.443967156014783,0.00373728130459376,0.436642084657779,0.451292227371787,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPL,Lipoprotein lipase,39868,-0.188658460001819,0.00436199855676697,-0.197207977173082,-0.180108942830556,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFGE8,Lactadherin,39858,0.245295665451691,0.00380673049959329,0.237834473672488,0.252756857230894,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPY,Pro-neuropeptide Y,40030,0.379503654032321,0.00573227425967148,0.368268396483365,0.390738911581277,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.13368493211335,0.00278007052120245,0.128235993891793,0.139133870334907,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,37437,0.152140447686269,0.00371129720686465,0.144866305160815,0.159414590211724,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROC,Vitamin K-dependent protein C,39908,0.0993702685152234,0.00238665880202509,0.0946924172632543,0.104048119767193,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH,Parathyroid hormone,37039,0.304138222585972,0.00732876254817511,0.289773847991549,0.318502597180395,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,39949,0.199713943846334,0.00432445359740016,0.191238014795429,0.208189872897238,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.138450301205969,0.0029970933552602,0.132575998229659,0.144324604182279,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.163009848053522,0.00394211229229811,0.155283307960618,0.170736388146427,0
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBC,Inhibin beta C chain,39858,0.150548619908358,0.00386791651493025,0.142967503539095,0.158129736277621,1.11253693449796e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF9,Protein turtle homolog A,37437,0.29656029811881,0.00763622994995128,0.281593287416905,0.311527308820714,1.11256663568371e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APCS,Serum amyloid P-component,37333,0.12481417515489,0.0032270537800429,0.118489149746006,0.131139200563774,1.12246839316989e-308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL23,C-C motif chemokine 23,39931,0.146144173511067,0.00384507168360798,0.138607833011195,0.153680514010938,8.95613683097861e-303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.283142461873287,0.00774069452835259,0.267970700597716,0.298314223148858,3.93571570150549e-281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADIPOQ,Adiponectin,37453,-0.225408081896556,0.00615875852556078,-0.237479248606655,-0.213336915186457,8.67688460554345e-280
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,39866,0.180576772782372,0.00495342756066808,0.170868054763463,0.190285490801282,1.35786900627364e-279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR37,Prosaposin receptor GPR37,39585,0.219534505692058,0.00603101657533534,0.207713713204401,0.231355298179715,1.29964280915523e-278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.287603440561131,0.00792911999432199,0.27206236537226,0.303144515750002,9.88389045938566e-277
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,39843,0.105803524863954,0.00294969175241521,0.10002212902922,0.111584920698688,4.52477921169341e-271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.289737607035599,0.0081470074551064,0.273769472423591,0.305705741647608,1.2129033835875e-266
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.481193375439931,0.0135861300555205,0.454564560531111,0.507822190348751,1.95820348282287e-264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTR,Transthyretin,37309,0.0833665175698356,0.00235209391347743,0.0787564134994198,0.0879766216402513,3.80413834402292e-263
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPM,Carboxypeptidase M,39955,0.113751436652472,0.00323973893830242,0.107401548333399,0.120101324971545,2.68820174488062e-260
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.215985412737547,0.00625472044904364,0.203726160657422,0.228244664817673,4.78966847593178e-252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCHE,Cholinesterase,37208,0.0888826047413449,0.00258370655290063,0.0838185398976596,0.0939466695850301,1.45441521385382e-248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG2,Desmoglein-2,39858,-0.0858253219357695,0.0025152258901973,-0.0907551646805562,-0.0808954791909828,2.13502996768922e-246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.254436354309351,0.00747662742165135,0.239782164562914,0.269090544055788,4.24881308921005e-245
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCS1,Neuronal calcium sensor 1,40030,0.0897048905402186,0.00265039085064211,0.0845101244729601,0.0948996566074772,1.12434039363486e-242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.361588673337483,0.010681458772486,0.340653014143411,0.382524332531556,1.14826943524206e-242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS15,Enteropeptidase,39788,0.282126941247895,0.00839398149933875,0.265674737509191,0.298579144986599,2.47042111700745e-239
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,39749,0.0919898790732035,0.00274283917830228,0.086613914283731,0.097365843862676,2.50758456275511e-238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,40058,0.242563172859772,0.0072387290672335,0.228375263887995,0.25675108183155,4.41634477396318e-238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.336093539783851,0.0100385963400833,0.316417890957287,0.355769188610414,1.47892048540237e-237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP1,Neuropilin-1,39949,-0.0873684006762568,0.00261154854015699,-0.0924870358149645,-0.0822497655375491,2.74357673242125e-237
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA1,Glutathione S-transferase A1,39841,0.267403852068496,0.00800384229776227,0.251716321164882,0.28309138297211,1.27208510305161e-236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0607120619558799,0.00181991378900385,0.0571450309294324,0.0642790929823275,6.20225245838883e-236
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFH,Complement factor H,36763,0.0731923915048123,0.00220628519115341,0.0688680725301516,0.077516710479473,1.16077821707614e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLTP,Phospholipid transfer protein,39976,-0.111895870856939,0.0033913832771761,-0.118542982080205,-0.105248759633674,4.45837895698223e-231
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.105207174002231,0.00320085936271656,0.0989334896513066,0.111480858353155,2.04982612706031e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,39858,0.0860350016026356,0.00261848134499208,0.0809027781664512,0.0911672250388201,3.50031244921562e-229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIP2,Cysteine-rich protein 2,39749,0.111142043279785,0.00338954325699784,0.104498538496069,0.117785548063501,3.0987554213651e-228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFI,Complement factor I,37453,0.0614896961131175,0.00187726583836584,0.0578102550699205,0.0651691371563146,1.46596613568483e-226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAT,Tissue-type plasminogen activator,40002,0.152663181936051,0.00468862533341997,0.143473476282548,0.161852887589554,2.71052034302528e-225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA4,Kallistatin,37241,0.0711301314546927,0.00220131700041193,0.0668155501338853,0.0754447127755001,1.24657328625911e-220
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F9,Coagulation factor IX,39908,0.0553324407321373,0.00171801856679796,0.0519651243412133,0.0586997571230613,1.38352354019826e-220
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTA3,Glutathione S-transferase A3,39477,0.231421490633345,0.00722969679541791,0.217251284914326,0.245591696352364,8.10982593336299e-218
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFP,Properdin,37453,0.0697957029193717,0.00218014277872212,0.0655226230730764,0.0740687827656671,7.0118002465348e-217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.370121311490188,0.0116275861320024,-0.392911380308913,-0.347331242671463,1.03434602598983e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP5,Retinol-binding protein 5,39788,0.168098934145099,0.00529124951430179,0.157728085097068,0.178469783193131,8.18851424730016e-215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN3,Contactin-3,39858,0.0979716970362405,0.00309236067819543,0.0919106701069775,0.104032723965504,1.04479025355696e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,37283,0.0952400913367695,0.00299773660030092,0.0893645276001797,0.101115655073359,1.20784616971864e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPIND1,Heparin cofactor 2,37424,0.0842482898123624,0.00265414999545401,0.0790461558212725,0.0894504238034522,2.35056405488273e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,37254,0.0764687610701742,0.00240908913034662,0.0717469463746948,0.0811905757656535,2.94571339002703e-213
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,39868,0.0895223461729358,0.00285802308106878,0.0839206209340409,0.0951240714118306,4.36952500427359e-209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0885318818205754,0.00283799956074479,-0.0940943609596352,-0.0829694026815156,3.1673262899078e-206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY1,Aminoacylase-1,39868,0.181388782869715,0.00584513909860617,0.169932310236447,0.192845255502983,2.26881791259903e-205
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0912100724047931,0.00294318107969465,0.0854414374885916,0.0969787073209946,7.28686757892053e-205
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.182260463598925,0.00588858275652897,-0.193802085801722,-0.170718841396129,2.15201753142608e-204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFM,Afamin,37453,0.0555778638508744,0.00179093063338679,0.0520676398094363,0.0590880878923125,2.38705172521703e-204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUSB,Beta-glucuronidase,39919,0.171750391877576,0.00556426673893517,0.160844429069263,0.182656354685889,2.76611245955726e-203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",39489,0.148903160307931,0.00484031984559266,0.139416133410569,0.158390187205292,8.06568961083611e-202
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCA,Alpha-synuclein,37124,0.336482022912894,0.0109622501198488,0.314996012677991,0.357968033147798,6.0443278695938e-200
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.171359565159843,0.00561292457646828,0.160358232989965,0.18236089732972,7.03363249251951e-199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0557734187514385,0.00182718233448255,0.0521921413758527,0.0593546961270243,8.83101155309991e-199
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYNU,Kynureninase,40058,0.131385038551528,0.00431174073640512,0.122934026708174,0.139836050394882,2.36227755031278e-198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBP,Protein AMBP,40003,0.0558394991829092,0.0018331724155809,0.0522464812483706,0.0594325171174477,3.37209469712959e-198
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0864855361302579,0.00285414484711586,0.0808914122299108,0.092079660030605,3.83534391803164e-196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPB1,Beta-ureidopropionase,37437,0.264067052721324,0.00869843682395228,0.247018116546377,0.28111598889627,6.43613392120559e-196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0974455271714602,0.00322407306997827,-0.103764710388618,-0.0911263439543028,2.88551785457018e-195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,37437,0.161770563074711,0.00536069129766876,0.151263608131281,0.172277518018142,1.09023610339272e-193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,39477,0.314138359542084,0.0104521926409267,0.293652061965868,0.334624657118301,5.64637247669273e-193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.148295845877387,0.00496878131361848,0.138557034502695,0.158034657252079,1.44341610190497e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROS1,Vitamin K-dependent protein S,37453,0.0692060207407109,0.00231757871454434,0.064663566460204,0.0737484750212178,7.87471878819445e-190
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.166560951816036,0.00560576434733692,-0.177548249936816,-0.155573653695256,7.45869571531991e-189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRP,Gastrin-releasing peptide,37043,0.145638487999402,0.00492721607201603,0.135981144498251,0.155295831500553,5.63357251952561e-186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F10,Coagulation factor X,37445,0.0739357027117018,0.0025103689392946,0.0690153795906844,0.0788560258327192,7.16889211681529e-185
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL16,C-C motif chemokine 16,40052,0.144792554404244,0.00495709871368938,0.135076640925413,0.154508467883076,7.92014483212328e-183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR2,Cadherin-related family member 2,39788,0.201552362114975,0.00693032206414565,0.187968930869249,0.2151357933607,3.13135738927781e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.150975055664728,0.00519168245468224,0.14079935805355,0.161150753275905,3.84276805288207e-181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LG,CMRF35-like molecule 9,39858,-0.101155939705792,0.003486065847393,-0.107988628766682,-0.0943232506449013,1.82479684701941e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9,Complement component C9,37445,-0.145941773756242,0.00502606519020153,-0.155792861529037,-0.136090685983447,6.63077087114438e-180
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR3,Anterior gradient protein 3,39464,0.162070128146271,0.00560923517134172,0.151076027210441,0.173064229082101,7.1402546811473e-179
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,39931,-0.077300468766829,0.00267899241589407,-0.0825512939019814,-0.0720496436316767,1.54513677728606e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.231212084818131,0.00800193266001501,0.215528296804501,0.24689587283176,3.47327870799406e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELN,Elastin,37437,0.0919159184448759,0.00318342621020709,0.0856764030728701,0.0981554338168818,5.83397336901996e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOST,Sclerostin,39846,0.10473127825045,0.00363792036064747,0.0976009543435813,0.111861602157319,9.83900350147934e-178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHBG,Sex hormone-binding globulin,37445,-0.141023193433632,0.00488765088374687,-0.150602989165775,-0.131443397701488,1.00712141766511e-177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,P4HB,Protein disulfide-isomerase,39776,0.106160975400525,0.0037021182889689,0.0989048235541461,0.113417127246904,2.26342330988954e-176
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.200977108602814,0.00705051535135841,0.187158098514151,0.214796118691476,2.38349291700121e-174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,39913,0.0582583411452748,0.00205329808062211,0.0542338769072555,0.0622828053832942,7.77997624934666e-173
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0745330808463323,0.00263434700385802,0.0693697607187705,0.079696400973894,6.72924041162282e-172
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.193019873379323,0.00685839313682227,0.179577422831152,0.206462323927495,4.23812100636495e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.124536703337267,0.00442569290820549,0.115862345237184,0.133211061437349,4.81751301368331e-170
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0671100350467414,0.00238856238656283,0.0624284527690783,0.0717916173244046,1.33898530341623e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.180924149438811,0.00643787455313925,0.168305915314658,0.193542383562964,1.44442370856853e-169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0565392125139057,0.0020188457270454,0.0525822748888967,0.0604961501389147,1.44494483247973e-168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAB2,Stabilin-2,37437,0.0744944673686515,0.00266178183917971,0.0692773749638593,0.0797115597734437,1.28847762900119e-167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,37056,0.22828557840745,0.00817733908477314,0.212257993801295,0.244313163013606,1.1043686842292e-166
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,39913,0.0674558999915059,0.0024334501329375,0.0626863377309484,0.0722254622520634,3.02248148463265e-165
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.182730429746545,0.00658856923190021,0.169816834052021,0.19564402544107,1.05471656657347e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.164497935898048,0.00594995067731116,0.152836032570518,0.176159839225578,2.6717257187691e-164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRN,"Attractin, Isoform 2",37453,0.0426116562393988,0.00154822375926062,0.039577137671248,0.0456461748075496,2.52224142576902e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO3,Beta-enolase,37043,0.157846061208331,0.00573358206449925,0.146608240361913,0.16908388205475,2.84108093735206e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPC,C-type natriuretic peptide,39866,0.119517191553696,0.00435574119607579,0.110979938809387,0.128054444298004,5.14931579708782e-162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEG1,Protein HEG homolog 1,37124,0.0705757154319063,0.00257740408482373,0.0655240034256518,0.0756274274381608,1.24257747484773e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,40009,0.152976142958536,0.00561348722546656,0.141973707996622,0.163978577920451,6.46077659744601e-160
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,37224,0.0350112596964041,0.00128263826737013,0.0324972886923586,0.0375252307004495,1.07829818266417e-159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL22,C-C motif chemokine 22,39686,0.130217796786344,0.00480697316926867,0.120796129374577,0.139639464198111,5.15958502514826e-158
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUMB,Protein numb homolog,37056,0.218306493142189,0.0080484087451669,0.202531612001662,0.234081374282716,1.03421087694326e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,39788,0.32081788054984,0.0118683143529782,0.297555984418003,0.344079776681677,2.1959633324961e-157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR5,Cadherin-related family member 5,39868,0.099109013308779,0.00370063444185492,0.0918557698027433,0.106362256814815,1.32242333107564e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,39904,0.0853153585462745,0.00318760337494106,0.07906765593139,0.091563061161159,2.00561411429294e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLN,Promotilin,39866,0.227368301627896,0.00849934044642566,0.210709594352901,0.24402700890289,2.88289388051543e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTYMK,Thymidylate kinase,37437,0.174919098898253,0.0065336628470316,0.162113119718071,0.187725078078435,6.54567872586379e-154
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORT1,Sortilin,39846,0.0949722809068288,0.00355854612622882,0.0879975304994203,0.101947031314237,1.45311967572638e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0660998675012326,0.0024804492941612,0.0612381868846767,0.0709615481177886,4.2286537683736e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.163995402858003,0.00614305228382883,0.151955020381699,0.176035785334308,4.5115032777276e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.3579795889362,0.0134146423544236,0.331686889921529,0.38427228795087,6.07919471424874e-153
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,37124,0.192109611044043,0.00721739242697862,0.177963521887164,0.206255700200921,4.05179496029108e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM20A,Pseudokinase FAM20A,37437,0.0714881587452502,0.00268869841585934,0.0662183098501659,0.0767580076403345,6.91997563848719e-152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYAP1,Synapse-associated protein 1,37124,0.145542263226449,0.00547909758589262,0.134803231958099,0.156281294494799,1.60336517064099e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL16,Pro-interleukin-16,40058,0.104178803314023,0.00393126682690496,0.0964735203332894,0.111884086294757,1.61442240808601e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS1,Protein MTSS 1,37382,0.279113179373247,0.0105111887057451,0.258511249509987,0.299715109236507,1.71387834455983e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCLY,Selenocysteine lyase,39984,0.124404135698537,0.00469793538681678,0.115196182340376,0.133612089056698,2.73689037724102e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EEF1D,Elongation factor 1-delta,37437,0.230236170551755,0.00868938471471995,0.213204976510904,0.247267364592606,7.0984665510337e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPY30,Protein dpy-30 homolog,39979,0.149582768627553,0.00565716658808244,0.138494722114912,0.160670815140195,7.44360754620267e-151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLKB1,Plasma kallikrein,37187,0.0627838824995309,0.00238028609718879,0.0581185217490409,0.067449243250021,1.68859960827153e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MME,Neprilysin,39788,0.197600518276569,0.00750873271602802,0.182883402153154,0.212317634399983,1.92906898459853e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,39587,0.213952413716284,0.00814411820328351,0.197989942037849,0.22991488539472,6.62514276134454e-149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.12469883424137,0.00475107557672972,0.115386726110979,0.13401094237176,1.09924823295402e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,40058,0.107333192925027,0.00409902268688166,0.099299108458739,0.115367277391315,4.66184688259782e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,37411,0.14488137893697,0.00552262229060846,0.134057039247377,0.155705718626562,5.21131659112177e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11R,Junctional adhesion molecule A,39858,0.141620200609298,0.00540867778423822,0.131019192152191,0.152221209066405,5.23424145974147e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLA,Alpha-galactosidase A,37088,0.0944655299424455,0.00360176976058719,0.0874060612116947,0.101524998673196,7.51264430589744e-148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,39913,0.228147947992176,0.00872389584732793,0.211049112131414,0.245246783852939,1.1369906592458e-147
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH9,Myosin-9,37437,0.277054055653059,0.0106164666928656,0.256245780935042,0.297862330371075,1.58517906170233e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,40058,0.0809540484781125,0.003109291724984,0.0748598366971438,0.0870482602590811,1.95524442741902e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0561861393439759,0.00215903731388362,0.051954426208764,0.0604178524791878,2.86250453804338e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,37039,0.299569175032902,0.0115074176798556,0.277014636380385,0.322123713685419,9.87295769746805e-146
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH1,Somatotropin,39846,-0.447551313507149,0.0172430915647607,-0.48134777297408,-0.413754854040218,1.60759601470593e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOMO1,Nodal modulator 1,39858,0.0588655910781982,0.00226890549058213,0.0544185363166572,0.0633126458397392,2.09967424211872e-145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0534189205843674,0.00206116576161436,0.0493790356916033,0.0574588054771316,1.64886738761675e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORD,Sorbitol dehydrogenase,39963,0.169245430673493,0.00654741325452603,0.156412500694622,0.182078360652364,2.15489417741312e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FN1,Fibronectin,37453,0.0657537475483211,0.00253926115160609,0.0607767956911731,0.070730699405469,2.34186610943692e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN2,Ficolin-2,39810,0.0999851249508806,0.00387091380390386,0.092398133895229,0.107572116006532,3.71224678677501e-144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.196892940213981,0.00762382001956232,0.181950252975639,0.211835627452323,1.34367869996611e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKB,Creatine kinase B-type,37437,-0.143127949151909,0.00554585532214132,-0.153997825583306,-0.132258072720512,2.00956479223971e-143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGRN,Agrin,39931,0.0798422972058304,0.00312022575507761,0.0737266547258783,0.0859579396857825,1.37660742313956e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF21,Fibroblast growth factor 21,40011,0.291572401086988,0.0113993378941565,0.269229698814441,0.313915103359534,1.73260101907419e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,39788,0.278515056207976,0.0108931506053767,0.257164481021438,0.299865631394514,2.42648535578408e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,39877,0.0963014511084006,0.00376676243065803,0.0889185967443108,0.10368430547249,2.44802277837237e-141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,39788,0.166587217000305,0.00653372524325707,0.153781115523521,0.179393318477089,1.40168557747825e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0952382153670869,0.00374077218689343,0.0879063018807758,0.102570128853398,3.47297690642384e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4R,Reticulon-4 receptor,40030,0.0806233593318294,0.00316986667527731,0.0744104206482858,0.0868362980153729,5.86293556754675e-140
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHK,Ketohexokinase,37043,0.156908027531508,0.00617336271052033,0.144808236618888,0.169007818444128,3.5783889813341e-139
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3F,Semaphorin-3F,39868,0.0616025400222718,0.00244109277378478,0.0568179981856536,0.06638708185889,7.94432624114158e-138
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0703287082500728,0.00279405457055362,0.0648523612917877,0.0758050552083579,1.11056288105697e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.164146686494701,0.00652090180528924,0.151365718956334,0.176927654033068,1.33370105847173e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.125589452649017,0.00499796752569099,0.115793436298663,0.135385468999372,3.21836556515858e-136
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FYB1,FYN-binding protein 1,39836,0.21923635832945,0.00878978952518365,0.20200837086009,0.23646434579881,9.69810254842703e-135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0615634512250766,0.0024760137848404,0.0567104642067894,0.0664164382433638,1.77798498140201e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.116341536487611,0.0046797803190361,0.107169167062301,0.125513905912922,2.19858260383053e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0931828743701154,0.00375875716331278,-0.100550038410208,-0.0858157103300223,3.62075870042628e-133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.103314312059403,0.00417457048615361,0.0951321539065422,0.111496470212264,1.02163236037218e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0471315154572078,0.00190617324827316,0.0433954158905925,0.0508676150238232,1.74150079125274e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK1,Dickkopf-related protein 1,40009,0.141235357480603,0.0057204937453795,0.130023189739659,0.152447525221547,3.87677892053611e-132
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MVK,Mevalonate kinase,39587,0.186760775482333,0.00757643110245573,0.17191097052152,0.201610580443146,1.13961638764377e-131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLUL1,Clusterin-like protein 1,39840,-0.105973629386436,0.00432823629060757,-0.114456972516027,-0.0974902862568456,5.33964577469254e-130
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0693041859876346,0.00283037762025943,0.0637566458519262,0.0748517261233431,1.35955652782757e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.169366852732957,0.00693932766544279,0.155765770508689,0.182967934957225,3.16801599971107e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.124996548410479,0.00512927739438178,0.114943164717491,0.135049932103467,8.10238606049793e-129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.197780170613193,0.00810855427609889,0.18188740423204,0.213672936994347,1.45443643115705e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL17,C-C motif chemokine 17,39836,0.210323424723014,0.00864447764949609,0.193380248530002,0.227266600916027,2.00972348817843e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEP,Leptin,39868,0.157783704252096,0.006489927533619,0.145063446286203,0.170503962217989,3.05632918998797e-128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.208088867318904,0.00857909974567938,0.191273831817372,0.224903902820436,1.21477030549535e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,37390,0.254262205177126,0.0104687181831995,0.233743517538055,0.274780892816197,1.39400119090149e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP20,Centrosomal protein 20,39477,0.171521494654701,0.00708010546534562,0.157644487942624,0.185398501366778,2.62666651232085e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,39868,-0.0906461871581094,0.00374271174979086,-0.0979819021876995,-0.0833104721285193,2.68582674067175e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,39786,-0.146922545325935,0.00606663849049196,-0.1588131567673,-0.135031933884571,2.84123350144256e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.109902580850264,0.00453584907821116,0.10101231665697,0.118792845043558,6.10641637778523e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCXR,L-xylulose reductase,39913,0.124850959767468,0.00516383021528307,0.114729852545513,0.134972066989422,6.97326663927661e-127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS8,Prostasin,39805,0.0928458421209645,0.00384476544382228,0.0853101018510729,0.100381582390856,1.43194376755538e-126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,39585,0.115111656585208,0.00478451279747867,0.10573401150215,0.124489301668266,1.23339966689098e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,39866,0.063913740608018,0.00266540956332838,0.0586895378638944,0.0691379433521416,7.27439022682524e-125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.131226853507791,0.00548482238648412,0.120476601630282,0.1419771053853,7.13778679611266e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTD,Biotinidase,37453,0.0469548101585018,0.00196401839995267,0.0431053340945946,0.050804286222409,9.02316701041477e-124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.0641597428292529,0.00268847446668962,0.0588903328745413,0.0694291527839646,1.02323426849074e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.0877599157896285,0.0036837979831911,-0.0949801598366831,-0.080539671742574,2.61184351907742e-123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",39788,0.184940677851828,0.00779222724217031,0.169667912457174,0.200213443246482,2.1233874281325e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE4,Ribonuclease 4,37051,0.0590471267996918,0.00248668855283622,0.0541732172361328,0.0639210363632508,4.39697508083908e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.117133989323253,0.00494765186814778,0.107436591661683,0.126831386984823,9.06367524748582e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHBP1,EH domain-binding protein 1,37437,0.170249180584946,0.0071827844614366,0.156170923040531,0.184327438129362,9.9442642450955e-122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0788164377328544,0.00334075253196065,0.0722685627702116,0.0853643126954973,5.2393994422599e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUOM,Fucose mutarotase,37124,0.143614044833964,0.00608014733016758,0.131696956066835,0.155531133601092,7.35221606275915e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.09310495510687,0.00394350215533283,0.0853756908824176,0.100834219331322,8.3604903423796e-121
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSO,Cathepsin O,40058,0.067168474541763,0.00287105130031135,0.0615412139931528,0.0727957350903733,4.48701935535285e-119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJAP1,Tight junction-associated protein 1,39913,0.185807846647473,0.00796933177297669,0.170187956372439,0.201427736922508,2.83672650155412e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPY,Pancreatic prohormone,39826,0.223683594976185,0.00960822355356709,0.204851476811194,0.242515713141177,6.39286633426972e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXLNA,Alpha-taxilin,39749,0.199114146102535,0.00855822188627147,0.182340031205443,0.215888260999627,9.07738107639085e-118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.182890350528442,0.00785104479500518,0.167502302730232,0.198278398326652,1.02645748399923e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5E,5'-nucleotidase,39913,0.123164446165957,0.00530715139646179,0.112762429428892,0.133566462903023,3.24496172592342e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD63,CD63 antigen,39720,0.114592215135914,0.00493916700021711,0.104911447815488,0.124272982456339,3.96306685137367e-117
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUCB2,Nucleobindin-2,39995,0.0832937037866537,0.00359779811690949,0.0762420194775111,0.0903453880957963,1.116411876101e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0871090119327736,0.00376362627890211,0.0797323044261255,0.0944857194394218,1.26768611896734e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB2,Carboxypeptidase B2,37424,0.050120533507859,0.0021623123553113,0.0458824012914488,0.0543586657242692,1.34461327621799e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,39931,0.145995856245099,0.0063274264711535,0.133594100361638,0.15839761212856,6.49324569272594e-116
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.181963328309402,0.00790207536855656,0.166475260587031,0.197451396031772,1.78774698279526e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THOP1,Thimet oligopeptidase,39798,0.0671702976192804,0.00291966834817291,0.0614477476568615,0.0728928475816994,3.0289981367162e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.120464023520559,0.00523788349089767,0.110197771878399,0.130730275162718,3.97063270902936e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPL,N-acetylneuraminate lyase,37437,0.0970144774756183,0.0042142758547716,0.088754496800266,0.105274458150971,4.58375391099541e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,39489,0.175612313872923,0.00764617235330363,0.160625816060448,0.190598811685399,7.81312508696214e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.156498866625554,0.00680750896173964,0.143156149060544,0.169841584190563,9.17542427777371e-115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,40009,0.211888813351875,0.0092507273514638,0.193757387743006,0.230020238960744,2.7206983599283e-114
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.213505238847669,0.00936626729665645,0.195147354946222,0.231863122749116,6.72095009476638e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.119616224648729,0.00525539944520822,0.109315641736121,0.129916807561337,7.4409635147014e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.213160944774119,0.0093674544969719,0.194800733960055,0.231521155588184,7.91694170725626e-113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.0631300293893012,0.00278091581972499,0.0576794343826402,0.0685806243959621,2.45731418498466e-112
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,39805,0.247473018953598,0.0109358569176423,0.226038739395019,0.268907298512177,1.26389368876585e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,37388,0.102205356393916,0.00451153725416828,0.0933627433757458,0.111047969412085,1.4894268841798e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELP,P-selectin,39931,0.124527310072583,0.00550754464142561,0.113732522575388,0.135322097569777,1.86765658441099e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.197944837637947,0.00875853373055507,0.18077811152606,0.215111563749835,2.53975690929588e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN1,Perilipin-1,39489,0.0751122404410345,0.00332660809044198,0.0685920885837682,0.0816323922983008,4.12396598564726e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.24542751141836,0.0108543808704822,0.224152924912215,0.266702097924505,4.13886942929737e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.044377461349877,0.00196797035421993,0.0405202394556059,0.0482346832441481,7.27939411516237e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0795998914832949,0.00353186704499492,0.0726774320751049,0.0865223508914849,9.33663289999864e-111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2AP,CD2-associated protein,39868,0.136980907535787,0.00608270700834516,0.125058801799431,0.148903013272144,1.38047152636036e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.115445408916011,0.00513263643587784,0.10538544150169,0.125505376330332,2.58104528606742e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EZR,Ezrin,40009,0.0518242000604689,0.0023092024028574,0.0472981633508684,0.0563502367700694,7.21495588372446e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HJV,Hemojuvelin,37411,0.0955774985762275,0.00425405202588595,0.087239556605491,0.103915440546964,8.65409527826963e-110
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST3,Cystatin-C,39897,0.0571579497957078,0.00255095874119871,0.0521580706629583,0.0621578289284573,1.6233541439428e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.152716011910901,0.00681869124462548,0.139351377071435,0.166080646750367,2.22333899587865e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.144513602327842,0.00646150392781563,0.131849054629324,0.157178150026361,4.39431676572905e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGF,Hepatocyte growth factor,40058,0.0729050262438753,0.00326272133995211,0.0665100924175691,0.0792999600701814,5.96944537496358e-109
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.232453988260076,0.010407113505884,0.212056045788544,0.252851930731609,1.496347622616e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FETUB,Fetuin-B,39908,0.0720327129343086,0.0032320076309973,0.0656979779775539,0.0783674478910633,2.15326128584057e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTSS2,Protein MTSS 2,37368,0.213500594473788,0.00956616994758431,0.194750901376523,0.232250287571053,2.21003788614268e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL5,C-C motif chemokine 5,39931,0.215985492063404,0.00969653115111128,0.196980291007226,0.234990693119582,2.82517383343434e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.176968593651183,0.00793235647174509,0.161421174966562,0.192516012335803,2.88265700077402e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,39866,0.0929267518271502,0.00417228214986868,0.0847490788134076,0.101104424840893,3.00172484357878e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTBS,Di-N-acetylchitobiase,37296,0.0590955790470371,0.00264972789683387,0.0539021123692427,0.0642890457248314,3.17983142774617e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES3,Carboxylesterase 3,39788,0.147046846613305,0.00660942669387323,0.134092370293314,0.160001322933297,5.1767346535387e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAB2,Disabled homolog 2,40030,0.238284298133447,0.0107181838064358,0.217276657872833,0.259291938394061,6.96208848486941e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.209446619228882,0.00942471327167443,0.1909741812164,0.227919057241364,8.71191404777657e-108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.226630923283031,0.0102126629249068,0.206614103950214,0.246647742615848,1.73678559303817e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,36838,0.0679971189996112,0.00306041586141503,0.0619987039112377,0.0739955340879846,2.26945285254938e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.221982288589811,0.0100250450580557,0.202333200276022,0.2416313769036,5.04522957057296e-107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BECN1,Beclin-1,37043,0.128531401711953,0.00580422762059517,0.117155115575586,0.139907687848319,1.02923254594053e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0551375449898088,0.002496056687132,0.0502452738830301,0.0600298160965875,1.47356502384184e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,39913,0.117994803819454,0.00534150608685765,0.107525451889213,0.128464155749695,1.51129891588391e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.154038895609535,0.00697268929878043,0.140372424583925,0.167705366635144,3.17389552456457e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN1,Dynactin subunit 1,40030,0.137774652315917,0.00625008277769368,0.125524490071638,0.150024814560197,3.99767471248265e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARF6,ADP-ribosylation factor 6,37382,0.225284271533365,0.0102063951600073,0.20527973701975,0.245288806046979,4.26351998042455e-106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,39477,0.134822611857186,0.00614170565135121,0.122784868780538,0.146860354933835,3.21485993204596e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXIN1,Axin-1,39866,0.200851396791047,0.00917149029399018,0.182875275814827,0.218827517767268,9.01861176990707e-105
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNA4,Plexin-A4,39866,0.170606399061471,0.00780425879449195,0.155310051824267,0.185902746298676,2.06257264679443e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,37368,0.116901229327619,0.00535159866160019,0.106412095950883,0.127390362704355,5.5167527828199e-104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.101641034370685,0.00466737692604053,0.0924929755956452,0.110789093145724,1.17481664016568e-103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZN,Kazrin,37382,0.21694935219428,0.0100002085230992,0.197348943489006,0.236549760899555,1.28826389912469e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0762606632619075,0.0035177391580606,0.0693658945121088,0.0831554320117063,1.78450608371534e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYY,Peptide YY,37021,0.192227870559206,0.0088651210276747,0.174852233344964,0.209603507773449,1.80231238113628e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD6,T-cell differentiation antigen CD6,40040,0.108778605130507,0.00504038260485607,0.0988994552249888,0.118657755036025,7.30198971649059e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,37021,0.127268964167192,0.00588820759143599,0.115728077287977,0.138809851046406,7.71368029695417e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFC,Platelet-derived growth factor C,39477,0.0605396791991836,0.00280562717038875,0.0550406499452217,0.0660387084531456,8.82663401919882e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN2,CCN family member 2,39880,0.121326488277845,0.00562426821118862,0.110302922583915,0.132350053971774,9.2004575456815e-102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSD,Cathepsin D,38721,0.0813817583008364,0.00377281702096205,0.0739870369397507,0.088776479661922,1.2220208916527e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.079735599326965,0.00370046634248704,0.0724826852956904,0.0869885133582396,1.4906437784552e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,39931,0.261604412902876,0.0121519359420222,0.237786618456512,0.28542220734924,2.30079636279089e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBIN,Erbin,39788,0.212467092941124,0.00987498616723312,0.193112120053347,0.231822065828901,3.05294751450422e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.225529281227998,0.0104823095970021,0.204983954417874,0.246074608038122,5.52347191690504e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.171477454784104,0.0079865840506038,0.15582375004492,0.187131159523287,8.34950240049681e-101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0682297314124348,0.00319191204865223,0.0619735837970765,0.0744858790277932,5.52534427696987e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC1,Stanniocalcin-1,40009,0.0861532875244986,0.00403473108118956,0.078245214605367,0.0940613604436301,8.74626132835137e-100
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANG,Angiogenin,39843,0.0693321169099281,0.00324840590409331,0.0629652413379052,0.075698992481951,1.10056506461018e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA5,Integrin alpha-5,39858,0.0509163145425992,0.00238704569340047,0.0462377049835343,0.0555949241016641,1.44279377429094e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F13B,Coagulation factor XIII B chain,37380,0.0523011449307314,0.00244919801889568,0.0475007168136958,0.0571015730477669,1.55108561773392e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,37382,0.176269934741887,0.00826075919853066,0.160078846712767,0.192461022771007,2.16645077013293e-99
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0530060909059094,0.00249536435632654,0.0481151767675093,0.0578970050443094,1.73963409247076e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCR,Breakpoint cluster region protein,39866,0.187382296126038,0.00884241039286395,0.170051171756025,0.204713420496051,2.56460237669702e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.151874277194003,0.00715914471676513,0.137842353549143,0.165906200838862,3.08188955505422e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGF,Placenta growth factor,40058,0.0522934540623891,0.00247442137989826,0.0474435881577885,0.0571433199669897,8.13860663001178e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAXX,Protein PAXX,37124,0.0935073521832107,0.0044188392920812,0.0848464271707315,0.10216827719569,8.94194858613851e-98
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTBDN,Retbindin,39788,0.0594727071583776,0.00281918320481635,0.0539471080769376,0.0649983062398177,1.86728773634972e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.218502000274674,0.0103453789701829,0.198225057493115,0.238778943056232,1.8808523435301e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,37373,0.120560649710522,0.00571866876873003,0.109352058923811,0.131769240497232,4.23178972113424e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,40011,0.0544854849246317,0.00258830610440388,0.0494124049600001,0.0595585648892633,4.52548500867365e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0457714332468562,0.00217761231908424,0.0415033131014511,0.0500395533922613,9.33676327304251e-97
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINH1,Serpin H1,37169,0.259451774902802,0.0123342215579933,0.235276700649135,0.283626849156469,1.16227413755642e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,39868,0.175295603787871,0.00836963238283669,0.158891124317512,0.191700083258231,4.10596587546002e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,37388,0.177733882443768,0.00847649074556787,0.161119960582455,0.194347804305081,4.32336196736926e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A4,Protein S100-A4,39913,0.114555634743593,0.00547309744072296,0.103828363759776,0.12528290572741,5.37289436509849e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.1240309041221,0.00592651950912094,0.112414925884223,0.135646882359977,6.12338204062997e-96
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,39866,0.0811435602162895,0.00389062258398661,0.0735179399516757,0.0887691804809032,2.47374010884804e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP5,Fatty acid-binding protein 5,39972,0.136881332675711,0.00656865807936329,0.124006762840159,0.149755902511263,3.47537319589716e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.0471265788892144,0.00226202921274819,0.0426930016322279,0.0515601561462008,3.9091921280565e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH2,Cadherin-2,39868,0.0702612826084242,0.0033771038894604,0.0636421589850818,0.0768804062317666,6.97329698476136e-95
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.189404562149189,0.00911416536116136,0.171540798041313,0.207268326257065,1.1224993101793e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.169020520628892,0.0081255794549468,0.153094384897196,0.184946656360588,1.26619443634147e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R9B,Neurabin-2,40058,0.189318613652863,0.00911463537816654,0.171453928311657,0.20718329899407,1.35438208676497e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.149553583945927,0.00719441505362962,0.135452530440813,0.163654637451042,1.83807722995933e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,37411,0.128035435449277,0.00616682357271644,0.115948461246753,0.140122409651801,2.78607110462187e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.0637987386170339,0.00307748904879142,0.0577668600814028,0.0698306171526651,3.12666396132526e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMIP,C-Maf-inducing protein,37368,0.165533671573546,0.00797591517065595,0.14990087783906,0.181166465308032,3.29391688095808e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.206955643962984,0.0100005701032605,0.187354526560594,0.226556761365375,6.57951746757059e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0982401599970165,0.00474948873239213,0.0889311620815279,0.107549157912505,8.63108725591162e-94
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0832641432230243,0.00402779880565101,0.0753696575639483,0.0911586288821003,1.07786319819849e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL13,C-C motif chemokine 13,40024,0.136715745461158,0.00662280043583996,0.123735056606912,0.149696434315405,1.7993865107674e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,37021,0.133639015504971,0.00647219799851746,0.120953507427876,0.146324523582065,3.02604793360454e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.167443909243025,0.00813347339737158,0.151502301384177,0.183385517101874,5.80399350177786e-93
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINK1,Misshapen-like kinase 1,37388,0.183853252985657,0.00893543151584044,0.166339807214609,0.201366698756704,1.17925890994476e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD5,Programmed cell death protein 5,40009,0.114769787376497,0.00558608172338134,0.10382106719867,0.125718507554325,1.28277441699716e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0736274225036669,0.00358110299685156,0.0666084606298379,0.080646384377496,1.72205120718072e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCTN3,Tectonic-3,37437,0.0580818434637665,0.00283611508903036,0.052523057889267,0.063640629038266,7.97997881332158e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.202914079668772,0.00990675685464058,0.183496836233677,0.222331323103868,8.24904114205709e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,40052,0.133290062244783,0.0065181663838342,0.120514456132468,0.146065668357098,8.82507725661471e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,40030,0.253964762842213,0.0124194080680228,0.229622723028889,0.278306802655538,8.85463607940441e-92
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,40058,0.149209406749027,0.00730402693987331,0.134893513946875,0.163525299551178,1.33135016632388e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPD52L2,Tumor protein D54,37124,0.214591122507598,0.0105080892965509,0.193995267486358,0.235186977528838,2.71203218865615e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.113945087488567,0.00559063326990372,0.102987446279556,0.124902728697578,3.57044136429219e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLA2,Src-like-adapter 2,37411,0.206774494438151,0.0101364195657216,0.186907112089337,0.226641876786966,3.95267271512229e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.195325763081036,0.00959248492943107,0.176524492619352,0.214127033542721,4.96178371565504e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,39788,0.269441971655919,0.0132489323674005,0.243474064215814,0.295409879096024,8.60437252122435e-91
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.137809086856035,0.00678207871843845,0.124516212567896,0.151101961144175,1.25389459148697e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.063589423936433,0.0031372559473725,0.0574404022795829,0.0697384455932831,3.28466820652406e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BACH1,Transcription regulator protein BACH1,39866,0.144712250574443,0.00713986448388991,0.130718116186019,0.158706384962868,3.31856193370716e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0783413735490471,0.00386258729245906,0.0707707024558274,0.0859120446422669,4.03294205652591e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,39931,0.167232864948601,0.00825622013889217,0.151050673476373,0.18341505642083,4.23438309349437e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AAMDC,Mth938 domain-containing protein,37043,0.104125931260396,0.00514216532280809,0.0940472872276918,0.1142045752931,8.29514392341922e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,39931,0.206918833474967,0.0102362360998738,0.186855810719214,0.22698185623072,9.53374205676788e-90
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPK2,SRSF protein kinase 2,39866,0.163536617602154,0.00809934833687896,0.147661894861871,0.179411340342437,1.51748863732491e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,39993,0.110817307479756,0.0054906814495887,0.100055571838562,0.121579043120949,1.76055522195943e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS9,Galectin-9,39859,0.061124277665801,0.00303540043484091,0.0551748928135128,0.0670736625180892,4.42128685489376e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,39866,0.122406302131803,0.00608843496602981,0.110472969598385,0.134339634665222,8.35634860355864e-89
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,37411,0.221246252022679,0.0110261451768046,0.199635007476142,0.242857496569216,2.81063821276288e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,39866,0.177673355823499,0.00887644436453714,0.160275524869007,0.195071186777992,4.73751565575592e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0848819653647191,0.00424098147507269,0.0765696416735766,0.0931942890558616,4.94470994899337e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLM2,Protein GOLM2,40009,0.0426708275425233,0.0021343310354191,0.0384875387131019,0.0468541163719447,7.36857549773606e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREG1,Protein CREG1,39660,0.0724769512822824,0.00362684780101172,0.0653683295922995,0.0795855729722654,9.29127381958965e-88
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.186626460931338,0.00935436965725581,0.168291896403117,0.20496102545956,1.78094031524665e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,40009,0.128438317062502,0.00643895033392603,0.115817974408007,0.141058659716997,1.79283795110619e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.122818181324604,0.00615752102807066,0.110749440109585,0.134886922539622,2.87043898899509e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.17392724773318,0.00873203733044305,0.156812454565511,0.191042040900848,4.97004970079696e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK2,Docking protein 2,39868,0.235066912819538,0.0118211119071831,0.211897533481459,0.258236292157617,6.09670138523367e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PENK,Proenkephalin-A,37124,0.0558617809018638,0.00280597180736874,0.0503620761594211,0.0613614856443065,6.39445557729837e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USO1,General vesicular transport factor p115,39788,0.171807708864684,0.00864291231671453,0.154867600723923,0.188747817005444,7.05546609482396e-87
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.135446997926475,0.00682752799970921,0.122065043047045,0.148828952805905,1.58438364450751e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.145586060831341,0.00734811528198159,0.131183754878657,0.159988366784025,3.79627556683645e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,39477,0.117002901333797,0.00591374558000322,0.10541195999699,0.128593842670603,4.53957957692621e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.217905726164762,0.0110238294671876,0.196299020409074,0.23951243192045,9.33132532579392e-86
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLK1,Protein delta homolog 1,40052,0.106112691177241,0.0053757474964524,0.0955762260841944,0.116649156270288,1.01071911961165e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,40052,0.0408672953634967,0.00207087783828759,0.036808374800453,0.0449262159265404,1.1103387140957e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.123376193265806,0.00625151124364596,0.11112323122826,0.135629155303352,1.18140313652195e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.147328411745628,0.00745821178863984,0.132710316639894,0.161946506851362,1.18679340404849e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.179826131479076,0.00911931598087025,0.16195227215657,0.197699990801582,1.55002257064802e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,37056,0.151098333354028,0.00766519401772748,0.136074553079283,0.166122113628774,2.83917982869632e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEC31A,Protein transport protein Sec31A,37043,0.146149593750742,0.0074159098989932,0.131614410348715,0.160684777152768,3.11515149083127e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.21456024468201,0.0109123837278619,0.1931719725754,0.235948516788619,4.5870357727649e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,39908,0.098642002668214,0.00501837696241748,0.0888059838218758,0.108478021514552,5.11121510598526e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,39585,0.138993855255863,0.00707169251823164,0.125133337920129,0.152854372591597,5.47882234302945e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,37411,-0.0850362089795438,0.004326170856228,-0.0935155038577507,-0.0765569141013369,7.73772860068548e-85
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0506272208498767,0.00258284630358373,0.0455648420948526,0.0556895996049008,1.48734010461073e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO1,Forkhead box protein O1,39866,0.162380692101468,0.0082873873062201,0.146137412981277,0.17862397122166,1.70664703423451e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.204348347059361,0.0104265205808222,0.183912366720949,0.224784327397772,2.33058471898292e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.101149611910486,0.00516146961754417,0.091033131460099,0.111266092360872,2.51837051024308e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.0956694772173825,0.0048963320694267,0.0860726663613062,0.105266288073459,7.89071874249083e-84
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM1,Isthmin-1,39866,0.0747179024448844,0.00384367148562577,0.0671843063330579,0.0822514985567109,3.27095037968383e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.130081646449255,0.0066847714543982,0.116979494398635,0.143183798499876,3.31646357826916e-83
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,40003,0.0613534037606238,0.00317040640998463,0.055139407197054,0.0675674003241937,1.68711039540925e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP43,Centrosomal protein 43,39476,0.13062114829618,0.00674995091879921,0.117391244495333,0.143851052097026,1.82869981775726e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,39862,-0.0635560094667864,0.00328681365686989,-0.0699981642342514,-0.0571138546993214,2.29456188158266e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEXIM1,Protein HEXIM1,39866,0.152088604725386,0.00787103081770557,0.136661384322683,0.167515825128088,2.99450466537088e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,37411,0.135094509162136,0.0069865709799058,0.12140083004152,0.148788188282751,3.39147382560734e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP10,Stromelysin-2,39857,-0.109347112066622,0.00566217945144154,-0.120444983791448,-0.098249240341797,3.67362798773267e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB3,Plexin-B3,39812,0.0886349855877415,0.00459418374389328,0.0796303854497106,0.0976395857257723,5.29078528890702e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINC1,Antithrombin-III,37424,0.0270573174174479,0.00140269622965592,0.0243080328073223,0.0298066020275735,8.17402482223178e-82
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,39713,0.0436994047706685,0.00227132753784066,0.0392476027965008,0.0481512067448362,1.46570741023943e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.103766289702453,0.00540281113542653,0.0931767798770168,0.114355799527889,2.63992241376371e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.18953702287361,0.00986920866211796,0.170193373895859,0.208880671851362,4.03737229194828e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,37382,0.142025053100693,0.00739526751478908,0.127530328771707,0.15651977742968,4.03955441722646e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0367650689483874,0.00191512940813024,0.0330114153084521,0.0405187225883227,4.65944785593578e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN1,Pantetheinase,37445,0.134042010520454,0.0069828705582657,0.120355584226253,0.147728436814655,4.73023121587291e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS1,Galectin-1,39868,0.0619161674094827,0.003232916405062,0.0555796512555612,0.0682526835634042,7.49033452596468e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0502893898994037,0.00262656074099801,0.0451413308470476,0.0554374489517598,8.69825185674423e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.124369625514401,0.00649818355952283,0.111633185737737,0.137106065291066,9.98236315994831e-81
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BID,BH3-interacting domain death agonist,39866,0.121954468097615,0.00637807326505699,0.109453444498103,0.134455491697127,1.337808431266e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.141266396756976,0.00739924611922491,0.126763874363296,0.155768919150657,2.3214938954219e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.167148058311516,0.00876240229237958,0.149973749818452,0.18432236680458,4.52166214335134e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXN,Paxillin,39489,0.095030322697493,0.00499053481702654,0.085248874456121,0.104811770938865,6.1302398114355e-80
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNMBP,Dynamin-binding protein,39749,0.113684168973306,0.00598353019252964,0.101956449795948,0.125411888150664,1.31187071539235e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELE,E-selectin,40052,0.0911956541954817,0.00480436120554308,0.0817791062326172,0.100612202158346,1.7561034101232e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,37437,0.165900889186184,0.00873323486961375,0.148783748841742,0.183018029530627,1.94890546574282e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGFR,Opioid growth factor receptor,39788,0.0597256187530041,0.00315151621111518,0.0535486469792183,0.0659025905267898,3.19626876714038e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGLN1,Egl nine homolog 1,39866,0.0974753330683483,0.00514590915599583,0.0873893511225965,0.1075613150141,3.74860005085722e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.127899140665792,0.00674452606284506,0.114679869582615,0.141118411748968,3.85754363735031e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBPL,FK506-binding protein-like,37382,0.108817476176657,0.00574019285638182,0.0975666981781486,0.120068254175165,4.08291082347469e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0923548949278033,0.00487623674022279,0.0827974709169666,0.10191231893864,4.11757973224433e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAG1,Dystroglycan,39931,0.0885040675455138,0.00468486273362457,0.0793217365876097,0.097686398503418,9.54567047580342e-79
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.203828387017507,0.0108085407554501,0.182643647136825,0.225013126898189,1.81954900711492e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX2,Heme oxygenase 2,39489,0.0860645475268651,0.0045651949871237,0.0771167653521027,0.0950123297016276,2.08122681197435e-78
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMN,Protein amnionless,39587,0.0862195556081514,0.00460021474100649,0.0772031347157787,0.0952359765005242,1.55696258358537e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH2,Neutral ceramidase,39749,0.0945841655750385,0.00505533854369005,0.084675702029406,0.104492629120671,2.78682250323352e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,39859,0.171000165329819,0.00914727265352711,0.153071510928906,0.188928819730732,3.66592497164088e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EREG,Proepiregulin,39713,0.143999903912955,0.00770576455239803,0.128896605390255,0.159103202435656,4.22621306009817e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,37445,0.0480794416194399,0.00257074523884897,0.0430407809512959,0.0531181022875839,4.3743771461122e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT2,Omega-amidase NIT2,37377,0.135953628130257,0.00726984142846944,0.121704738930457,0.150202517330057,4.54462265877061e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,37437,0.130246581401651,0.00696695406470974,0.11659135143482,0.143901811368482,5.03474099240487e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THPO,Thrombopoietin,39585,0.0687634216245967,0.00368200251764931,0.061546696690004,0.0759801465591894,5.32217188675369e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,37124,0.140516429408847,0.00751978089516307,0.125777658854328,0.155255199963367,6.21080159151626e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTDH,Protein LYRIC,37056,0.166826869060912,0.00892907955785908,0.149325873127509,0.184327864994316,6.59933465114866e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.112831776004113,0.00604044998121211,0.100992494040937,0.124671057967289,6.74133113862564e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.154196794326436,0.00825691283242033,0.138013245174892,0.17038034347798,7.78794596508033e-77
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COCH,Cochlin,37437,0.0822229357000501,0.0044083870194586,0.0735824971419113,0.090863374258189,1.11263954643241e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,39788,0.152135154458075,0.00816524154237733,0.136131281035016,0.168139027881135,1.1521765229947e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.118237139868994,0.00634097923973325,0.105808820559116,0.130665459178871,1.2231988044027e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,37382,0.173324918051058,0.00929779466443142,0.155101240508772,0.191548595593343,1.34623518830198e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.18712932126022,0.0100493130335549,0.167432667714452,0.206825974805987,1.38436609815527e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.110520135413721,0.00593992436346686,0.0988778836613255,0.122162387166116,1.82726689051498e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QDPR,Dihydropteridine reductase,39790,0.0780778270321543,0.00419668365305667,0.0698523270721632,0.0863033269921454,1.9004097221609e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,39738,0.0663228874057508,0.00356702335686353,0.0593315216262983,0.0733142531852033,2.35016542106838e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNST,Consortin,39868,0.193798048980785,0.0104239900803064,0.173367028423384,0.214229069538185,2.39267943113437e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC4,Syndecan-4,39868,0.0813762510306704,0.00437815847204735,0.0727950604254576,0.0899574416358832,2.60574478945693e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,37411,0.137319287711424,0.00738838330540932,0.122838056432821,0.151800518990026,3.69131266166682e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXT,Oxytocin-neurophysin 1,40009,0.248412797275233,0.0133846449188847,0.222178893234219,0.274646701316247,4.22178220980673e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0548548329439602,0.00295443317950664,0.0490641439121272,0.0606455219757932,5.2205927105537e-76
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC13,Mucin-13,39489,0.0903814369618131,0.00489254775465703,0.0807920433626853,0.0999708305609408,2.14831218864461e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2B3,SH2B adapter protein 3,39477,0.175459957190181,0.00951781151967896,0.15680504661161,0.194114867768752,4.31145532335318e-75
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,39585,0.134744536132065,0.00733491461782468,0.120368103481129,0.149120968783001,1.36841573135991e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNCG,Gamma-synuclein,39749,0.114925944475436,0.00627316608355719,0.102630538951664,0.127221349999208,3.31060795734062e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIAE,Sialate O-acetylesterase,39875,0.0833920097292319,0.00455813453324612,0.0744580660440695,0.0923259534143943,5.12354013457025e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1S,Complement C1s subcomponent,37453,0.0369567424200222,0.0020198672764848,0.032997802558112,0.0409156822819324,6.77167416029645e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.128373743500527,0.00702190735651889,0.11461080508175,0.142136681919304,8.92647562065054e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.11251735856112,0.00615996748535906,0.100443822289816,0.124590894832424,9.05654418753104e-74
NMR metabolomics,X23495.Concentration of Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,37453,0.0301092450866375,0.00164833999031953,0.0268784987056112,0.0333399914676638,1.16285843803069e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C3,Complement C3,36816,0.0812306192847739,0.0044473897968507,0.0725137352829465,0.0899475032866013,1.32019461871217e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD36,Platelet glycoprotein 4,37056,0.0805222183654574,0.00441308878347443,0.0718725643498475,0.0891718723810673,1.77042698324293e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP2,Methionine aminopeptidase 2,40011,0.101563163054381,0.00557616256953876,0.0906338844180849,0.112492441690677,2.17494465990754e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,39489,0.150056142136586,0.00824145678496838,0.133902886838047,0.166209397435124,2.57521601112305e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,37056,0.171766349789123,0.00942737526020053,0.15328869427913,0.190244005299116,2.82884003657593e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.10780577660485,0.00592648367045807,0.0961898686107525,0.119421684598948,3.35828274272041e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0514874085278501,0.00283306361819614,0.0459346038361856,0.0570402132195145,4.50968736185718e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CES2,Cocaine esterase,39788,0.0948550091509586,0.00522419076142726,0.0846155952585612,0.105094423043356,6.15712338972617e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,39830,0.0343464182773922,0.00189429375460121,0.0306336025183738,0.0380592340364106,9.63595022783054e-73
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,37411,0.0970529697350861,0.00534958119744839,0.0865677905880872,0.107538148882085,1.07127460434529e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,39866,0.0989586695573306,0.00546184863533851,0.0882534462320671,0.109663892882594,1.21780425905474e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.17745404119678,0.00979716299520996,0.158251601726169,0.196656480667392,1.33988106763411e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0489584681651824,0.00270330823944333,0.0436599840158734,0.0542569523144913,1.40524789043952e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,39931,0.226553508817808,0.0125190591549162,0.202016152874173,0.251090864761444,1.77293637365722e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,37056,0.154719190025467,0.00854194592581872,0.137976976010862,0.171461404040072,1.89801106443155e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.180152558716653,0.00995793487065186,0.160635006370175,0.19967011106313,1.94020505084776e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,37388,0.110182080543838,0.00608861234603375,0.0982484003456116,0.122115760742064,2.4200891342198e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0878686016373478,0.00486846452956874,0.078326411159393,0.0974107921153025,4.2022161356814e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.184964921893688,0.0102494552005476,0.164875989700614,0.205053854086761,6.06168320385209e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0780989173552445,0.00433665022366671,0.0695990829168578,0.0865987517936313,8.52127137838421e-72
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSNL1,Visinin-like protein 1,37388,0.0655777948025945,0.00364514921375371,0.0584333023436372,0.0727222872615517,1.57525385525219e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,39866,0.149806102624904,0.00833505507055478,0.133469394686617,0.166142810563191,1.59887653458644e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,39585,0.0597595798278264,0.00332602839969229,0.0532405641644295,0.0662785954912233,1.82165438710645e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYDGF,Myeloid-derived growth factor,37437,0.175596040604987,0.0097752933166033,0.156436465704445,0.19475561550553,2.5251077594565e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,39585,0.0843497338733286,0.00470073380761123,0.0751362956104106,0.0935631721362466,2.74819012364778e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,37411,0.131243363543831,0.00731072443316508,0.116914343654827,0.145572383432834,3.07969913400682e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSB,Arylsulfatase B,39788,0.0956609777607617,0.00533459236664044,0.0852051767221464,0.106116778799377,3.31217763864117e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.150440267438039,0.00839865398288348,0.133978905631587,0.166901629244491,4.63776992024812e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX15,Sorting nexin-15,37124,0.0932797806563078,0.00520517087685749,0.0830776457376672,0.103481915574949,5.58344270620645e-71
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.138660698746421,0.0077564161018087,0.123458123186876,0.153863274305966,1.15429781694443e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR,GMP reductase 1,40058,0.0855814206001164,0.0047923509118778,0.0761884128128359,0.0949744283873969,1.19246918437897e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,39788,0.0610494659453709,0.00342019123455684,0.0543458911256395,0.0677530407651023,1.41345620789896e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2,Prothrombin,37453,0.0253249431746932,0.00141762457413732,0.0225463990093841,0.0281034873400023,1.42997406382644e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.162364187761327,0.00910269160262294,0.144522912220186,0.180205463302468,1.80472621426033e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0483446817146258,0.00271177691241116,0.0430295989662999,0.0536597644629517,2.0648360348921e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAMBP,STAM-binding protein,39713,0.110916489148052,0.00622180993508417,0.0987217416752867,0.123111236620817,2.11960845944851e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.129366515921515,0.00725722064314048,0.11514236346096,0.14359066838207,2.13044553952566e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.053822576406157,0.00301883612754025,0.0479056575961781,0.0597394952161359,2.81191917878029e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MITD1,MIT domain-containing protein 1,39749,0.167102995054292,0.00938922247808156,0.148700118997252,0.185505871111332,3.55528564932034e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDUA,Alpha-L-iduronidase,40030,0.0788850129269097,0.00443307602368711,0.070196183920483,0.0875738419333365,3.62689954012442e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0652652612744981,0.00366798498634786,0.0580760107012563,0.0724545118477399,3.75351976250672e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0940365474717511,0.00528760026480107,0.083672850952741,0.104400243990761,4.41080902022405e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRAP,BRCA1-associated protein,37249,0.189313829522071,0.0106395838400152,0.168460245195642,0.210167413848501,5.08292897723892e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D23,TBC1 domain family member 23,39788,0.154452328057556,0.00869302474732257,0.137413999552804,0.171490656562309,5.97876880474391e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC5,Glypican-5,39749,0.0959373832642238,0.00540241890394129,0.0853486422124989,0.106526124315949,7.04275715496169e-70
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,39866,0.0568475131206506,0.00320596345160562,0.0505638247555036,0.0631312014857977,1.10462051214963e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.152566783229403,0.00860508652214502,0.135700813645999,0.169432752812808,1.50857940804943e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,37021,0.0732168324322828,0.00413104522035008,0.0651199838003966,0.0813136810641689,1.7666067274464e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0474471204690365,0.00267929974809351,0.0421956929627732,0.0526985479752998,2.25138630857586e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.102530328983594,0.00579601582361167,0.0911701379693153,0.113890519997873,2.26775224431536e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.123452313137898,0.00697144935860967,0.109788272395023,0.137116353880773,2.27123225886776e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.182279467625272,0.0102986345495479,0.162094143908158,0.202464791342386,2.55055820833755e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0503682134473777,0.00284946558552863,0.0447832608997415,0.0559531659950138,2.90048787512034e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,39858,0.0881870638179661,0.0049899335658956,0.0784067940288107,0.0979673336071215,3.07888495217812e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.101878299511357,0.00576125204151244,0.090586245509993,0.113170353512722,3.38043692272045e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,40009,0.110963858159853,0.00628185937562174,0.0986514137836347,0.123276302536072,3.53934882464659e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C19orf12,Protein C19orf12,39489,0.110846452436428,0.00627784412726764,0.0985418779469835,0.123151026925873,4.22797456929218e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASHC3,WASH complex subunit 3,37388,0.129291977699646,0.00731918660321409,0.114946371957346,0.143637583441946,4.65928578807601e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.209791687037091,0.011885107218147,0.186496876889523,0.23308649718466,4.67399581606567e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL11,Eotaxin,40058,0.0649855758325987,0.00368702579585408,0.0577590052727247,0.0722121463924727,6.90050589146905e-69
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0490427550698238,0.00278621503083686,0.0435817736093835,0.054503736530264,1.03795458644819e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0590716545926095,0.00335720006449695,-0.0656517667190235,-0.0524915424661955,1.18034233458477e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0806448106544582,0.00457937355258659,0.0716692384913885,0.0896203828175279,1.19385761535125e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.116356671487579,0.0066258390772709,0.103370026896128,0.12934331607903,2.11524710864784e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCC,Tubulin-specific chaperone C,39749,0.137940794009726,0.0078568657468654,0.12254133714587,0.153340250873582,2.33398768378032e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL7,C-C motif chemokine 7,39866,0.0987448689700996,0.00563096500687952,0.0877081775566157,0.109781560383583,3.29990814467903e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0974817729204429,0.00555489819247852,0.086594172463185,0.108369373377701,3.61994971521514e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GLB2,Endophilin-B2,37388,0.112019077150484,0.00639049848943668,0.0994937001111878,0.12454445418978,4.8544812490016e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,37411,0.202622509332928,0.0115618256307441,0.179961331096669,0.225283687569186,5.1738155751473e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.197805766175623,0.0112984530359734,0.175660798225116,0.219950734126131,5.45329187119712e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0900474646018505,0.00514331376132788,0.0799665696296478,0.100128359574053,7.00911362444126e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0859355183450337,0.00491445585078213,0.0763031848775007,0.0955678518125666,8.06530359534859e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD1,COMM domain-containing protein 1,37043,0.104708455487527,0.00598585723961203,0.0929761752978872,0.116440735677166,9.47611668780119e-68
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,37124,0.139849042722205,0.00800117302214537,0.1241667435988,0.15553134184561,1.19355287963127e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS8,Galectin-8,40009,0.103151890742845,0.00591447082572296,0.0915595279244285,0.114744253561262,1.68551009843887e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.185574895330955,0.0106421514892611,0.164716278412003,0.206433512249907,1.78282881172982e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.085113893425663,0.00487990893846838,0.0755492719062649,0.094678514945061,2.1722686372784e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,39788,0.100153646958968,0.00576229345569791,0.0888595517857998,0.111447742132136,4.78476570502965e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.0966272665541508,0.00556031223588198,0.0857290545718222,0.10752547853648,4.93978335227779e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TALDO1,Transaldolase,37415,0.0750965621777295,0.004320373970223,0.0666286291960924,0.0835644951593666,6.00404278591452e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM13A,Protein FAM13A,37382,0.113754853519413,0.00654643107689953,0.10092384860869,0.126585858430136,6.60272512889797e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEFTY2,Left-right determination factor 2,40011,0.0894774639428521,0.00515684657639719,0.0793700446531136,0.0995848832325906,7.79475946138142e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPHN1,Oligophrenin-1,37388,0.181052661908482,0.0104299570357551,0.160609946118402,0.201495377698562,8.92340117815985e-67
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,37437,0.137150061075744,0.00792176285327492,0.121623405883326,0.152676716268163,1.93502172582917e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRKL,Crk-like protein,39881,0.17898216197288,0.0103501970235511,0.15869577580672,0.19926854813904,2.14071342647881e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDHD2,Phospholipase DDHD2,37411,0.111413483423375,0.00644580910231931,0.0987796975828289,0.124047269263921,3.14581502667584e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.139909928029637,0.00809722651762807,0.124039364055086,0.155780492004188,3.49436575822581e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.246069508991669,0.0142518643331195,0.218135854898754,0.274003163084583,4.34662243787966e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.0444972872383063,0.00257997226438039,0.0394405416001207,0.0495540328764918,4.63540820884006e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.154454296485334,0.00895956772873329,-0.172015049233651,-0.136893543737017,5.33234016334422e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.151919753355151,0.00880746562671466,0.13465712072679,0.169182385983512,6.01093592717857e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAX,Protein max,39489,0.175596826235857,0.0102001504402749,0.155604531372918,0.195589121098796,8.26697517650103e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.130257730075004,0.00756756524550502,0.115425302193814,0.145090157956194,8.63210626149524e-66
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0660175843236058,0.00384161455320338,0.0584880197993272,0.0735471488478844,1.36860285994914e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0547151860821514,0.00318090889155433,0.0484806046547049,0.0609497675095979,1.38559541486248e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,39858,0.0400209604309275,0.00233080532061341,0.0354525820025252,0.0445893388593298,1.70675752461112e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.0896584226954746,0.00522452287687206,0.0794183578568053,0.0998984875341438,2.01816266917953e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,39858,0.0872353578275502,0.00508501609567517,0.0772687262800269,0.0972019893750736,2.20205520743589e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.0946108173318576,0.00551273553566691,0.0838058556819505,0.105415778981765,2.50571263941961e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,39866,0.092541439948034,0.00539807152413962,0.0819612197607203,0.103121660135348,2.69291813627734e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL4,C-C motif chemokine 4,39882,0.1032936474887,0.00602968112247521,0.0914754724886489,0.115111822488752,3.32482935349502e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,40052,0.0665627994903758,0.00388989486732005,0.0589386055504285,0.0741869934303231,4.52922483446108e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBNL,Drebrin-like protein,39931,0.153781445594062,0.00899990030103883,0.136141641004026,0.171421250184099,6.93551727188288e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,37411,0.12833689003392,0.00750449143130138,0.113628086828569,0.143045693239271,6.94457456518308e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,37056,0.130237260079371,0.00761606998943054,0.115309762900087,0.145164757258655,7.36411816706913e-65
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IST1,IST1 homolog,37287,0.164613424842163,0.0096484390467554,0.145702484310522,0.183524365373803,1.38258601086655e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.119741611951026,0.00702909349399338,0.105964588702799,0.133518635199253,1.66156068146544e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGA,Protein O-GlcNAcase,37382,0.117273418391693,0.0068800017715858,0.103788614919384,0.130758221864001,1.77597313312864e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,39866,0.0615754470840468,0.00361558409201449,0.0544889022636984,0.0686619919043952,1.80102907041366e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,37043,0.150783805929668,0.00884927022009421,0.133439236298283,0.168128375561053,2.05681698955355e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK10,Kallikrein-10,39856,0.0648310983491144,0.00381020027703021,0.0573631058061352,0.0722990908920936,2.33487097177183e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,37056,0.0821868936298747,0.00482654600333501,0.0727268634633381,0.0916469237964113,2.46952067170745e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.102710656096228,0.00603846285504509,0.0908752689003401,0.114546043292117,3.38891827609812e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",39585,0.153103287601319,0.00903009088232203,0.135404309471968,0.17080226573067,6.55503098699622e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTPBP2,GTP-binding protein 2,37039,0.13262626316738,0.00781715940047945,0.11730463074244,0.147947895592319,6.97053094097228e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,40034,0.0380864475433725,0.00224721079080834,0.0336819143933882,0.0424909806933569,7.04623903222138e-64
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM2,Paralemmin-2,37388,0.0618548959344042,0.00365656386333111,0.0546880307622752,0.0690217611065331,1.53781608922335e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.136249198015458,0.00806751838051291,0.120436861989653,0.152061534041263,1.93239395307643e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOA,Elongin-A,39788,0.0833776084788009,0.00493864005570829,0.0736978739696126,0.0930573429879891,2.14549405094478e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RB,Interleukin-17 receptor B,39644,-0.0879248512848235,0.00520929478303505,-0.0981350690595722,-0.0777146335100748,2.32921548816931e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OCLN,Occludin,37411,0.0700264201662784,0.00414785711816922,0.0618966202146667,0.0781562201178901,2.67895037993976e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.075962786855775,0.0045058555672859,0.0671313099438947,0.0847942637676554,3.18192763978331e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.138791959269493,0.00823359944648167,0.122654104354388,0.154929814184597,3.38517569432006e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,37056,0.0892167519034695,0.005298333911395,0.0788320174371353,0.0996014863698037,5.76717806729106e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,39892,0.0572308776089009,0.00340586155656484,0.0505553889580338,0.063906366259768,7.91177619097449e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLG,Plasminogen,37162,0.0367838393250515,0.00218743800271517,0.0324964608397298,0.0410712178103732,8.29436229438379e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,39913,0.0552632171421086,0.00328969311503545,0.0488154186366391,0.0617110156475781,8.54513295065148e-63
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL18,C-C motif chemokine 18,39715,0.114681777989251,0.0068303643011067,0.101294263959082,0.12806929201942,1.00545521276449e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.126572010204765,0.0075449291019864,0.111783949164872,0.141360071244658,1.56716187805632e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD22,B-cell receptor CD22,40058,0.0650023686628355,0.00387818937514907,0.0574011174875433,0.0726036198381277,1.58241327158638e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUS,RNA-binding protein FUS,39455,0.0636653646331437,0.0037984053351708,0.0562204901762089,0.0711102390900784,1.65561475415469e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0946466630697722,0.0056432737060575,0.0835858466058995,0.105707479533645,1.73186432039813e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0691167191878149,0.00412910240696552,0.0610236784701625,0.0772097599054673,2.28733927804014e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA11,Annexin A11,39829,0.10808558926761,0.00646345937623501,0.0954172088901895,0.120753969645031,3.03735164972239e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIP,Gastric inhibitory polypeptide,37043,0.0702363263095089,0.00421391089937911,0.0619770609467259,0.078495591672292,9.62764076962733e-62
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY4,Protein canopy homolog 4,39788,0.121574615039644,0.00731322039229738,0.107240703070741,0.135908527008547,1.54220475494491e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1A,Meprin A subunit alpha,37382,0.115117746035482,0.00692060686474493,0.101553356580582,0.128682135490382,1.6120830537954e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,40052,0.115349084370243,0.00694899281122608,0.10172905846024,0.128969110280246,2.26249883046765e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0728161269314204,0.00438609269661383,0.0642193852460573,0.0814128686167835,2.27729593991411e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS6,Growth arrest-specific protein 6,39947,-0.0410050001184949,0.00247071883624568,-0.0458476090375365,-0.0361623911994534,2.39485966856887e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASC3,Protein CASC3,37039,0.0673349563184857,0.00405400171677729,0.0593891129536022,0.0752807996833692,2.49615968380489e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,39868,0.129481624240314,0.00780918407336679,0.114175623456515,0.144787625024113,3.11429845073686e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILPL2,RILP-like protein 2,37437,0.158327552745496,0.00954566631358448,0.13961804677087,0.177037058720121,3.4960880129573e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.117347618183072,0.00708230851794576,0.103466293487899,0.131228942878246,3.7632918710292e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.108627865086743,0.0065535364146285,0.0957829337140712,0.121472796459415,4.18523051274718e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,39477,0.148355168623421,0.00896004137192913,0.13079348753444,0.165916849712402,4.68933244438473e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.123540176540932,0.00746493364723486,-0.138171446489512,-0.108908906592352,5.17828364120597e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.108917354556315,0.00658554568039446,0.0960096850227414,0.121825024089888,7.82319574627469e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.119503979395863,0.00723430435040041,0.105324742869078,0.133683215922647,8.58602531999124e-61
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0555672056532514,0.00336674524337751,0.0489683849762315,0.0621660263302713,1.07612197384771e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,39931,-0.052151974449278,0.00316109936152343,-0.0583477291978639,-0.0459562197006921,1.19435487985392e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0424473869406135,0.00257475938717976,0.0374008585417412,0.0474939153394858,1.46156843041314e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.137881063345125,0.00836019652110146,0.121495078163766,0.154267048526484,1.66533751733305e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.125202529733035,0.00760822418575731,0.11029041032895,0.140114649137119,2.38909369894306e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPART,Spartin,37124,0.124141363576387,0.00755340020173511,0.109336699180986,0.138946027971788,4.20296279944413e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TWF2,Twinfilin-2,37437,0.134207615328063,0.00817704368619568,0.11818060970312,0.150234620953007,5.85484303328948e-60
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YJU2,Splicing factor YJU2,37368,0.0514344968891052,0.00314177899957063,0.0452766100499467,0.0575923837282636,1.15296975149852e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.108550662530307,0.00663102552233775,0.0955538525065252,0.121547472554089,1.21087468703938e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18,Interleukin-18,39795,0.0719991056665476,0.00440817534598509,0.0633590819884168,0.0806391293446784,1.7462368868204e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0447936424291643,0.00274331460307655,0.0394167458071342,0.0501705390511943,1.89084293249985e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD207,C-type lectin domain family 4 member K,39496,0.0593923515117141,0.00363790755856233,0.052262052696932,0.0665226503264963,2.00020898259551e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0764492485758917,0.00468040454196801,0.0672756556736345,0.085622841478149,2.09951584460632e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2,Microtubule-associated protein 2,37388,0.072727722953158,0.00445285711178721,0.0640001230140551,0.081455322892261,2.13205525766153e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.088380500855526,0.00541743872858449,0.0777623209475004,0.0989986807635516,2.33802325452779e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,39749,0.125738298119552,0.00770719591374316,0.110632194128616,0.140844402110489,2.36720782133167e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4D,Semaphorin-4D,40009,0.0471692864689049,0.00289892961831319,0.041487384417011,0.0528511885207987,4.65474686763279e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NIT1,Deaminated glutathione amidase,37043,0.074180148459803,0.00455725577554976,0.0652479271397255,0.0831123697798806,5.3677544220666e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0891167005009942,0.0054808380089898,0.0783742580033742,0.0998591429986142,5.6672085346014e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,39826,0.101764250516069,0.00626996111843598,0.0894751267239346,0.114053374308204,9.07369804689035e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPBP,Platelet basic protein,37371,0.133552400372717,0.00822306460554332,0.117435193745852,0.149669606999582,9.27917821879451e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD69,Early activation antigen CD69,39785,0.137977054639582,0.0085041319198589,0.121308956076658,0.154645153202505,9.97467133222263e-59
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSZ,Cathepsin Z,39865,0.0486449911461879,0.00299965540805439,0.0427656665464013,0.0545243157459745,1.12503714766883e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICA1,Islet cell autoantigen 1,39587,0.125837615824769,0.00776422899804213,0.110619726988607,0.141055504660932,1.33478769958502e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RWDD1,RWD domain-containing protein 1,40009,0.100075795646022,0.00618034203887395,0.0879623252498288,0.112189266042215,1.64319142770059e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOT,Angiomotin,37124,0.0648145211821643,0.00399943682917079,0.0569756249969895,0.072653417367339,1.66883808686944e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRY2,Protein sprouty homolog 2,39587,0.145190097229008,0.00896631503573215,0.127616119758973,0.162764074699043,1.68361865965199e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.113840639780477,0.00702887828461311,0.100064038342635,0.127617241218318,1.96658453471372e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOK1,Docking protein 1,37388,0.214858708282825,0.0132751496285476,0.188839415010872,0.240878001554778,2.27099253500699e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,40009,0.0456951494638663,0.00282583334150385,0.0401565161145187,0.0512337828132138,2.33915053007187e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD2,Polycystin-2,37021,0.09323025099115,0.00576371114655655,0.0819333771438991,0.104527124838401,2.74158553169049e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST13,Hsc70-interacting protein,37124,0.0865495016776557,0.00535118735665622,0.0760611744586095,0.0970378288967018,2.78008141551269e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,39489,0.0973595330127662,0.00602665098985301,0.0855472970726543,0.109171768952878,3.10992494873646e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,37437,0.041310318960483,0.00255754119912723,0.0362975382101937,0.0463230997107724,3.80380443790205e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG2,Secretogranin-2,39949,0.0485007368319903,0.00301140474982401,0.0425983835223352,0.0544030901416453,6.5994951506531e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.123084026201922,0.00764288138250187,0.108103978692219,0.138064073711626,6.93519470447794e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.133189393276158,0.00826694968966231,0.11698617188442,0.149392614667896,7.37613655233108e-58
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNMT,Histamine N-methyltransferase,39669,0.0718591109658283,0.00447485558800159,0.0630883940133452,0.0806298279183114,1.42393581413032e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,37411,0.0937008588050213,0.00583909123420103,0.0822562399859873,0.105145477624055,2.02167761321e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2,Complement C2,39908,0.0366623205202202,0.0022864769259062,0.032180825745444,0.0411438152949963,2.05144885547883e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,40030,0.0577658901835011,0.00360600143675624,0.0506981273674589,0.0648336529995434,2.58331161359085e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.137323406139577,0.00858238366875317,0.120501934148821,0.154144878130333,3.52928221159656e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0694552040216423,0.00434294696520737,0.0609430279698359,0.0779673800734488,4.81074542529349e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0970150653769011,0.00606997090772869,0.0851179223977529,0.108912208356049,5.58265097114558e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,39866,0.109792144316672,0.00687504655086293,0.0963170530769805,0.123267235556363,5.72641961078319e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPP,Lipoma-preferred partner,37021,0.10380142060926,0.00649527566674322,0.091070680302443,0.116532160916076,5.94090711642175e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS2,Trypsin-2,39931,0.0792970681925017,0.00496742784114182,0.0695609096238637,0.0890332267611397,6.29455254323001e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESYT2,Extended synaptotagmin-2,37388,0.127205696106378,0.00796809029757407,0.111588239123133,0.142823153089624,7.47278364675457e-57
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PF4,Platelet factor 4,37385,0.148932009882584,0.00934482060165311,0.130616161503344,0.167247858261824,1.14267587051248e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGF,Pro-epidermal growth factor,39808,0.15983387517763,0.0100374444730129,0.140160484010525,0.179507266344736,1.18456137669909e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT1,Angiopoietin-1,39794,0.129977460936483,0.00816654810196751,0.113971026656626,0.145983895216339,1.34298544396018e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBKS,Ribokinase,39504,0.0761552606004511,0.00479383287917769,0.0667593481572628,0.0855511730436394,2.18287740124379e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0764891634423254,0.00481655667792836,0.0670487123535858,0.085929614531065,2.84202494244019e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0456981917987691,0.00288125820625659,0.0400509257145062,0.051345457883032,3.22106576666857e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM17,Splicing factor 45,37411,0.117451527316118,0.00741201299498963,0.102923981845938,0.131979072786297,4.76265225455865e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0483323108573079,0.00305348201249914,0.0423474861128096,0.0543171356018062,5.27998541250511e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.160502174600262,0.0101429955364084,0.140621903348902,0.180382445851623,5.65123578505981e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN3,Centrin-3,37382,0.121024146298649,0.00764486464812876,0.106040211588317,0.136008081008982,6.06499963830856e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.117782883485048,0.00744691743312101,0.103186925316131,0.132378841653965,6.52075721705521e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARC,SPARC,39913,0.107897175078102,0.00682857704722755,0.0945131640655362,0.121281186090668,8.087723000274e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.147381377937728,0.00933409433997997,0.129086553031367,0.165676202844089,9.66865816813548e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD226,CD226 antigen,37056,0.0641424478737141,0.00405929347453252,0.0561862326636304,0.0720986630837979,9.86319817293788e-56
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSS,Cathepsin S,36543,0.0373598897754584,0.00236686966942961,0.0327208252233764,0.0419989543275405,1.34373625208504e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0498280757955162,0.00316100166200001,0.0436325125379962,0.0560236390530362,1.4545689787752e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0726739861269551,0.00461634893949118,0.0636259422055523,0.0817220300483578,2.38127824887798e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD72,B-cell differentiation antigen CD72,37124,0.0632874929085185,0.00402065477360733,0.0554070095522482,0.0711679762647889,2.52205856134571e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0850447650458919,0.00540963641186335,0.0744418776786397,0.095647652413144,2.86209005525808e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0895666939892138,0.00571024366374553,0.0783746164082726,0.100758771570155,5.01809828515274e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CETN2,Centrin-2,39489,0.102811813498647,0.0065634574401257,0.0899474369160008,0.115676190081293,6.93827182839541e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX8,Syntaxin-8,39866,0.0739485272193052,0.00472183263956337,0.064693735245761,0.0832033191928494,7.13996444785318e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP7,Matrilysin,39563,0.0749554359402318,0.00479045591968235,0.0655661423376544,0.0843447295428092,9.0488994907641e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,37124,0.191903885203453,0.0122601721440366,0.167873947801142,0.215933822605765,9.83699606346757e-55
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOC1,Apolipoprotein C-I,37424,0.0566847953744555,0.00362407767880844,0.0495816031239909,0.06378798762492,1.14545694443933e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,39868,0.194331761975798,0.0124345870105669,0.169959971435087,0.21870355251651,1.18321713306983e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0827128061954876,0.0052938593653757,0.0723368418393512,0.0930887705516239,1.26512456964394e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPSE,Heparanase,37306,0.142391349667164,0.00910760106618419,0.124540451577443,0.160242247756885,1.28472187478752e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0886099162678534,0.00567416692863824,0.0774885490877225,0.0997312834479844,1.7298223965013e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.128754436709505,0.00826434838230812,0.112556313880181,0.144952559538829,2.57140803952659e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRAS,Ras-related protein R-Ras,37039,0.198729318833289,0.0127475880526395,0.173744046250115,0.223714591416462,2.61662338905713e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53,Cellular tumor antigen p53,39477,0.066589472919686,0.00427864111033505,0.0582033363434293,0.0749756094959427,3.30354507521252e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RFC4,Replication factor C subunit 4,37368,0.0322096989844571,0.0020693303821441,0.0281538114354547,0.0362655865334596,3.69944446388656e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLB1,Beta-galactosidase,39749,0.0635051331144894,0.00408271687212814,0.0555030080451182,0.0715072581838605,3.71175958902306e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLG4,Disks large homolog 4,37388,0.107990798130395,0.00693982015455604,0.0943887506274649,0.121592845633325,3.94197498263663e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDC,Nuclear migration protein nudC,40058,0.0968062873709883,0.00623095631793417,0.0845936129878373,0.109018961754139,4.83216605754328e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.10188514901839,0.00655638284246949,0.0890346386471499,0.11473565938963,5.62043229876165e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA2,Apolipoprotein A-II,37445,-0.0716061251029382,0.00461025836490972,-0.0806422314981613,-0.0625700187077152,6.13440613127382e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0657764810554805,0.0042351753467812,0.0574755373757893,0.0740774247351716,6.36088466605517e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL3,C-C motif chemokine 3,39866,0.0943274529014527,0.00607820858244388,0.0824141640798627,0.106240741723043,6.37926179089264e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0584943847535256,0.00376758468808726,0.0511099187648746,0.0658788507421766,6.92112578324264e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,39866,0.126513259504101,0.00815781846125034,0.11052393532005,0.142502583688152,7.52167097995856e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.115485865404491,0.00744516577805384,0.100893340479505,0.130078390329476,8.65486419672598e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AP2B1,AP-2 complex subunit beta,37039,0.0736581870077842,0.00474910428116455,0.0643499426167017,0.0829664313988668,8.87385283870438e-54
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMPR2,GMP reductase 2,37124,0.100533471764121,0.00649410639365539,0.0878050232325568,0.113261920295686,1.37665234979414e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBXN1,UBX domain-containing protein 1,37124,0.104006888341531,0.00672513599418997,0.0908256217929182,0.117188154890143,1.73950327900834e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0891448803550705,0.00577001196255401,0.0778356569084646,0.100454103801676,1.87235419680603e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFB,Complement factor B,37220,0.0493069105056368,0.00319509077059799,0.0430445325952647,0.0555692884160089,2.86811300464075e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0476628590563923,0.00309126499202844,0.0416039796720166,0.0537217384407681,2.94339285569212e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMA,Granzyme A,40058,0.0503976850005152,0.00327323100465264,0.043982152231396,0.0568132177696344,4.08176353775491e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTNB,Dystrobrevin beta,37348,0.0656079230612197,0.00425800814728418,0.0572622270925427,0.0739536190298967,4.08899584368555e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATOX1,Copper transport protein ATOX1,39913,0.108506455565327,0.00705205003478512,0.0946844374971478,0.122328473633505,4.82032550054796e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEXN,Nexilin,37445,0.102358534202964,0.00666491129578033,0.0892953080632345,0.115421760342693,8.71175492310963e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6AP2,Renin receptor,39477,0.0605805796280634,0.00394776938003604,0.0528429516431928,0.068318207612934,9.20758744305806e-53
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F11,Coagulation factor XI,37249,0.046407635367752,0.0030274240312794,0.0404738842664444,0.0523413864690597,1.36621159540469e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSTN,Growth/differentiation factor 8,39585,0.0769614048259918,0.00502578632715021,0.0671108636247774,0.0868119460272063,1.49188135107315e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGLL,Monoglyceride lipase,39908,0.129486278537291,0.0084622297624286,0.112900308202931,0.146072248871651,1.74871224916158e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF19,Fibroblast growth factor 19,39931,0.113382619823515,0.00741375815895814,0.0988516538319573,0.127913585815073,1.97546551139129e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.127615263307612,0.00834178909916543,0.111265356673248,0.143965169941976,2.19605348278864e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0851028212048296,0.00556707958795946,0.0741913452124291,0.0960142971972302,2.20890081405619e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0909165682195084,0.00595842316200709,0.0792380588219745,0.102595077617042,3.35918472389215e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRADD,Death domain-containing protein CRADD,39713,0.112844358632546,0.00739616201818277,0.0983478810769077,0.127340836188184,3.46436685191523e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0680552427161194,0.00445777975798626,0.0593179943904663,0.0767924910417725,3.47238906530825e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRL,Appetite-regulating hormone,39868,0.113203374057774,0.00742980595993351,0.0986409543763046,0.127765793739244,4.70099427201598e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0678650932468608,0.00445335285692152,0.0591365216472946,0.0765936648464269,5.39247586631786e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.105392782766571,0.00692220801159312,0.0918252550638487,0.118960310469294,5.54462949752663e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPACT,Protein IMPACT,37388,0.0816588959339788,0.00536221739351824,0.0711489498426831,0.0921688420252746,6.15772771805103e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGLAP,Osteocalcin,37437,0.127422707257558,0.00837254666700183,0.111012515790234,0.143832898724881,7.07353094559443e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINE2,Glia-derived nexin,37437,0.0951483314700452,0.00625213498561546,0.0828941468982389,0.107402516041851,7.13496103699106e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSL,Cathepsin L1,39868,0.0351756797153729,0.00231313425596692,0.0306419365736777,0.039709422857068,7.3268321803544e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIFBP,KIF-binding protein,39788,0.122117173400919,0.00803649672969185,0.106365639810723,0.137868706991115,8.76175938417996e-52
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,37124,0.166408515887531,0.01095604937304,0.144934659116373,0.187882372658689,1.14182721217408e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN3,Ataxin-3,37388,0.0901598523834343,0.00593707378204044,0.078523187770635,0.101796516996234,1.16849227355797e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0617442824910417,0.00407126575813725,0.0537646016050927,0.0697239633769907,1.58002498298452e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,37405,0.0901512077319654,0.00594924647102143,0.0784906846487634,0.101811730815167,1.89977413426201e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MENT,Protein MENT,37124,-0.0326361702679442,0.00215372775712162,-0.0368574766719025,-0.0284148638639858,1.94001190359349e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.144319336851895,0.0095338641372721,0.125632963142841,0.163005710560948,2.12026843351831e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F12,Coagulation factor XII,37453,0.0607887130706599,0.00401548672932048,0.0529183590811917,0.068659067060128,2.36310756047174e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP7,Caspase-7,37388,0.123490590547222,0.00817043357403081,0.107476540742122,0.139504640352322,3.4099712017893e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM3,Junctional adhesion molecule C,37124,0.0741307121425241,0.00490435282482319,0.0645181806058706,0.0837432436791775,3.42550103382877e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APP,Amyloid-beta precursor protein,39829,0.0974436406323688,0.00645430148604969,0.0847932097197114,0.110094071545026,3.79280748165131e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.126872512760278,0.00840857553229831,0.110391704716973,0.143353320803582,4.42971926317983e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXJ3,Forkhead box protein J3,37056,0.065534588959403,0.00434833428013394,0.0570118537703405,0.0740573241484655,6.64153477947369e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.142806444329977,0.00949260656800713,0.124200935456683,0.161411953203271,9.72482244710347e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0522308240402422,0.00347190729069705,0.0454258857504759,0.0590357623300084,9.75617713519637e-51
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.0841049916053168,0.00559662930291192,0.0731355981716094,0.0950743850390241,1.09166297190491e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK13,Kallikrein-13,39490,0.0614104078641841,0.00408965415515805,0.0533946857200743,0.0694261300082938,1.29934038986662e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED8,Protein TMED8,37382,0.150644245123458,0.0100278563369112,0.130989646703112,0.170298843543804,1.33662474818545e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMNL1,Formin-like protein 1,39489,0.0886428145773697,0.00590823700676149,0.0770626700441172,0.100222959110622,1.57118801876321e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,39868,0.113109635795179,0.00754288432161048,0.098325582524822,0.127893689065535,1.72892469859573e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDT,D-dopachrome decarboxylase,37437,0.0583438092360861,0.00388878061022219,0.0507217992400506,0.0659658192321216,1.77732412565522e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0819923367401413,0.00547593692091715,0.0712595003751437,0.092725173105139,2.45581526482818e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.12395842213996,0.00827965392776673,0.107730300441538,0.140186543838383,2.84545559984948e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.106482760514979,0.00712177591851543,0.0925240797146889,0.120441441315269,3.90743061577395e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,37445,0.105697176916362,0.00707043241500153,0.0918391293829595,0.119555224449765,3.94569563495716e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.115538691128225,0.00773030513066436,0.100387293072123,0.130690089184328,4.24396830425093e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0817327854558216,0.00547839488353339,0.0709951314840962,0.0924704394275471,5.38584206250199e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0900288656382758,0.00603610509653992,0.0781980996490575,0.101859631627494,6.5317243250771e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,37382,0.121022369547785,0.00811473342191124,0.105117492040839,0.136927247054731,6.6680821714432e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL8,C-C motif chemokine 8,40003,0.0870733876031452,0.00584795846441908,0.0756113890128838,0.0985353861934066,8.25054044775692e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EHD3,EH domain-containing protein 3,37043,0.16953203854157,0.0113863219527461,0.147214847514187,0.191849229568952,9.83307441019205e-50
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM106A,Transmembrane protein 106A,37368,0.102753326871407,0.00690345641927654,0.0892225522896245,0.116284101453189,1.03162969285256e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.140124199079876,0.00941734394483597,0.121666204947998,0.158582193211755,1.1343817106199e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTF1,Cardiotrophin-1,39585,0.122293134263574,0.00822707162065072,0.106168073887099,0.13841819464005,1.2133678526401e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0672402795486411,0.00452359123578,0.0583740407265123,0.0761065183707699,1.37741000600164e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDCP1,CUB domain-containing protein 1,39749,0.0717863615596871,0.00483418869111473,0.0623113517251022,0.081261371394272,1.50117498745192e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,37135,0.093771991553529,0.00631058613763179,0.0814032427237707,0.106140740383287,1.5100032262388e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX4,Syntaxin-4,39788,0.0851789544993221,0.00573932915143749,0.0739298693625046,0.0964280396361396,1.69666920107909e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0914969254301197,0.00616802831874964,0.0794075899253704,0.103586260934869,1.86524054797443e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2L,Ataxin-2-like protein,37411,0.0690558651122304,0.00465383882816355,0.0599343410090298,0.078177389215431,2.0175202080021e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0427521534713202,0.00288129085863704,0.0371048233883916,0.0483994835542488,2.0554123640053e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.134601742449523,0.00907363415304668,0.116817419509552,0.152386065389495,2.14233134704588e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,36874,0.0769165658320365,0.00518849885704802,0.0667471080722224,0.0870860235918507,2.57017356733986e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP10,Caspase-10,39489,0.102635576772205,0.00692944713129155,0.089053860394874,0.116217293149537,2.66505387216843e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.105216147461303,0.00711028609366834,0.0912799867177133,0.119152308204893,3.72267844479435e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,37124,0.0322380288463358,0.00217858969697518,0.0279679930402645,0.0365080646524072,3.7381830936708e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOM,Apolipoprotein M,39908,0.0380629088393513,0.00257872999408119,0.0330085980509522,0.0431172196277505,5.53034886059643e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C4BPB,C4b-binding protein beta chain,39913,0.0566989865590399,0.00384356155614922,0.0491656059089874,0.0642323672090924,6.27490593297308e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0511921893833377,0.0034710689233573,0.0443888942935573,0.057995484473118,6.62204278798951e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.137609571340056,0.00933070917393056,0.119321381359152,0.15589776132096,6.64184270996863e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,39855,0.111874551346435,0.00758646729950131,0.0970050754394123,0.126744027253457,6.7770626392773e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.111040638901615,0.00753157489768179,0.0962787521021586,0.125802525701071,7.1051559049023e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,39788,0.123263923674729,0.00836130737215418,0.106875761225307,0.139652086124152,7.25053778227063e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCB,Tubulin-folding cofactor B,39749,0.144721549033497,0.00982167744936688,0.125471061232738,0.163972036834257,8.07753131753768e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.109516396436986,0.00743998176181434,0.0949340321838303,0.124098760690143,9.97157389943249e-49
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM3,Dynamin-3,37411,0.0782993875355711,0.00531783327479527,0.0678764343169724,0.0887223407541698,1.07585656319217e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0727576143830367,0.00494540299965698,0.063064624503709,0.0824506042623643,1.28006979558301e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",39818,0.156535916265584,0.0106490856852185,0.135663708322556,0.177408124208612,1.35025272627009e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,39913,0.0514465729150352,0.00350446549829701,0.044577820538373,0.0583153252916973,1.77762796908721e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMVK,Phosphomevalonate kinase,39480,0.158102430151176,0.010771234503499,0.136990810524318,0.179214049778034,1.86906830964127e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.141518358190731,0.00964129455842555,0.122621420856217,0.160415295525245,2.14388802047222e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0705434811899418,0.00480603247496501,0.0611236575390104,0.0799633048408732,2.18479888926582e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BIN2,Bridging integrator 2,39858,0.127578552853207,0.00869993252305848,0.110526685108012,0.144630420598401,2.24812701572819e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.0732920998280729,0.00500562778443736,0.0634810693705757,0.0831031302855701,3.1109942763481e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPB1,Carboxypeptidase B,40052,0.0814601457251893,0.00556637319445912,0.0705500542640495,0.0923702371863292,3.44533702552612e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,37124,0.0985077230913512,0.00672828966134079,0.0853202753551233,0.111695170827579,3.66109546109881e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB2,Lysosome membrane protein 2,39486,0.0407676942412276,0.00278817003516264,0.0353028809723089,0.0462325075101464,4.24626385645324e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOD,Apolipoprotein D,36780,-0.0616163000411841,0.00421150306293626,-0.0698708460445392,-0.053361754037829,4.35022057053968e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D5,TBC1 domain family member 5,39866,0.110367358055507,0.00755078984232355,0.0955678099645526,0.125166906146461,4.48769644143089e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7,Interleukin-7,39866,0.0923610443778957,0.00631892157896425,0.0799759580831258,0.104746130672666,4.49293972902362e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0561428647638508,0.0038418990844906,0.0486127425582492,0.0636729869694524,4.77096360589847e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,40058,0.0959421353235503,0.0065675814805314,0.0830696756217088,0.108814595025392,5.01325245821669e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB6,Serpin B6,39970,0.0852570832288302,0.00583696998031993,0.0738166220674032,0.0966975443902573,5.18391344497394e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,37382,0.0825962575896425,0.00565316247672974,0.0715160591352522,0.0936764560440328,5.57469840553158e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0875445915024334,0.00599251099839183,0.0757992699455855,0.0992899130592814,5.83093064364395e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,37124,0.169158321462583,0.011582592731199,0.146456439709433,0.191860203215734,6.18742816615098e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,37039,0.112968248095597,0.00773593058366682,0.0978058241516096,0.128130672039584,6.35489388214785e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0731610044559503,0.0050126599079019,0.0633361910364626,0.0829858178754381,7.10567831019487e-48
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMT,Catechol O-methyltransferase,39403,0.120051797781323,0.00824917350722314,0.103883417707166,0.136220177855481,1.14718695753858e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.0906775844337138,0.00623084855415624,0.0784651212675676,0.10289004759986,1.30039709183192e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,37411,0.0879133408184434,0.00604325462709206,0.076068561749343,0.0997581198875438,1.3859624150134e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,39573,0.0478005398522704,0.00329085501838456,0.0413504640162366,0.0542506156883041,1.70248615123875e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0394495788171549,0.00271748889892171,0.0341233005752684,0.0447758570590415,1.88995615828659e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD83,CD83 antigen,39866,0.0460741402055409,0.0031795131412852,0.0398422944486219,0.0523059859624599,2.75395294055827e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADD1,Alpha-adducin,37124,0.0970118401401941,0.00669053778198493,0.0838983860875037,0.110125294192885,2.7905332487631e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO9B,Unconventional myosin-IXb,39587,0.0927661302406967,0.00640789724038602,0.0802066516495401,0.105325608831853,3.41306314565507e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164,Sialomucin core protein 24,39858,0.036790581886523,0.00254250939183937,0.0318072634785179,0.0417739002945282,3.71158872839998e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACYBP,Calcyclin-binding protein,37088,0.145748084643848,0.01006573809349,0.126019237980608,0.165476931307088,3.73762380915676e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0941596513676366,0.0065038191970819,0.0814121657413561,0.106907136993917,3.8286152546623e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12A_IL12B,Interleukin-12,39788,0.103200652136634,0.0071343932761181,0.0892172413154424,0.117184062957825,3.99689701842534e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID1,Nidogen-1,39892,0.0526519458278773,0.00364005707880396,0.0455174339534216,0.0597864577023331,4.01586258549398e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YWHAQ,14-3-3 protein theta,37124,0.104232350881654,0.00720165378786733,0.0901171094574344,0.118347592305874,4.0773362294285e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3,Galectin-3,39901,0.0413483796137848,0.00286011647979642,0.0357425513133838,0.0469542079141858,4.48350917117652e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0474644245228611,0.00328352360742223,0.0410287182523136,0.0539001307934087,4.56389602987391e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.123128475610818,0.00851327607293917,0.106442454507857,0.139814496713779,4.63540777885123e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F2R,Proteinase-activated receptor 1,39908,0.0818667484179846,0.00566375731202475,0.070765784086416,0.0929677127495531,4.63858527065466e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,37411,0.0949135824367558,0.00656854683507692,0.0820392306400051,0.107787934233507,5.62380582492818e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.1465173980519,0.0101493980824346,0.126624577810328,0.166410218293472,6.95243962970391e-47
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB1,Heat shock protein beta-1,39617,0.0972373022779176,0.00675437759517933,0.0839987221913661,0.110475882364469,1.08148647291833e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH9,Protocadherin-9,37382,0.0463908338334906,0.00322225400959702,0.0400752159746805,0.0527064516923008,1.19507567060558e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,40052,0.0596442094351128,0.00414726451209267,0.0515155709914112,0.0677728478788144,1.30832653080742e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,37368,0.0767144247969886,0.00533428280453582,0.0662592305000984,0.0871696190938788,1.49396504000578e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA1,Carboxypeptidase A1,40052,0.0823083782274386,0.00573367230153039,0.0710703805164391,0.0935463759384382,1.90385066450259e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,37056,0.0444959365268231,0.00310480415006919,0.0384105203926875,0.0505813526609587,3.09939060792316e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TADA3,Transcriptional adapter 3,37368,0.0550161550403443,0.00384139479193236,0.0474870212481569,0.0625452888325317,3.47707010518556e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0654344450324348,0.00457268817409824,0.0564719762112023,0.0743969138536674,4.20506690491542e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,37437,0.0851579984671258,0.00595905896714238,0.0734782428915267,0.0968377540427249,5.40382492979457e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,39868,0.0922122661768338,0.00645679940014675,0.0795569393525461,0.104867593001121,5.47585718871447e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.128143861918451,0.00897716543734416,0.110548617661257,0.145739106175646,6.04693386215012e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.102907818296939,0.00722013752274955,0.0887563487523496,0.117059287841528,8.32923184374929e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0796514131935561,0.00559288644724638,0.0686893557569532,0.090613470630159,9.62971280806321e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.130845451707979,0.00918227345589828,0.112848195734418,0.148842707681539,9.64332528709439e-46
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.138968144842672,0.00976329278516992,0.119832090983738,0.158104198701605,1.07512082023741e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0938200349912271,0.00659974567219474,0.0808845334737254,0.106755536508729,1.38666486377057e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0895764166832737,0.00629867207933909,0.0772310194077691,0.101921813958778,1.43608856621438e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0330648210918505,0.00232561631016509,0.0285066131239269,0.037623029059774,1.51078445145388e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0650325165497929,0.00458001278348892,0.0560556914941546,0.0740093416054312,1.74037979895386e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0554070333080297,0.00390455869063818,0.0477540982743789,0.0630599683416805,1.99583894823268e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.154340607747296,0.0108875590439126,0.133000992021227,0.175680223473364,2.42449257700015e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0564807572319504,0.00398514567375846,0.0486698717113838,0.064291642752517,2.53079672083366e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RILP,Rab-interacting lysosomal protein,39984,0.0815427404246831,0.00575485040985927,0.070263233621359,0.0928222472280073,2.65036511244388e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0447251872509317,0.0031573612176853,0.0385367592642685,0.0509136152375949,2.82616438375298e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.154928575159659,0.0109392113318011,0.133487720949329,0.176369429369989,2.97037014967115e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON2,Spondin-2,39775,-0.0459830045363198,0.00325104530749877,-0.0523550533390174,-0.0396109557336222,3.81398303177635e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0391045231309466,0.00276772928584121,0.0336797737306978,0.0445292725311953,5.26285145848914e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THTPA,Thiamine-triphosphatase,37345,0.120796704197237,0.0085657454328551,0.104007843148841,0.137585565245633,7.65400901382956e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,37021,0.0917693720442759,0.0065119152319787,0.0790060181895977,0.104532725898954,8.93010325924986e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.121676288339494,0.00863705209788627,0.104747666227637,0.138604910451351,9.3369582501651e-45
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MESD,LRP chaperone MESD,39858,0.166618612800546,0.0118490949978584,0.143394386604744,0.189842838996349,1.20404688544444e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL1,Growth-regulated alpha protein,39839,0.129416576612744,0.00920657719995897,0.111371685300825,0.147461467924664,1.28744524069112e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0834337787104706,0.00594365572905883,0.0717842134815153,0.095083343939426,1.69347721384178e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CERT,Ceramide transfer protein,39489,0.0838835399743511,0.00597971034264801,0.072163307702761,0.0956037722459412,1.95350637448376e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.0524995790748392,0.00374141863980916,0.0451663985408133,0.0598327596088652,2.06711004219196e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LARP1,La-related protein 1,37368,0.0872249102018291,0.00621755403171262,0.0750385042996724,0.0994113161039858,2.12801955024202e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0907095027744202,0.00646924028537986,0.0780297918150757,0.103389213733765,2.39466165241502e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG6,Large proline-rich protein BAG6,39585,0.050237634689146,0.00358682766161542,0.0432074524723798,0.0572678169059123,2.63876639520063e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIAPIN1,Anamorsin,39913,0.0856736150116424,0.00612435484946518,0.0736698795066906,0.0976773505165941,3.30742887481204e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0638690970515542,0.00456342558240948,0.0549247829100316,0.0728134111930768,3.35451407029601e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0521306247557914,0.00372547268897338,0.0448286982854036,0.0594325512261792,3.4935898743523e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,37445,0.0643505150749426,0.00460422510685362,0.0553262338655095,0.0733747962843758,4.38522561078525e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD244,Natural killer cell receptor 2B4,40058,0.0360892630897382,0.00258916101837617,0.0310145074937209,0.0411640186857554,6.61885095859235e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0504978074115002,0.00362506291060323,0.0433926841067179,0.0576029307162826,7.56575268118187e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL32,Interleukin-32,39866,-0.057825190087199,0.00415141665652501,-0.065961966733988,-0.04968841344041,7.60843854709109e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,39698,0.0372727914715573,0.00267707656698235,0.0320257214002719,0.0425198615428427,8.32725901705408e-44
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.138150278300424,0.00992806444520524,0.118691271987822,0.157609284613026,1.0442563158719e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1,Allograft inflammatory factor 1,39477,0.0711493986030523,0.00511887658434235,0.0611164004977413,0.0811823967083633,1.16213047953323e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,39811,0.12073121516805,0.00868692997296833,0.103704832421032,0.137757597915068,1.16994310603092e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,37056,0.0601148742037731,0.00432312549285833,0.0516415482377708,0.0685882001697754,1.19288292747736e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0598667494637675,0.00430899058145161,0.0514211279241224,0.0683123710034127,1.24908783060283e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0459790748502553,0.00331779916507851,0.0394761884867015,0.0524819612138092,2.0478158386343e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0880673703060885,0.00636291697621849,0.0755960530327002,0.100538687579477,2.55826381941294e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.144978915409525,0.0104788653729667,0.12444033927851,0.165517491540539,3.07449775562679e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,37388,0.134229290375961,0.00970651243112571,0.115204526010955,0.153254054740967,3.36126725955935e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB2,Calretinin,39489,0.0391294320639084,0.00283116259253793,0.0335803533825341,0.0446785107452828,3.41892246892973e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.133363752472983,0.0096538097937072,0.114442285277317,0.152285219668649,4.07639189255346e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.122221667005796,0.00884649948958317,0.104882528006213,0.139560806005379,4.08258256154145e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.061390051527009,0.00444708183962421,0.0526737711213456,0.0701063319326725,4.76542202660039e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.091254325324845,0.00662137149628948,0.0782764371921176,0.104232213457572,5.85276605951651e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MIF,Macrophage migration inhibitory factor,39826,0.0911978775681964,0.00661860276320417,0.0782254161523162,0.104170338984077,6.0025726031526e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.126683133912963,0.00920147375077454,0.108648245361445,0.144718022464481,7.01774391894393e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0806434412837782,0.00585869347848523,0.0691604020659472,0.0921264805016093,7.38885350797185e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP2,Caspase-2,39866,0.0911812603061826,0.00662673121485893,0.0781928671250591,0.104169653487306,7.8168846046777e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMSB10,Thymosin beta-10,39858,0.103193904514284,0.0075000068236847,0.0884938911398623,0.117893917888706,7.86609827346615e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,37366,0.117876341981055,0.00856417287357488,0.101090563148848,0.134662120813261,8.17336917116162e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.040582168385006,0.00294886237085199,0.0348023981381361,0.0463619386318759,8.41461086012826e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPT,Dermatopontin,40052,0.0357484736959034,0.00259966798198622,0.0306531244512104,0.0408438229405964,8.7172517612449e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.100941251545148,0.00733799968319912,0.0865587721660778,0.115323730924218,9.07557492869904e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAP3,Cytosol aminopeptidase,39587,0.0648493040334676,0.00471872905513756,0.055600595085398,0.0740980129815372,9.91092729687337e-43
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP5,Platelet glycoprotein V,37124,0.0482635678869591,0.00351169223735159,0.04138065110175,0.0551464846721683,1.0896376772885e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3C,Protein FAM3C,39846,0.0385461515418451,0.00280689858490342,0.0330446303154343,0.0440476727682558,1.13048998848945e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.109117442432909,0.00795028292544855,0.0935348878990298,0.124699996966788,1.25434562341233e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0815462476224714,0.00594021207691359,0.0699034319517207,0.093189063293222,1.3577462303392e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,39749,0.0551754735864046,0.00402812323741148,0.0472803520410781,0.0630705951317311,1.8295969330198e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLMH,Bleomycin hydrolase,40052,0.0424792843478951,0.00310376511722062,0.0363959047181427,0.0485626639776475,2.10867240972848e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.130954408406219,0.00957652973479315,0.112184410126024,0.149724406686413,2.74724048714758e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.122650141666127,0.00897022741759571,0.10506849592764,0.140231787404615,2.85736547955752e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,39866,-0.0658452787210769,0.00482030503715035,-0.0752930765938915,-0.0563974808482622,3.03704760976538e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0707072490820007,0.00517357194833255,0.0605670480632688,0.0808474501007325,3.08768437088477e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1R,Complement C1r subcomponent,37453,0.0255635903709527,0.00187590066437998,0.021886825068768,0.0292403556731375,5.19716475587181e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.125375946106536,0.0092072393945974,0.107329756893125,0.143422135319947,5.45184539020428e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEPR,Leptin receptor,39868,-0.0408096770950106,0.00299705474238755,-0.0466839043900902,-0.034935449799931,5.46776400842376e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,37411,0.103220070106896,0.00758433271936484,0.088354777976941,0.118085362236851,6.61578990052106e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,37043,0.0752320136579711,0.0055297820119971,0.0643936409144568,0.0860703864014854,7.17987946813675e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0708332537028361,0.00521399530513035,0.0606138229047807,0.0810526845008916,9.20696530778712e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB1,Beta-crystallin B1,37437,0.0876856610081509,0.00645621958810126,0.0750314706154724,0.100339851400829,9.64751432919127e-42
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMMT,MICOS complex subunit MIC60,37368,0.0577539601866399,0.00425787639331985,0.049408522455733,0.0660993979175468,1.22575594821824e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICALL2,MICAL-like protein 2,37039,0.0894787503537091,0.00659813108565958,0.0765464134258163,0.102411087281602,1.29275096326891e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0554684530585199,0.004092002180779,0.0474481287841931,0.0634887773328467,1.3936515190162e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0525186975430594,0.00387536071915683,0.044922990533512,0.0601144045526068,1.43740564194588e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUGT1,Protein SGT1 homolog,39477,0.106577948016965,0.00786883281240021,0.091155035704661,0.12200086032927,1.46960302104577e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRB1,Chymotrypsinogen B,39858,0.0701395114039007,0.00518826749075697,0.059970507122017,0.0803085156857843,2.0431173423154e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0852078106750206,0.00629913582150322,0.0728615044648743,0.0975541168851669,2.05152001255292e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,39477,0.0587425054521532,0.00434655134505683,0.0502232648158418,0.0672617460884646,2.18724777060552e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,37430,0.0631532435629611,0.00467302712458072,0.0539941103987829,0.0723123767271393,2.37984046940656e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARK7,Parkinson disease protein 7,39858,0.0687325070348044,0.00509365530119883,0.0587489426444547,0.0787160714251541,2.86266847363163e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBI,Acyl-CoA-binding protein,39793,0.104680034505612,0.00776328806066399,0.0894639899067101,0.119896079104513,3.27013463244598e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,40052,0.0408889763160821,0.00303292874709609,0.0349444359717737,0.0468335166603904,3.34483671759518e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GMFG,Glia maturation factor gamma,37437,0.0942374547599822,0.00698775919677177,0.0805414467343095,0.107933462785655,3.47753044558788e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0507435686297866,0.00376464492650609,-0.0581222726857385,-0.0433648645738346,3.48870272858272e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.101195973420123,0.00750494177572604,0.0864862875396998,0.115905659300546,3.587561017058e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOXO3,Forkhead box protein O3,39477,0.127616250727048,0.0094789802559018,0.10903744942548,0.146195052028615,4.37194925392758e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,39822,0.0370781193932063,0.00275765821484689,0.0316731092921064,0.0424831294943062,5.46787537485218e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,36991,0.0616531062172943,0.0045852899025002,0.0526659380083939,0.0706402744261947,6.07467608264652e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0393166059816845,0.0029271101162674,0.0335794701538004,0.0450537418095686,6.52336949120341e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WDR46,WD repeat-containing protein 46,37368,0.0470325563974928,0.00350064770891308,0.0401712868880232,0.0538938259069624,6.86458092751045e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0496470485410687,0.00370334721264828,0.042388488004278,0.0569056090778593,9.27619215710564e-41
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,39477,0.0716478626458678,0.00534738595046326,0.0611669861829598,0.0821287391087758,1.03301690741588e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0844247426275434,0.0063166076291892,0.0720441916743326,0.0968052935807542,1.73714439131261e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,40009,0.0591527893336501,0.00443400423084987,0.0504621410411843,0.0678434376261159,2.19493214538005e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP3,Caspase-3,40052,0.115001806577856,0.00863274514414896,0.0980816260953244,0.131921987060388,2.82521622842251e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.132511951470765,0.00994209557410033,0.113025444145528,0.151998458796002,2.84144902174011e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RP2,Protein XRP2,39788,0.0538640705387189,0.00404928018355665,0.0459274813789479,0.06180065969849,3.68419554152822e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.145114649993325,0.010910748436882,0.123729583057036,0.166499716929613,3.80590264286595e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA4,Ephrin-A4,39720,0.0357054020156639,0.0026856993402021,0.0304414313088677,0.04096937272246,4.07671146832235e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.155615136689246,0.011710062808509,0.132663413584568,0.178566859793923,4.36347092540796e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,37382,0.113853708289072,0.00856870301242735,0.0970590503847139,0.130648366193429,4.89748113185247e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,39477,0.0507961472528177,0.00382697899470315,0.0432952684231995,0.0582970260824359,5.45476626808225e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.078164067624625,0.00589103467052176,0.0666176396704023,0.0897104955788477,6.34859301853213e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.103421728332678,0.00779970963511755,0.088134297447848,0.118709159217509,7.13263788998961e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP1,Guanylate-binding protein 1,37376,0.0817722942944947,0.00616820253778564,0.0696826173204348,0.0938619712685545,7.28177825074903e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.163492859075303,0.0123338376173093,0.139318537345377,0.187667180805229,7.40967189613241e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,39575,0.0385138157287556,0.00290828207750089,0.0328135828568539,0.0442140486006573,8.1154390443596e-40
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,37437,0.105714719308937,0.0080079284079989,0.0900191796292592,0.121410258988615,1.51183641547107e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB9,Serpin B9,39749,0.0428104960725334,0.0032446476923206,0.036450986595585,0.0491700055494817,1.52972926073831e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMTN,Smoothelin,37342,0.123127171637783,0.00935017133394026,0.10480083582326,0.141453507452306,2.33228229774005e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0736501183541368,0.00560089612816723,0.0626723619429291,0.0846278747653446,2.74022941976405e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0513492937347657,0.00390743147027289,0.0436907280530308,0.0590078594165006,3.31097089326654e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF6,SLAM family member 6,39477,0.048086040851276,0.00366482537927383,0.0409029831078993,0.0552690985946527,4.02175891415042e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TST,Thiosulfate sulfurtransferase,39455,0.0974098263502759,0.00742558486775504,0.0828556800094761,0.111963972691076,4.17577959830333e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRGN,Neurogranin,37445,0.116761123662498,0.0089014261841379,0.0993143283415878,0.134207918983408,4.53763126938112e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.094194331287139,0.00718989228580617,0.0801021424069589,0.108286520167319,5.60400875546543e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTD,Deoxycytidylate deaminase,37124,0.121830865440601,0.00930053106567223,0.103601824551884,0.140059906329319,5.79462627443504e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.112243654008783,0.00856881604150185,0.0954487745674394,0.129038533450127,5.81421939622689e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,39749,0.0425265339406575,0.00325633786843297,0.0361441117185289,0.0489089561627861,8.86976520004214e-39
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0727788658543932,0.00557430111963609,0.0618532356599065,0.0837044960488799,1.01835162268473e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA3,Annexin A3,39985,0.0884313792619247,0.00677840038500308,0.0751457145073186,0.101717044016531,1.05086426677708e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0634828127566962,0.00486781044562195,0.0539419042832772,0.0730237212301152,1.11536728119028e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL2,C-C motif chemokine 2,39720,0.0653985918080384,0.00501451305795992,0.0555701462144369,0.0752270374016398,1.11795911456127e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,37043,0.0976581622596244,0.0074875028521658,0.0829826566693794,0.112333667849869,1.21085796586265e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP6,Platelet glycoprotein VI,39836,0.112294669557462,0.00861533097436628,0.0954086208477046,0.12918071826722,1.22942416414069e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0828673373651126,0.00637311172347571,0.0703760383871002,0.095358636343125,1.8714043066198e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML2,Trem-like transcript 2 protein,39858,0.0418001385818367,0.00321831066262459,0.0354922496830925,0.0481080274805809,2.23092129978053e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0734989015208235,0.00566531784494398,0.0623948785447333,0.0846029244969137,2.73508945884417e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTF2,Transcription termination factor 2,37039,0.061950781418627,0.00477464629116624,0.0525924746879412,0.0713090881493129,2.91061629755717e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATG4A,Cysteine protease ATG4A,39477,0.074097306768063,0.00571586012694097,0.0628942209192587,0.0853003926168673,3.10509700521287e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGL1,Fibrinogen-like protein 1,37445,-0.0778537418499284,0.00601268024662659,-0.0896385951333165,-0.0660688885665403,4.03931133908021e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF2,Growth/differentiation factor 2,39868,0.0442319281913952,0.00342405512326864,0.0375207801497886,0.0509430762330017,5.51614335250419e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.048268061146236,0.00374225984554358,0.0409332318489706,0.0556028904435014,7.70147839988384e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0295764313177734,0.00229424699661115,0.0250797072044155,0.0340731554311312,7.74273087581645e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,40009,0.0974074794025347,0.00755706194975059,0.0825956379810236,0.112219320824046,7.91495898232158e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.076065920325257,0.00590884252027279,0.0644845889855224,0.0876472516649917,9.80017856309392e-38
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XCL1,Lymphotactin,40030,0.0684884503813012,0.00532307142852239,0.0580552303813973,0.0789216703812051,1.06591066425519e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0696706898274157,0.00541212646875278,0.0590629219486603,0.0802784577061712,1.06887601350412e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DXO,Decapping and exoribonuclease protein,37388,0.0568200732836207,0.00441437804992193,0.0481678923057737,0.0654722542614677,1.08239572278819e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.152990529022459,0.0118931051341782,0.129680042959469,0.176301015085448,1.10594991635819e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,39913,0.104464653265297,0.00812784025640592,0.0885340863627415,0.120395220167853,1.27333007409057e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,39866,0.0619275596088123,0.00482237007787488,0.0524757142561775,0.071379404961447,1.46695644254534e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0449759894574801,0.00350245905732262,0.0381111697051278,0.0518408092098325,1.46833054072639e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCA,Calcitonin,39713,0.0759639916688908,0.00591689880832361,0.0643668700045765,0.087561113333205,1.53538512044195e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREH,Trehalase,37437,0.0939195310149077,0.00731506411312812,0.0795820053531766,0.108257056676639,1.63442030627624e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,37453,0.0375523559625725,0.0029251522228681,0.031819057605751,0.043285654319394,1.66397390865662e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRD2,Protein ZNRD2,37382,0.0846285099223564,0.00659397433009798,0.0717043202353643,0.0975526996093484,1.74507080844126e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.136155761168315,0.0106133043312703,0.115353684679026,0.156957837657605,1.91986163416196e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KITLG,Kit ligand,39868,-0.0460621139991988,0.00359620336773827,-0.0531106725999658,-0.0390135553984318,2.24110203133553e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF23,Fibroblast growth factor 23,40008,0.072593854420821,0.00566804975857453,0.0614844768940149,0.0837032319476271,2.26121172075971e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0453361762432032,0.00353918911526829,0.0383993655772774,0.0522729869091291,2.4152924245123e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0540692246629676,0.00422734377136061,0.0457836308711008,0.0623548184548344,3.09017322705345e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAP,Prosaposin,37347,0.0347285576867817,0.00271542760398069,0.0294063195829795,0.0400507957905838,3.09389743296255e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAL,Integrin alpha-L,37056,0.0530930454319109,0.00415234072114981,0.0449544576184572,0.0612316332453645,3.25172778236126e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UMOD,Uromodulin,40012,-0.0653802830501159,0.00511714687126547,-0.0754098909177962,-0.0553506751824355,3.34948955800688e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.05946003222531,0.00465833155697689,0.0503297023736353,0.0685903620769847,4.3027064587501e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0858066455259966,0.00674143474715804,0.0725934334215668,0.0990198576304263,6.79667723677188e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,37021,0.0869146458561716,0.00682923177186737,0.0735293515833115,0.100299940129032,6.91735682041975e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAP,Prolyl endopeptidase FAP,40052,0.0336857536774626,0.0026486892445061,0.0284943227582307,0.0388771845966946,7.06060722833383e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL26,C-C motif chemokine 26,39866,0.105606461441018,0.00830432483959792,0.0893299847554063,0.12188293812663,7.17077488264149e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD46,Membrane cofactor protein,39777,0.0349822234972289,0.00275153425079084,0.0295892163656788,0.0403752306287789,7.49656614246205e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL24,C-C motif chemokine 24,39908,0.101735208318718,0.0080040643001486,0.0860472422904265,0.117423174347009,7.78755780903859e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0248672802769779,0.0019568087532952,-0.0287026254334365,-0.0210319351205193,8.01954471366721e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDHB,Succinate dehydrogenase,37382,0.0865928664596779,0.00681266840816195,0.0732400363796805,0.0999456965396753,8.38774184797656e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASS1,Argininosuccinate synthase,37021,0.0986372494503789,0.00776085612551516,0.0834259714443692,0.113848527456389,8.60514356932668e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,37411,0.060790887318802,0.00478697369420006,0.0514084188781699,0.0701733557594341,9.66887484411047e-37
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNF,Tumor necrosis factor,39555,0.0468375264842368,0.00369131825093249,0.0396025427124092,0.0540725102560645,1.03644857407979e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12B,Interleukin-12 subunit beta,40058,0.0643784729873053,0.00507875616805599,0.0544241108979156,0.0743328350766951,1.19881380183556e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBN1,Drebrin,37056,0.0644932024904147,0.00509177075614745,0.0545133318083657,0.0744730731724637,1.48597312437782e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPPK1,Epiplakin,37043,0.0915858379645078,0.00724136207496511,0.0773927682975762,0.105778907631439,1.8778770665903e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0941408810801652,0.00745337406679754,0.079532267909242,0.108749494251088,2.29600027093512e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBCA,Tubulin-specific chaperone A,37124,0.106024155277303,0.00840079553036893,0.08955859603778,0.122489714516826,2.62402869657927e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POSTN,Periostin,37437,-0.0454676571793563,0.00360856580296337,-0.0525404461531645,-0.0383948682055481,3.3690571593177e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBN,Nibrin,39587,0.0629640674458749,0.00500248228741676,0.0531592021625381,0.0727689327292118,3.73934731174609e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,39913,0.082933548767505,0.00659286935015695,0.0700115248411974,0.0958555726938126,4.06393306709448e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,39931,0.107602378403916,0.00856712046742674,0.0908108222877592,0.124393934520072,5.17662376407705e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLNK,B-cell linker protein,37056,0.0477525759822424,0.00380030697472551,0.0403039743117804,0.0552011776527044,5.25550288673499e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,37382,0.120729403267398,0.00961596391980296,0.101882113984584,0.139576692550211,5.91350026635958e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST2,Bone marrow stromal antigen 2,40009,0.0648542492859247,0.00516983253659159,0.0547213775142052,0.0749871210576442,6.24704045314455e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,39689,0.0517085533966195,0.00412646215932781,0.043620687564337,0.059796419228902,7.47859961833327e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0772926928124956,0.00616841993098259,0.0652025897477697,0.0893827958772215,7.5000077134359e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN4,Cerebellin-4,40030,0.0377136685587188,0.00301027486691848,0.0318135298195586,0.043613807297879,7.6671286955383e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGR1,Prostaglandin reductase 1,37437,0.0967774721598411,0.00773096510357858,0.0816247805568271,0.111930163762855,9.35638193073117e-36
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0920635169515633,0.00737011311386949,0.0776180952483791,0.106508938654747,1.30656622111218e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2,Brorin,39684,0.0466299675217119,0.00374001599962288,0.039299536162451,0.0539603988809727,1.64161337699335e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,37056,0.10459865763964,0.00839206668057914,0.0881502069457051,0.121047108333575,1.85790187306238e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0456077452828364,0.0036604417524269,0.0384332794480797,0.0527822111175931,1.9406464363249e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.086105589542414,0.00693226187287568,0.0725183562715777,0.0996928228132503,3.12361648377317e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,37432,0.0231968330625466,0.00186844475223881,0.0195346813481585,0.0268589847769346,3.36230819342529e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH7,Protocadherin-7,37382,0.040446304833539,0.00326219298978287,0.0340524065735645,0.0468402030935134,4.13105752061847e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,37424,0.0226389008465979,0.00182665996183821,0.019058647321395,0.0262191543718008,4.38239364356647e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GET3,ATPase GET3,37437,0.0673353538578783,0.00543747435357473,0.0566779041248719,0.0779928035908848,4.95734546295696e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0538793711522719,0.00435303160449696,0.0453474292074579,0.062411313097086,5.41361696226807e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,37437,0.0331031873568647,0.00267844747617088,0.0278534303035698,0.0383529444101597,6.70084763241313e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0646607976666488,0.00523691841797244,0.0543964375674229,0.0749251577658748,7.28993889302804e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ING1,Inhibitor of growth protein 1,39453,0.0539817964137864,0.00437432411081865,0.0454081211565819,0.062555471670991,7.9595454509191e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PARD3,Partitioning defective 3 homolog,37169,0.0885652330524632,0.00718075656121211,0.0744909501924874,0.102639515912439,9.23474801436472e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0783025900192461,0.00635323369734167,0.0658502519724564,0.0907549280660358,9.63099762206781e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,39585,0.0634513173883325,0.00514864908891503,0.053359965174059,0.0735426696026059,9.74611467881968e-35
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFP,Alpha-fetoprotein,39699,0.080846975762922,0.0065619393613583,0.0679855746146598,0.0937083769111843,1.01207224310695e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSNAX,Translin-associated protein X,37021,0.0469536566680961,0.00380917618759783,0.0394876713404043,0.0544196419957878,1.01408164551817e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,37388,0.0778992358354003,0.00632208057209759,0.065507957914089,0.0902905137567116,1.06142342890388e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL25,C-C motif chemokine 25,40058,0.059503441636702,0.0048384606582401,0.0500200587465515,0.0689868245268526,1.32459675115632e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADM,Pro-adrenomedullin,40030,0.0313799464968055,0.0025559752669807,0.0263702349735233,0.0363896580200877,1.71263622815221e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA2,Carboxypeptidase A2,39933,0.0768519600140736,0.00626035062085252,0.0645816727972026,0.0891222472309445,1.73975060109194e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDK,Midkine,39843,0.0602950025543861,0.00491352482391955,0.0506644938995038,0.0699255112092685,1.84759310512067e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.143692291098123,0.0117322550627639,0.120697071175105,0.16668751102114,2.46437834014537e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0538794916561945,0.0044005893558277,0.0452543365187722,0.0625046467936168,2.78603940437268e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFA,Protransforming growth factor alpha,39866,0.0545143591955972,0.00445503294690664,0.0457824946196601,0.0632462237715342,2.82027660143322e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,39720,0.0468851059395153,0.0038399837290467,0.0393587378305837,0.0544114740484468,3.92553253538991e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL19,C-C motif chemokine 19,40009,0.137173158472058,0.0112373485542886,0.115147955305653,0.159198361638464,4.03713584303715e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMD,Dystrophin,37043,0.0614291786939959,0.00503028115932271,0.0515698276217234,0.0712885297662684,4.10546734896488e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0763515199758971,0.0062585016465587,0.064084856748642,0.0886181832031522,4.46016540389607e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL14,C-C motif chemokine 14,39843,0.0460390910254439,0.00377617242873093,0.0386377930651313,0.0534403889857565,4.85677340891765e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0629329041903149,0.00516005163992907,0.0528192029760539,0.0730466054045758,4.96813543270951e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",37043,0.103442798868994,0.00848481315679293,0.0868125650816798,0.120073032656308,5.25684423009558e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0841912206254518,0.00690760643198191,0.0706523120187672,0.0977301292321363,5.42004609412224e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN2,Nectin-2,39846,0.0333303434575731,0.0027381489315193,0.0279635715517952,0.0386971153633509,6.1486505085932e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0571873539476223,0.00470112665127716,0.0479731457111191,0.0664015621841255,6.82722136018521e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COLEC12,Collectin-12,39862,0.0293303670172352,0.00241236677281562,0.0246021281425166,0.0340586058919538,7.30641935497541e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX6,Peroxiredoxin-6,40030,-0.0696775433414119,0.00574148838753875,-0.0809308605809878,-0.0584242261018359,9.56697822613368e-34
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0525406811698357,0.00433093229860542,-0.0610293084751023,-0.044052053864569,1.00829607470691e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,39677,0.0428231962639531,0.00353290280033316,0.0358987067753001,0.0497476857526061,1.14938259150465e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0436079333183589,0.00359646784769104,0.0365588563368845,0.0506570102998334,1.17008072704021e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,37021,0.079830311222135,0.00658448031197875,0.0669247298106567,0.0927358926336134,1.19094792684647e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,39477,0.0627410025726276,0.00518587994292065,0.0525766778845031,0.0729053272607521,1.52077130671792e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.03621980458161,0.00299406107331329,-0.0420881642853041,-0.030351444877916,1.52449641727411e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,37021,0.070465246381331,0.00582638710613215,0.059045527653312,0.08188496510935,1.70687354666537e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FADD,FAS-associated death domain protein,39868,0.0901786396754664,0.00746617452167563,0.0755449376129821,0.104812341737951,1.92260138630816e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC3B,Tetranectin,37138,0.0248451900867395,0.00205692859198806,0.0208136100464429,0.0288767701270361,2.04655673548421e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGRN,Neugrin,37388,0.0250080802342986,0.00207157360745212,0.0209477959636925,0.0290683645049048,2.20353702537183e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,37368,0.0735573943280751,0.00609484440439348,0.0616114992954639,0.0855032893606863,2.29216233517143e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB10,Ras-related protein Rab-10,37437,0.0627027107326277,0.00519991910337283,0.052510869290017,0.0728945521752384,2.59175056597904e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0473438939969471,0.00392966372875437,0.0396417530885886,0.0550460349053057,2.94686560742573e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0792070080329436,0.00657678314738734,0.0663165130640644,0.0920975030018228,2.94823117357235e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSTB,Cystatin-B,39619,0.0496329602179044,0.00412158492162002,0.0415546537715291,0.0577112666642796,2.98362021631899e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPB6,Heat shock protein beta-6,40030,0.0438238983990333,0.00364039905184921,0.0366887162574089,0.0509590805406578,3.10364815091112e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARSA,Arylsulfatase A,39858,0.0525547579072101,0.00437129290357582,0.0439870238162015,0.0611224919982187,3.75184655635475e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABHD14B,Protein ABHD14B,39687,0.0671242441931816,0.00558553275984505,0.0561765999838853,0.0780718884024779,4.00666905600213e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN9,Septin-9,39788,0.0330310841041002,0.00274933435874548,0.027642388760959,0.0384197794472413,4.16001953824008e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA13,Carbonic anhydrase 13,39657,0.123043413459086,0.010247083343119,0.102959130106573,0.143127696811599,4.51243984202419e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0806494238333255,0.00671941386281007,0.0674793726622178,0.0938194750044333,4.76364856428595e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD40LG,CD40 ligand,40058,0.0906233826894196,0.00755354435165252,0.0758184357601807,0.105428329618659,5.05665769130134e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,39931,0.0529933631398203,0.00442204659601177,0.0443261518116373,0.0616605744680034,5.96289341937223e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.078318998676772,0.0065466718534395,0.0654875218440306,0.0911504755095134,8.19187908438992e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.101711638208642,0.0085095249086949,0.0850329693876002,0.118390307029684,9.19215763610772e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGMN,Legumain,39931,0.0416812668050337,0.00348919179756641,0.0348424508818036,0.0485200827282639,9.39549825564443e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,37382,0.0556892491909897,0.00465988847202149,0.0465558677858276,0.0648226305961518,9.4039104794098e-33
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0838673999023802,0.00702775237343769,0.0700930052504423,0.097641794554318,1.09252976057798e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF2,Fibroblast growth factor 2,39866,0.0772466795037029,0.00647359769886142,0.0645584280139345,0.0899349309934712,1.10165152452724e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN4,CCN family member 4,40030,0.0463922497039103,0.00389114241673925,0.0387656105671014,0.0540188888407193,1.23763370247698e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.026942672636937,0.00226403946602033,0.0225051552835372,0.0313801899903369,1.62027677977257e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.056916572189552,0.00478932362863568,0.047529497877426,0.0663036465016779,1.97644821911068e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0505396899599762,0.00425137702343315,0.0422069909940472,0.0588723889259052,1.98643802736547e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACYP1,Acylphosphatase-1,37073,0.0759086685777564,0.00638534713312159,0.0633933881968381,0.0884239489586748,2.00036200104049e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC79,Protein unc-79 homolog,36962,0.0652177538501238,0.00548919605099372,0.0544589295901761,0.0759765781100715,2.17592399077528e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL15,C-C motif chemokine 15,40052,0.0499941364988472,0.0042111769986067,0.0417402295815781,0.0582480434161164,2.2604004593398e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPLAH,5-oxoprolinase,37043,0.0800331858293159,0.00673812462406466,0.0668264615661491,0.0932399100924826,2.2612530287078e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0683484816202849,0.0057589337959479,0.057060971380227,0.0796359918603428,2.38347569878598e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0346203146758019,0.00291844477210711,0.028900162922472,0.0403404664291319,2.52956126079664e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0560760129121978,0.00472909564322349,0.0468069854514798,0.0653450403729158,2.83894249539613e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0957240024537736,0.00807645805040096,0.0798941446749877,0.11155386023256,2.85929293077905e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP6,Bone morphogenetic protein 6,39568,0.0480751710197278,0.0040633449295475,0.0401110149578147,0.0560393270816409,3.67759687266051e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MARCO,Macrophage receptor MARCO,39868,0.0300595922179213,0.00254642925421566,0.0250685908796586,0.035050593556184,5.01715549604803e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0343917485105814,0.00291904290397826,-0.0401130726023788,-0.0286704244187841,6.55245071924566e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0356665912464174,0.00302611434818553,0.0297354071239738,0.0415977753688611,6.58090788218119e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA6,Integrin alpha-6,39866,0.0606388101022062,0.00515298741511074,0.0505389547685891,0.0707386654358232,7.74610675429746e-32
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRBP,Acrosin-binding protein,37368,0.04383394492077,0.00373176314205441,0.0365196891623434,0.0511482006791966,1.05377494599019e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA1,Apolipoprotein A-I,37453,-0.0311548556100506,0.00265396478839631,-0.0363566265953074,-0.0259530846247938,1.14378939089106e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,37445,0.0288824428799922,0.0024617150767796,0.0240574813295042,0.0337074044304803,1.23205663728135e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0495438579383851,0.00422687840441381,0.0412591762657341,0.0578285396110362,1.42448000031185e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.100854952955149,0.0086197344146512,0.0839602735024325,0.117749632407865,1.71188408939014e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0509111533394325,0.00435349009799918,0.0423783127473541,0.0594439939315109,1.8321898132072e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0623860322242983,0.00533259594974596,0.0519341441627962,0.0728379202858003,1.84472066299389e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.062501269235631,0.0053454009649898,0.052024283344251,0.072978255127011,1.8820898085781e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTC,Probetacellulin,39477,0.0839721890626268,0.00719531547972643,0.069869370722363,0.0980750074028906,2.43648594857457e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0245614874481828,0.00210763947079,0.0204305140854344,0.0286924608109312,2.94741823127717e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NID2,Nidogen-2,39858,0.0822984489166924,0.00706529451672655,0.0684504716639083,0.0961464261694764,3.13035528133327e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,39477,0.0619247602115792,0.00531727024178297,0.0515029105376846,0.0723466098854739,3.23796136711586e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,40058,0.0516589308640123,0.00443657364611112,0.0429632465176345,0.0603546152103901,3.28260688262938e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.0312630144676322,0.00268534368181981,0.0259997408512654,0.036526288083999,3.57878359080348e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0788535479210472,0.00679201302020243,0.0655412024014504,0.092165893440644,4.90305469067551e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.101801430650853,0.00876819913122027,0.084615760353661,0.118987100948044,5.16863967965188e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,40052,0.0360341958311579,0.00311024280218901,0.0299381199388674,0.0421302717234483,6.45167885276542e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,39477,0.0497676386485897,0.00429599488206217,0.0413474886797478,0.0581877886174315,6.59373608778692e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.134993110405515,0.0116647594660805,0.112130181851998,0.157856038959033,7.51357097362778e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0407165922799174,0.0035242775432788,0.033809008295091,0.0476241762647439,9.39022767820822e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0568600739714836,0.00492277548796713,0.047211434015068,0.0665087139278992,9.72679589009189e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX9,Sorting nexin-9,39868,0.0777941540721026,0.00673569260842724,0.0645921965595851,0.09099611158462,9.82451584640463e-31
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.0221811459360217,0.00192233263424762,-0.025948917899147,-0.0184133739728964,1.11534165196868e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.102335004623733,0.00886873213113918,0.0849522896467004,0.119717719600766,1.16869829794457e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,37411,0.0668993907486821,0.00582306873046805,0.0554861760369647,0.0783126054603995,2.07965606366355e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFASC,Neurofascin,40058,0.0308752871821493,0.00269002352411533,0.0256028410748832,0.0361477332894153,2.2378889548518e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLTA,Clathrin light chain A,39585,0.0518729490397723,0.00452568365871969,0.0430026090686817,0.0607432890108629,2.70382299450999e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.0983945642417073,0.00859022152354642,0.0815577300555563,0.115231398427858,2.93897909002997e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD84,SLAM family member 5,39866,0.0346543936449348,0.00302623254589242,0.0287229778549856,0.0405858094348839,3.03696562157334e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0524214390941494,0.00458407385894386,0.0434366543306194,0.0614062238576794,3.66174466527998e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPH,Hephaestin,37437,0.02925800677624,0.00255835417829086,0.0242436325867899,0.0342723809656901,3.78547633362656e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3B,Protein FAM3B,39788,0.0398522805565131,0.00348608884596934,0.0330195464184132,0.046685014694613,3.80178165581895e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0269662754456206,0.0023699376824034,0.0223211975881099,0.0316113533031313,6.97388975993741e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF22,Kinesin-like protein KIF22,37021,0.134142442262022,0.0117860504323906,0.111041783414536,0.157243101109508,7.13455696693108e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.0305136392031232,0.00268237956741614,0.0252561752509876,0.0357711031552589,7.2106871778707e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0307135392464035,0.00270147771805574,0.0254186429190142,0.0360084355737927,7.74028866372405e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRN1,Secernin-1,39866,0.0621045993373508,0.00546521880674829,0.0513927704761241,0.0728164281985774,8.25667362063711e-30
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0737576380934108,0.00650314869338604,0.0610114666543742,0.0865038095324475,1.11531399074441e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0392573052391815,0.00346866828322361,0.0324587154040633,0.0460558950742998,1.4566202171321e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0556248454254409,0.00491752580098015,0.0459864948555198,0.065263195995362,1.49871067919303e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARFIP1,Arfaptin-1,37411,0.075958155138558,0.00673276010328615,0.0627619453361172,0.0891543649409989,2.18060046402458e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS27,Serine protease 27,39818,0.0439539785064872,0.00390351501214755,0.036303089082678,0.0516048679302964,2.66360572419655e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,37411,0.0385844740665834,0.00342748988176445,0.0318665938983251,0.0453023542348417,2.87332885538034e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO1A,Coronin-1A,39520,0.0976947350482171,0.00869365448535351,0.0806551722569242,0.11473429783951,3.45194828168716e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEP1B,Meprin A subunit beta,39868,0.125732120564738,0.0111916431652356,0.103796499960876,0.1476677411686,3.55092966114682e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0346776858131415,0.00308900926835709,0.0286232276471616,0.0407321439791214,3.88866385338168e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.107939818772218,0.00962078447713517,0.0890830811970326,0.126796556347402,4.20039438190782e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",37388,0.116339550530639,0.0103666270660224,0.0960209614812352,0.136658139580043,4.25065064735883e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.103412606329529,0.00922314524872341,0.0853352416420316,0.121489971017027,4.56398776363418e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0397750521238448,0.00354717120011133,0.0328225965716266,0.046727507676063,4.74666313426544e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0652659434907026,0.0058204610054956,0.0538578399199312,0.0766740470614739,4.75452470244498e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLF4,Krueppel-like factor 4,36991,0.0429889281974638,0.00383434565978318,0.0354736107042888,0.0505042456906388,4.84887879274866e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NADK,NAD kinase,39868,0.0580607369694489,0.00518683997668598,0.0478945306151444,0.0682269433237535,5.59904706125826e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENAH,Protein enabled homolog,39587,0.0521834079227411,0.00466417887336642,0.0430416173309429,0.0613251985145392,5.99630748299263e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD302,CD302 antigen,39788,0.0315575299226583,0.00282113184339693,0.0260281115096004,0.0370869483357163,6.11260107933944e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO2,Roundabout homolog 2,40009,0.0247144997985,0.00221041899423755,0.0203820785697944,0.0290469210272056,6.45765457330712e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0520389107014418,0.00465574286090425,0.0429136546940695,0.0611641667088142,7.04377795612286e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOF,Apolipoprotein F,37445,-0.0280644876469342,0.00251700335997332,-0.0329978142324819,-0.0231311610613864,9.54757883609344e-29
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR5,Complement factor H-related protein 5,37267,0.0447427320702248,0.00401661145062372,0.0368701736270023,0.0526152905134473,1.0776446382221e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.119583370861777,0.0107414617184344,-0.140636635829908,-0.0985301058936453,1.10807221271679e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0262575610496716,0.00235866708157442,0.0216345735697857,0.0308805485295574,1.11268477892923e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_E,,39866,0.0295588020399716,0.00266058400871652,0.0243440573828872,0.0347735466970559,1.42835424551393e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCN1,Ficolin-1,37430,0.0607046432499642,0.00547045641868944,0.0499825486693329,0.0714267378305955,1.72373332001423e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0373353007882017,0.00336694491816117,0.0307360887486058,0.0439345128277976,1.80888180721462e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FST,Follistatin,39908,0.0554379938278447,0.00499985598997537,0.045638276087493,0.0652377115681964,1.82186898331177e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0436110846679959,0.00393328335760952,0.0359018492870813,0.0513203200489106,1.92346095599941e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA2,Annexin A2,36879,0.0749961151433184,0.00677228471637726,0.061722437099219,0.0882697931874178,2.24608187659643e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX,Glutaredoxin-1,39771,0.0602218412616815,0.00544911984496032,0.0495415663655593,0.0709021161578038,2.72743046881626e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0650219640948025,0.00588349324197865,-0.0765536108490807,-0.0534903173405244,2.86596661620344e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,37437,0.0268388506462877,0.0024312179080726,0.0220736635464654,0.03160403774611,3.25674081031515e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.0466409809140671,0.00422843845706156,0.0383532415382264,0.0549287202899077,3.46823460867866e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASAH1,Acid ceramidase,37340,0.050601234292173,0.00459632937916076,0.0415924287090179,0.0596100398753281,4.5513491567487e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0409566663705614,0.00372788769861386,0.0336500064812782,0.0482633262598446,5.61379799383353e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOL1,Apolipoprotein L1,37445,0.0653999485368278,0.00596742067175759,0.0537038040201829,0.0770960930534726,7.82417895030946e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPL,Periplakin,37056,0.0342040759232389,0.00312234727123243,0.0280842752716233,0.0403238765748545,8.32022023576199e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0326680282074201,0.00298345777845965,-0.038515605453201,-0.0268204509616392,8.61456697391854e-28
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,39587,0.0716138827802374,0.00655445690055512,0.0587671472551494,0.0844606183053255,1.08900753328369e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0315458751313125,0.0028904240813286,0.0258806439319085,0.0372111063307166,1.23465310326969e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM,Paralemmin-1,37299,0.0301974503741419,0.00276596784751414,0.0247761533930142,0.0356187473552696,1.24191644240935e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.0300156308705232,0.00275332670008786,0.024619110538351,0.0354121512026955,1.48315435639234e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVR,Poliovirus receptor,40009,0.0394068962107787,0.0036175943175997,0.0323164113482833,0.0464973810732741,1.54979403142681e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0245315841468336,0.00225673137823695,0.0201083906454892,0.028954777648178,1.99277473128349e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FXN,"Frataxin, mitochondrial",40030,0.0775365518144954,0.00713558821882347,0.0635507989056014,0.0915223047233893,2.07777298680476e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0295804422648285,0.00272300929046255,0.0242433440555219,0.0349175404741351,2.25597227572647e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VGF,Neurosecretory protein VGF,37411,0.0308556499683342,0.0028428799928381,0.0252836051823715,0.0364276947542969,2.48205673400956e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",37403,0.0237765422912633,0.00219135656644056,0.0194814834210398,0.0280716011614868,2.57881830175715e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0705591291958303,0.00650566549480512,0.0578080248260122,0.0833102335656483,2.71562662275988e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0387374808877616,0.0035734745847946,0.0317334707015642,0.045741491073959,2.89129052725817e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BGN,Biglycan,39448,-0.12568887390557,0.0116021965710847,-0.148429179184896,-0.102948568626244,2.99665086482462e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX7,Syntaxin-7,37056,0.0520201446869769,0.00480382911273934,0.0426046396260078,0.061435649747946,3.26865003636766e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLO1,Lactoylglutathione lyase,39585,0.0608976718702277,0.00562866664964211,0.0498654852369292,0.0719298585035263,3.48066348813745e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1F,Protein phosphatase 1F,37437,0.0560311200593443,0.00517826966883118,0.0458817115084352,0.0661805286102534,3.55575594869654e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.027475668290066,0.00253940134456722,0.0224984416547142,0.0324528949254177,3.5813516712233e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.0742719899537572,0.00686793796870293,0.0608108315350995,0.087733148372415,3.82718927719781e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO2,Gamma-enolase,40009,0.0695477749493957,0.00643682695278191,0.0569315941219432,0.0821639557768483,4.05022861003986e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0404039499795689,0.00373893101914538,0.033075645182044,0.0477322547770939,4.14727424285455e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,37169,0.0797405949675841,0.00739039393090422,0.0652554228630118,0.0942257670721564,4.9776677113245e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.080573056054126,0.00747897019515019,0.0659142744716316,0.0952318376366203,5.725686126975e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,39749,0.0493729672713235,0.00459043826971073,0.0403757082626904,0.0583702262799565,6.90117663346728e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0760124703034575,0.00706750193659661,0.0621601665077281,0.0898647740991868,6.92007410014707e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,39788,0.0355332013399301,0.00330661854537707,0.029052228990991,0.0420141736888691,7.64244997259779e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0564468903426383,0.00525474769931462,0.0461475848519816,0.066746195833295,7.95422680927478e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0909144414461215,0.00846382900788655,0.0743253365906639,0.107503546301579,8.33170639412822e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN2,Matrilin-2,39885,0.0310454019150051,0.00289297762791813,0.0253751657642856,0.0367156380657247,8.94815637926829e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLB,Beta-klotho,39489,-0.076833965797272,0.00716218652212678,-0.0908718513806405,-0.0627960802139035,9.34742946670029e-27
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,36593,-0.113483469669612,0.0105825458893401,-0.134225259612719,-0.0927416797265056,1.02504721977799e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL1,Fc receptor-like protein 1,39868,0.0456436384089141,0.00426646085010168,0.0372813751427148,0.0540059016751133,1.27599941046017e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP1,Interstitial collagenase,39314,0.0953930592290061,0.00891888555000913,0.0779120435509883,0.112874074907024,1.32202028897035e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN6,Dynactin subunit 6,39489,0.0738113251423525,0.00690897705181846,0.0602697301207883,0.0873529201639167,1.50333632758453e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0430205966299151,0.00403030850123729,0.03512119196749,0.0509200012923401,1.6479072016316e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCOF1,Treacle protein,37437,0.031612745811335,0.00296114420845585,0.0258089031627616,0.0374165884599085,1.68191489855333e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0400315825010035,0.00375244738761627,0.0326767856212756,0.0473863793807314,1.75753541066664e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.10017265017971,0.00939092345639964,0.0817664402051665,0.118578860154253,1.78667499419627e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMB,RGM domain family member B,40009,0.0263872881419506,0.0024787797105812,0.0215288799092114,0.0312456963746897,2.24364509895504e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBD,Thrombomodulin,39868,0.0281276056798522,0.0026430642182771,0.0229471998120291,0.0333080115476753,2.32634016471393e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNM1,Dynamin-1,37382,0.118395595170973,0.0111503714269593,0.0965408671741331,0.140250323167814,3.11477890987771e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPAG1,Sperm-associated antigen 1,37411,0.0602014900118802,0.0056714800678123,0.0490853890789681,0.0713175909447923,3.22457161244095e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0612230435854924,0.00576834149620844,0.0499170942529239,0.0725289929180609,3.26404014323577e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIT2,Slit homolog 2 protein,39489,0.0532655411418364,0.00502034197107971,0.0434256708785201,0.0631054114051526,3.28971533067988e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,37411,0.0932067509161312,0.00879083845375438,0.0759767075467726,0.11043679428549,3.66493319339771e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA4,Laminin subunit alpha-4,39931,0.0346433602437164,0.0032704309807302,0.0282333155214852,0.0410534049659476,3.9201661688181e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.092300301697853,0.00871767223685456,0.0752136641136181,0.109386939282088,4.31789922825247e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX16,Syntaxin-16,39477,0.0599688812462077,0.00566857130059999,0.0488584814970317,0.0710792809953837,4.55989523087915e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTN,Pleiotrophin,39585,0.0518221719146519,0.00490040072092641,0.0422173865016361,0.0614269573276676,4.755692336935e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTN2,Dynactin subunit 2,39788,0.0971948996495122,0.00921471584664747,0.0791340565900831,0.115255742708941,6.33191964196018e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA,Adenosine deaminase,40058,0.0355791080647874,0.00337910985583894,0.0289560527473431,0.0422021633822317,7.6853940523891e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PER3,Period circadian protein homolog 3,37056,0.120252939646356,0.0114348122672192,0.0978407076026063,0.142665171690106,9.17979637996997e-26
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POMC,Pro-opiomelanocortin,37043,0.0725002134471081,0.00690282850980539,0.0589706695678895,0.0860297573263267,1.05732018809141e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0326832007357655,0.00311226748395107,0.0265831564672214,0.0387832450043096,1.06758202049413e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XRCC4,DNA repair protein XRCC4,39489,0.0378307051411989,0.00361611046240344,0.0307431286348881,0.0449182816475096,1.57249924606818e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APLP1,Amyloid-like protein 1,39868,-0.0520188467024328,0.00497739744683429,-0.061774545698228,-0.0422631477066375,1.75101483228175e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100P,Protein S100-P,39585,0.0535361573963687,0.00512500208322789,0.043491153313242,0.0635811614794954,1.85017280546306e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FEN1,Flap endonuclease 1,39477,0.0632564447718333,0.00606797249121388,0.0513632186890541,0.0751496708546125,2.31801580683731e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOE,Apolipoprotein E,37453,0.0735238657827749,0.00705285822374245,0.0597002636642397,0.0873474679013101,2.38355637120045e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA2,Integrin alpha-2,37124,0.0340925813462534,0.00327404950843013,0.0276754443097304,0.0405097183827765,2.70806994966904e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0391007926279332,0.00377339976554333,0.0317049290874682,0.0464966561683981,4.42701449795481e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPA1,Inositol monophosphatase 1,39749,0.061797105201964,0.00596446821206193,0.0501067475063227,0.0734874628976054,4.48925255123372e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,39767,0.0468730569640863,0.00452444767656185,0.0380051395180251,0.0557409744101475,4.53155723338382e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,39489,0.0567494366367729,0.00548796362906817,0.0459930279237993,0.0675058453497466,5.5507501309933e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,36961,0.0559037743898723,0.00540907718015485,0.0453019831167688,0.0665055656629758,6.09074768207009e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0735277084096912,0.00713721028522704,0.0595387762506462,0.0875166405687362,8.26148845651302e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASET2,Ribonuclease T2,39974,0.0254991405839008,0.00247733538414777,0.0206435632309712,0.0303547179368304,9.044608441964e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.0636003838006345,0.00617685150001018,0.0514937548606145,0.0757070127406544,9.0624133575049e-25
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0336211628500023,0.0032738317709795,0.0272044525788825,0.0400378731211221,1.15219777466783e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0837558657613059,0.00818046657038228,0.0677221512833567,0.0997895802392552,1.63737858740874e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TF,Serotransferrin,37453,0.0217298998306717,0.00212431162684907,0.0175662490420475,0.0258935506192959,1.80053114174054e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA4,Annexin A4,39783,0.0719785987405011,0.0070484775131312,0.0581635828147639,0.0857936146662382,2.08498494190975e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,37333,0.0480939582266893,0.00471170561043912,0.0388590152302286,0.05732890122315,2.25500842201495e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0609165693853124,0.00597168388682422,0.0492120689671369,0.0726210698034879,2.41915283924934e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCRIB,Protein scribble homolog,37043,0.0894838252250706,0.00877866088295148,0.0722776498944857,0.106690000555656,2.61340606493649e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0401709784025976,0.00394616502630515,0.0324364949510395,0.0479054618541557,2.90375087489332e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP12,Macrophage metalloelastase,39900,0.0497129707893087,0.0048856158279732,0.0401371637664812,0.0592887778121362,3.02615740153819e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.0314361243532326,0.00309230492187491,0.0253752067063577,0.0374970420001074,3.33309161808516e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0371890547193534,0.00366001593835781,0.0300154234801721,0.0443626859585347,3.50910917601542e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,37169,0.0346024917295945,0.00340661962086169,0.0279255172727056,0.0412794661864835,3.76098600539771e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0610492106910344,0.00602151634282114,0.049247038659105,0.0728513827229638,4.56873477577307e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSHB,Follitropin subunit beta,37043,0.0644694644791039,0.00636484232335282,0.0519943735253324,0.0769445554328754,5.03034431288838e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.0409978487381482,0.00405088540372032,0.0330581133468564,0.0489375841294401,5.2962745054584e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA9,Serpin A9,39715,0.0714952580998707,0.00706482384205035,0.057648203369452,0.0853423128302894,5.33331105369786e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELOB,Elongin-B,37021,0.0386510469789671,0.00382007326990936,0.0311637033699448,0.0461383905879895,5.63247734354195e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,39695,0.0258511839917908,0.00256362250711157,0.0208264838778521,0.0308758841057295,7.68623221752094e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,39913,0.0259180814680687,0.0025733716034907,0.0208742731252269,0.0309618898109104,8.67640616222942e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,39822,0.0398134942288239,0.00395483002960541,0.0320620273707973,0.0475649610868505,9.09641251257113e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL20,C-C motif chemokine 20,40058,0.0824275666121166,0.00818912767016309,0.066376876378597,0.0984782568456363,9.21971826204488e-24
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0324863438220237,0.00323864446375637,0.0261386006730612,0.0388340869709861,1.30741688246951e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAST,Gastrin,37388,0.113239398968579,0.0112976341408564,0.0910960360525006,0.135382761884658,1.45530675400585e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.034125353823954,0.00340659985386677,-0.0408022895375328,-0.0274484181103751,1.55115104182707e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0329751299308697,0.00329637284976199,0.0265142391453362,0.0394360207164032,1.73184445341644e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0654776210388722,0.00654417133862647,0.0526510452151643,0.0783041968625801,1.73941244823035e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0540815245835659,0.00543302886591897,0.0434327880063648,0.0647302611607671,2.91495110235576e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK4,Dickkopf-related protein 4,39718,0.0438744702787861,0.00440948065903664,0.0352318881870743,0.052517052370498,2.94954410770286e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRG,Histidine-rich glycoprotein,37380,0.0306015609958435,0.00307906101305837,0.0245666014102491,0.0366365205814379,3.39606782731373e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,37169,0.0323457404123753,0.00325660019572947,0.0259628040287455,0.0387286767960051,3.62419218475783e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,39868,0.0841260035798651,0.00848330215711833,0.0674987313519132,0.100753275807817,4.10801516886385e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,40058,0.0714459556675238,0.00721191992812595,0.0573105926083969,0.0855813187266506,4.53008605777469e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C5,Complement C5,37453,0.0146345384771613,0.00148062326195859,0.0117325168837225,0.0175365600706001,5.83517089458404e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAEP,Glycodelin,39749,-0.138913002265344,0.014086072384685,-0.166521704139326,-0.111304300391361,7.09501818366836e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,39453,0.0635237664851254,0.00644252269421009,0.0508964220044736,0.0761511109657771,7.23254787273311e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SWAP70,Switch-associated protein 70,37382,0.0343413460942521,0.00349360739466102,0.0274938756007166,0.0411888165877877,9.98751481093874e-23
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0500422666765076,0.00509889673202227,0.0400484290817439,0.0600361042712712,1.16233865768549e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK6,Kallikrein-6,39889,0.0282119651736743,0.0028775509927765,0.0225719652278323,0.0338519651195162,1.2509137372907e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0461361232922804,0.0047053481801922,0.0369136408591037,0.0553586057254571,1.27400875596838e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0484105563589871,0.00493926176921071,0.0387296032913341,0.0580915094266401,1.2880490551547e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,39908,-0.0253750629262892,0.00259302023700462,-0.0304573825908183,-0.0202927432617602,1.49659875388159e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0280249793797924,0.00286582723375558,0.0224079580016315,0.0336420007579533,1.65238937982989e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENR,Density-regulated protein,37056,0.0549808589091729,0.00563031547571992,0.0439454405767618,0.0660162772415839,1.89272084861297e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,37124,0.0394699311168936,0.00404250064563523,0.0315466298514486,0.0473932323823387,1.91724631617258e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL8,Interleukin-8,39750,0.0627187773144831,0.00642807445737699,0.0501197513780242,0.075317803250942,1.9902066461053e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.079526942700325,0.00815384042822639,0.0635454154610012,0.0955084699396487,2.12209858178618e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOLA1,BolA-like protein 1,36991,0.0520912434758501,0.00534721872283171,0.0416106947791,0.0625717921726003,2.38170655426383e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR3,Small proline-rich protein 3,37388,0.0620411313215707,0.00637445357091602,0.0495472023225753,0.0745350603205661,2.58661422470968e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0863256963225985,0.00891055539593084,0.068861007746574,0.103790384898623,4.01756564921354e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSB,Cathepsin B,39847,-0.0483047554259192,0.00499510901807091,-0.0580951691013382,-0.0385143417505002,4.62879380234718e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPG,Macrophage-capping protein,39739,0.0545765052517351,0.00564725356992453,0.043507888254683,0.0656451222487872,4.91852135665693e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGA,Fibrinogen alpha chain,37149,0.0289920692149235,0.00299950361984624,0.0231130421200249,0.0348710963098221,4.98714521822128e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG4,Regenerating islet-derived protein 4,39885,0.0441594099903338,0.00457163961265952,0.0351989963495211,0.0531198236311465,5.14813548658192e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,39913,0.0279761764567383,0.0028987894989479,0.0222945490388004,0.0336578038746762,5.58596370649445e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,37411,0.0646071515530047,0.00670288260691473,0.0514695016434518,0.0777448014625576,6.45166201856705e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0345879190786093,0.0035947544256246,0.027542200404385,0.0416336377528335,7.41475521543536e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPR,Nucleoprotein TPR,37021,0.0439874855488644,0.00458142621871196,0.035007890160189,0.0529670809375399,9.30564974926257e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0438042288462081,0.00456657627673194,0.0348537393438135,0.0527547183486027,9.88281723940487e-22
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7,Complement component C7,37149,-0.0299411742761311,0.003121082174543,-0.0360584953382354,-0.0238238532140268,1.0041269223928e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JAM2,Junctional adhesion molecule B,40009,0.0233418929711636,0.00244020505557922,0.0185590910622283,0.0281246948800988,1.27351662587293e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0390103846321058,0.0040777803623856,0.03101793512183,0.0470028341423816,1.29385740997916e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.0437209713550765,0.00457738304425721,0.0347493005883324,0.0526926421218206,1.49413255961207e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0236811910769627,0.00248237021340584,0.0188157454586873,0.0285466366952382,1.67312144356183e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.110087556691636,0.0115424589339067,0.087464337181179,0.132710776202093,1.70764360503881e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBS,Cystathionine beta-synthase,37043,0.0472988432065733,0.00496196176398212,0.0375733981491683,0.0570242882639782,1.80420389680492e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR3,Toll-like receptor 3,40058,0.0564044549468785,0.00592653760330208,0.0447884412444065,0.0680204686493506,2.02255149882989e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0570945006276547,0.00600788573574194,0.0453190445856005,0.0688699566697089,2.37007895148796e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0485991006635267,0.00511757784669126,0.0385686480840118,0.0586295532430416,2.53694476413456e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,39477,0.0672483945713196,0.00708356568627801,0.0533646058262146,0.0811321833164245,2.54836019948482e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0485669651872418,0.00512107839407928,0.0385296515348464,0.0586042788396372,2.86793328590655e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0433709783821005,0.00458476045699784,0.0343848478863847,0.0523571088778163,3.50011145027438e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0275637359358963,0.00291303474164037,0.0218541878422812,0.0332732840295114,3.5038854524724e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD59,CD59 glycoprotein,39173,0.0194539823055274,0.00205638656923464,0.0154234646298274,0.0234844999812273,3.50879726604311e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSE,Cathepsin E,37124,0.0486403341248966,0.00514561730862782,0.0385549241999861,0.0587257440498071,3.84596147519203e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPOCK1,Testican-1,39749,0.0233082360402556,0.00246966320524483,0.0184676961579757,0.0281487759225355,4.32223115005703e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.0524626432404846,0.00556081229482772,0.0415634511426223,0.063361835338347,4.47676688266606e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TREML1,Trem-like transcript 1 protein,37445,0.0486866197390819,0.00516177165710526,0.0385695472911556,0.0588036921870082,4.65966901088826e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0607662637722691,0.00644345611295208,0.048137089790883,0.0733954377536552,4.72625967771363e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX6,Syntaxin-6,39477,0.0625711305290297,0.00663936736192954,0.0495579704996478,0.0755842905584116,4.92599263352166e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ULBP2,UL16-binding protein 2,39749,0.0334681627988765,0.00355302020317714,0.0265042432006493,0.0404320823971037,5.13524823075999e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMB1,Laminin subunit beta-1,37043,0.0278368959503912,0.00295950697063117,0.0220362622879541,0.0336375296128283,5.99878830861829e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXNB2,Plexin-B2,39984,0.0215963762278435,0.00229760668094245,0.0170930671331963,0.0260996853224907,6.20117332497677e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,39477,0.0442115801796965,0.00471342909248302,0.0349732591584298,0.0534499012009632,7.49083686121716e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0502965643798264,0.00537679001548251,0.0397580559494806,0.0608350728101721,9.72491659370693e-21
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0640766157287326,0.00686845812960972,0.0506144377946975,0.0775387936627677,1.20549599491356e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.0287181706495094,0.00308458797433297,0.0226723782198167,0.034763963079202,1.43913245007489e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRN,Progranulin,39787,0.0223462244068193,0.00240476911727838,0.0176328769369537,0.0270595718766849,1.69864344426688e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,39788,0.0659048009588756,0.00709318997995232,0.052002148598169,0.0798074533195821,1.71752216672428e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMM2,Phosphomannomutase 2,37021,0.0544167597758497,0.00585874394213003,0.0429336216492748,0.0658998979024245,1.8134880695709e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.0367427362496897,0.00396141240439201,0.0289783679370814,0.0445071045622981,2.04582496217031e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0538715325323095,0.00581513732086251,0.042473863383419,0.0652692016812001,2.21842805312629e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA,Lymphotoxin-alpha,39866,0.0354327628251281,0.00384116630750351,0.0279040768624213,0.042961448787835,3.19770673217823e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIT,Vitrin,37437,0.0329480323170768,0.00357984461326323,0.0259315368750809,0.0399645277590727,3.95465916018588e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFR,Epidermal growth factor receptor,40052,0.0143504555146833,0.00156045309935506,0.0112919674399474,0.0174089435894192,4.1451041074571e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGT,Angiotensinogen,37445,0.0200524805001607,0.00218326443927793,0.0157732821991759,0.0243316788011454,4.71910657544113e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,39913,0.0209521272751988,0.00228300917895402,0.016477429284449,0.0254268252659487,4.94227816937104e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.044915695996338,0.00489356271257692,0.0353243130796873,0.0545070789129888,5.0129238495438e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.102004787351479,0.0111201455590552,0.0802093020557304,0.123800272647227,5.25842923960218e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,39817,0.0352959547298044,0.0038531227696358,0.0277438341013182,0.0428480753582905,5.78907997746045e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0585675809091028,0.00641161940750122,0.0460008068704004,0.0711343549478052,7.33513627126664e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.0217696312402387,0.00238472584537479,-0.0264436938971733,-0.0170955685833041,7.9168468486106e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL1,Chordin-like protein 1,39908,0.0272126566639362,0.00298331713983638,0.0213653550698568,0.0330599582580155,8.26264725673885e-20
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX1,Peroxiredoxin-1,39434,-0.0803729330208243,0.00883394688328749,-0.0976874689120678,-0.0630583971295808,1.02759051995839e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.037492161672969,0.00412080009222287,0.0294153934922121,0.0455689298537258,1.04438990611107e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,XG,Glycoprotein Xg,39985,0.026606384002832,0.00292579705859196,0.0208718217679918,0.0323409462376723,1.06642788731713e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,36991,0.0678523769130807,0.00746734505818772,0.0532163805990328,0.0824883732271287,1.1670361620502e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0322686255903864,0.00355428937407868,0.0253022184171922,0.0392350327635806,1.25196247621047e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,37382,0.0371778423268443,0.0041024752836728,0.0291369907708456,0.045218693882843,1.45060805198219e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,37437,0.0279770183127614,0.00309250903500066,0.0219157006041601,0.0340383360213627,1.67104997047423e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG2,Bone marrow proteoglycan,37437,-0.0446033212219591,0.00493596054251371,-0.054277803885286,-0.0349288385586323,1.83522066665248e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0418154943582014,0.00462945011072596,0.0327417721411785,0.0508892165752242,1.87111746192705e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRDT,Bromodomain testis-specific protein,37021,0.0321392041038076,0.00356042701473638,0.0251607671549243,0.0391176410526909,2.0106777669736e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP8,Caspase-8,39984,0.0540575641230437,0.0060014032301936,0.0422948137918643,0.0658203144542232,2.33990041980629e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN3,CCN family member 3,40042,0.0283536238077092,0.00315007856224595,0.0221794698257071,0.0345277777897112,2.48241210758575e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0222641378490976,0.00247460236943343,-0.0271143584931871,-0.0174139172050081,2.6219182292104e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0195178599097582,0.0021704920534381,0.0152636954850195,0.0237720243344968,2.73599297144418e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB8,Serpin B8,40058,0.0481348954171888,0.00535647413943366,0.0376362061038988,0.0586335847304787,2.83367749944227e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,37388,0.0191787669381581,0.00213391822709468,0.0149962872130525,0.0233612466632637,2.85823115157891e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CIT,Citron Rho-interacting kinase,37039,0.0396126203812673,0.00441012461217839,0.0309687761413976,0.0482564646211369,3.01048799649062e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0324754534741127,0.00361833362871915,0.0253835195618232,0.0395673873864022,3.1434404028768e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPL14,60S ribosomal protein L14,37043,0.0352917125304924,0.00393919031379626,0.0275708995154518,0.0430125255455331,3.70716887479873e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP6,Gastrotropin,39564,0.0469231746963911,0.00526491130378765,0.0366039485409673,0.0572424008518149,5.53191840316217e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,37039,0.0507043064854135,0.00568961636027566,0.0395526584192732,0.0618559545515538,5.67720327196864e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0430733629209731,0.00483434755371217,0.0335980417156972,0.0525486841262489,5.75245712072901e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0510808878335325,0.00573588537042271,0.039838552507504,0.0623232231595611,5.9821557096006e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0216380934636265,0.00243062105804915,0.0168740761898501,0.0264021107374028,6.04491971896439e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,39868,0.0542474303454231,0.0060939023465241,0.0423033817462358,0.0661914789446103,6.06739081604674e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,39749,0.0450583707236304,0.00506694399660063,0.0351271604902931,0.0549895809569676,6.60013501726856e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0421531852717091,0.00475236021377926,0.0328385592527017,0.0514678112907164,8.0779141636234e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDGF,Hepatoma-derived growth factor,40014,0.0810141295435465,0.00913514625749556,0.0631092428788552,0.0989190162082378,8.18311238088382e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0638172005073953,0.00720640868422912,0.0496926394863062,0.0779417615284844,9.36439110538526e-19
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0411002824512253,0.0046527499795845,0.0319808924912397,0.050219672411211,1.11767050988528e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,39858,-0.0229701530240999,0.00260218317012549,-0.0280704320375459,-0.017869874010654,1.18194354457671e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,37056,0.0555875715589179,0.00630062933531468,0.0432383380617012,0.0679368050561347,1.2580931087496e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALCAM,CD166 antigen,40052,0.0166594417141427,0.00188887591233091,0.0129572449259741,0.0203616385023113,1.26195403506096e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,37021,0.0433961365189748,0.00492452578665531,0.0337440659771304,0.0530482070608192,1.37890632506798e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,37043,0.069030477583194,0.00783401857495741,0.0536758011762774,0.0843851539901105,1.38619441336899e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0525435388674652,0.00596503037246017,0.0408520793374433,0.0642349983974872,1.41912681328664e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA9,Carbonic anhydrase 9,40030,-0.0370866724201739,0.00421205071151117,-0.0453422918147358,-0.0288310530256121,1.44026250885727e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSG,Basigin,40040,0.0166368427292838,0.00189201326156325,0.0129284967366198,0.0203451887219477,1.5976409743404e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0553638311739362,0.00630124857136435,0.0430133839740621,0.0677142783738104,1.70588884052216e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE6,Ribonuclease K6,37386,0.0236339045872431,0.00269128006560872,0.01835899565865,0.0289088135158362,1.80229963110472e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,39846,0.0585712312912253,0.00667464453096197,0.0454889280105398,0.0716535345719107,1.87596324075621e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK3,NT-3 growth factor receptor,40009,-0.0182087437605074,0.00207574570792926,-0.0222772053480488,-0.0141402821729661,1.92520333199167e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,39971,-0.0195330775485763,0.00223384419535448,-0.0239114121714711,-0.0151547429256815,2.46538680609211e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR2,Complement factor H-related protein 2,37364,0.0479482955610678,0.00548820206555192,0.037191419512586,0.0587051716095496,2.68203021240231e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,37043,0.0444839018518084,0.00509382516349868,0.034500004531351,0.0544677991722658,2.77830412657678e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPPB,Natriuretic peptides B,39585,-0.107570584348751,0.0123305666109055,-0.131738494906126,-0.0834026737913762,2.95336957408055e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,39867,-0.0807148331324674,0.00925585530702862,-0.0988563095342435,-0.0625733567306914,3.04032287370634e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDA,Cytidine deaminase,37422,0.03939620144681,0.00451743103719416,0.0305420366139094,0.0482503662797105,3.07704260854574e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGA11,Integrin alpha-11,39866,-0.0288291810496151,0.00330903105035711,-0.035314881908315,-0.0223434801909152,3.26561616669104e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMS,Spermine synthase,36991,0.054165195124383,0.00624676881308875,0.0419215282507291,0.066408861998037,4.78534016969241e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0342061252657844,0.00395467347091721,0.0264549652627867,0.0419572852687822,5.74871550873804e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEK,Angiopoietin-1 receptor,39913,0.0182051077369547,0.00210874705959382,0.0140719635001508,0.0223382519737586,6.52167795753655e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,37437,0.0281743736634551,0.00326683108735536,0.0217713847322386,0.0345773625946716,7.15225405703146e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0474744192701975,0.00551974918795336,0.0366557108618089,0.0582931276785861,8.6513971886148e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAPK2,Death-associated protein kinase 2,37056,0.044602295115576,0.00518942387016841,0.0344310243300459,0.0547735659011061,9.26794291377111e-18
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.043516138837151,0.00507064455365341,-0.0534546021623116,-0.0335776755119903,1.01714370500995e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXN,Thioredoxin,37289,0.0360124336597298,0.00420657725123907,0.0277675422473012,0.0442573250721584,1.23969249678814e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA14,Carbonic anhydrase 14,40030,-0.0291928687891979,0.00341691016346189,-0.0358900127095832,-0.0224957248688126,1.41501057882584e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A13,Protein S100-A13,37056,0.0289409304647368,0.00338743185955898,0.0223015640200012,0.0355802969094724,1.4423887931913e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300E,CMRF35-like molecule 2,39991,0.0319564260616341,0.00374311891363915,0.0246199129909014,0.0392929391323669,1.49380473968188e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0287434970290933,0.00336898186692956,0.0221402925699113,0.0353467014882752,1.56874470520403e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0354125412830345,0.00415373765207733,0.027271215484963,0.0435538670811061,1.68634502036677e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD248,Endosialin,37437,-0.0329204633338607,0.00386238622753024,-0.0404907403398199,-0.0253501863279014,1.71219811436606e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0448974440582656,0.00528169482061516,-0.0552495659066713,-0.0345453222098599,2.05092405180777e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0290895372159552,0.00342962353259636,0.0223674750920663,0.035811599339844,2.4128528751794e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1,Programmed cell death protein 1,39998,0.0337501174248816,0.00398416404456575,0.0259411558975327,0.0415590789522305,2.63867338941683e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRSF1,G-rich sequence factor 1,36874,0.0666553000469625,0.00787506218209682,0.0512201781700527,0.0820904219238723,2.85565660407233e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL5,Insulin-like peptide INSL5,37382,0.0796684532479238,0.00943795394588224,0.0611700635139946,0.098166842981853,3.45547933191209e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS22,Brain-specific serine protease 4,37056,0.0276522481510386,0.00327856970342367,0.0212262515323282,0.034078244769749,3.6775434874961e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA6,Carbonic anhydrase 6,39817,-0.0521821543765818,0.0061927442728834,-0.0643199331514333,-0.0400443756017303,3.86726499002483e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300A,CMRF35-like molecule 8,37124,0.0237241353012043,0.00281915317073195,0.0181985950865697,0.0292496755158389,4.3158724613885e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA2,Carbonic anhydrase 2,39821,0.055594490805269,0.00661380849269371,0.0426314261595893,0.0685575554509486,4.60340559473084e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP3,Stromelysin-1,39858,-0.0390075701059286,0.0046436399374363,-0.0481091043833038,-0.0299060358285535,4.82671365447071e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK7,Kallikrein-7,36818,0.031969961321854,0.00380643135845281,0.0245093558592865,0.0394305667844215,4.97121818802085e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,39913,-0.0220802453693664,0.00263041465652908,-0.0272358580961634,-0.0169246326425695,5.07744840208415e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,37169,0.0581626909279019,0.00692954067671471,0.0445807912015411,0.0717445906542627,5.19439780162657e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,36962,0.0404179285482321,0.00482817405294698,0.030954707404456,0.0498811496920082,6.27475253374093e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRK1,Protein BRICK1,39489,0.0362939649836061,0.00433670231258661,0.0277940284509364,0.0447939015162759,6.29651369378092e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0791781215227894,0.00948037239125363,0.0605965916359323,0.0977596514096465,7.26917727529476e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB2,Lamin-B2,37388,0.0222244940092175,0.00266356041216495,0.0170039156013742,0.0274450724170608,7.87890653903225e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO1,Roundabout homolog 1,39885,0.0191424879334793,0.00229798915612015,0.0146384291874838,0.0236465466794748,8.72409142227938e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0531942109463313,0.00638988763166235,0.040670031188273,0.0657183907043895,9.27920314492176e-17
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0266039003676129,0.00319978551291648,-0.0328754799729292,-0.0203323207622966,1.01029331786988e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0381326577146749,0.00458802517841584,0.0291401283649798,0.0471251870643699,1.02336397783165e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0289964136702299,0.00349827245953926,0.0221397996495329,0.0358530276909268,1.23305565730444e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFC1,Cryptic protein,39477,0.0376440357712487,0.00454677327753086,0.0287323601472882,0.0465557113952092,1.33857759502168e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNA1,Ephrin-A1,39826,0.0212289748831322,0.00256698024145889,0.0161976936098728,0.0262602561563917,1.44392385724984e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,39788,0.0180674045471376,0.00218601821663147,0.01378280884254,0.0223520002517353,1.50619146585434e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300LF,CMRF35-like molecule 1,40030,0.047970277673518,0.005812025466882,0.0365787077584293,0.0593618475886067,1.65403092403523e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0524572725204657,0.00635950183422452,0.0399926489253856,0.0649218961155457,1.72426951148702e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.0219762666947384,0.00267559451141209,0.0167321014523707,0.0272204319371061,2.3091018451089e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0297183945871149,0.00362385472865113,0.0226156393189587,0.0368211498552711,2.60828611812895e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0311948798006022,0.00380639170664966,0.0237343520555688,0.0386554075456355,2.68856302730919e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,39738,0.0383881006977067,0.00468463010886744,0.0292062256843265,0.0475699757110869,2.7071266427434e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A12,Protein S100-A12,39615,0.059459138077354,0.00727235199467934,0.0452053281677824,0.0737129479869255,3.15443682090041e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMOX1,Heme oxygenase 1,39691,-0.0378234443890123,0.00464035121490365,-0.0469185327702234,-0.0287283560078011,3.87754315349439e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0292423037734878,0.00359049262296185,0.0222049382324826,0.0362796693144931,4.09653747725573e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0231100629166465,0.00284036635422747,0.0175429448623607,0.0286771809709323,4.37465205346816e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,37043,0.0247946107701279,0.00305082581887835,0.0188149921651264,0.0307742293751295,4.78345779181871e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0123888224746804,0.00152553083987911,0.00939878202851734,0.0153788629208434,4.95418943774163e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0431215169786382,0.00531073134047533,0.0327124835513066,0.0535305504059699,5.0128920371387e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP9,Caspase-9,37056,0.0500123974048662,0.00617426968821437,0.0379108288159661,0.0621139659937664,5.96957104097657e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,37043,0.0325969972349624,0.00403674505580442,0.0246849769255857,0.040509017544339,7.32610536088238e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PZP,Pregnancy zone protein,37453,0.0432887131149905,0.00536171587509977,0.032779749999795,0.0537976762301861,7.39190760755717e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0257448977482918,0.00318987708370355,0.0194927386642329,0.0319970568323508,7.5842677344844e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,39866,-0.041021972943005,0.00510369559950352,-0.0510252163180319,-0.0310187295679781,9.78854781487215e-16
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0249486531409859,0.00310523765933421,0.0188623873286909,0.0310349189532809,1.00641084725646e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0574191451744949,0.0071826157146848,0.0433412183737127,0.0714970719752771,1.39499155633923e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLU,Clusterin,37453,0.0247642922760965,0.00310358123324327,0.0186812730589397,0.0308473114932534,1.58935255537359e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0324460865881471,0.00407703840850051,0.0244550913074861,0.040437081868808,1.86423777337595e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0216818813260199,0.00273149576767146,-0.027035613030656,-0.0163281496213839,2.19474259829279e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0339095078815634,0.0042814741606779,0.0255178185266348,0.0423011972364921,2.52904989485695e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHPS,Deoxyhypusine synthase,37368,0.0316091606150474,0.00399320254494255,0.02378248362696,0.0394358376031348,2.64855997515342e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS1,Nephrin,37056,0.026408673361564,0.00333937637525818,0.0198634956660579,0.03295385105707,2.81670505195442e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,37388,0.0274907481406335,0.00348241991257989,0.0206652051119769,0.03431629116929,3.14695296785001e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX5,Sorting nexin-5,37043,0.0234187555840709,0.00296762614725212,0.0176022083354567,0.0292353028326851,3.22271704588266e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0361062925371422,0.00457687529541001,0.0271356169581386,0.0450769681161458,3.25105726294174e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCN5,CCN family member 5,39858,0.0295417058977947,0.00374941459013032,0.0221928533011393,0.0368905584944501,3.51065197941691e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,37124,0.0194201040474549,0.00247045813360279,0.0145780061055935,0.0242622019893164,4.10593314568766e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0307685149951997,0.00391694899232462,0.0230912949702434,0.0384457350201559,4.29937852834516e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18BP,Interleukin-18-binding protein,39931,0.0225631181163949,0.00287542263120007,0.0169272897592428,0.0281989464735471,4.53190595004946e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,39858,0.0676321976246333,0.00861971553483464,0.0507375551763574,0.0845268400729092,4.55719403838012e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAM,Integrin alpha-M,39858,-0.0240911794880481,0.00307283225742161,-0.0301139307125945,-0.0180684282635018,4.78569805007093e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAM,Signal transducing adapter molecule 1,37368,0.0276895917889229,0.00354845946174841,0.020734611243896,0.0346445723339498,6.47384951129794e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSF,Cathepsin F,39913,0.0306949699590016,0.00393860459464817,0.0229753049534912,0.038414634964512,6.92274714639888e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH1,Cadherin-1,39315,0.0305898685086272,0.00392520818041417,0.0228964604750154,0.0382832765422389,6.94831861811583e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0465098230748517,0.00596716270398715,0.0348141841750369,0.0582054619746665,6.95044363340932e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.0203496174267209,0.00261762708889468,0.0152190683324873,0.0254801665209545,8.05854478802459e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GC,Vitamin D-binding protein,37453,0.0195711061697853,0.00251913698414315,0.0146335976808647,0.0245086146587058,8.47778675490926e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,37368,0.0219814374226538,0.00283200691920645,0.0164307038610091,0.0275321709842984,8.97387732837229e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,39585,0.0399200119052114,0.00514763309880974,0.0298306510315443,0.0500093727788785,9.37192050714713e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCT,Secretin,37039,0.0333424060134683,0.00430221184574713,0.0249100707958039,0.0417747412311327,9.85556063517772e-15
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,39843,0.0625855345651432,0.0080830542810558,0.0467427481742739,0.0784283209560126,1.03045494654759e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.0180852861511316,0.00234351576795498,0.0134919952459398,0.0226785770563233,1.25990530987103e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,37437,0.0404295779243321,0.00523812575976052,0.0301628514352015,0.0506963044134627,1.26073725186797e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0249602483440325,0.00323738099643941,-0.0313055150970538,-0.0186149815910113,1.33305735584277e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0210467368086124,0.00273210201687723,0.0156918168555331,0.0264016567616918,1.40059381416216e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0284193657406751,0.0036906929538759,0.0211856075510784,0.0356531239302719,1.45154476282781e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGCR6,Protein DGCR6,36991,0.0324976764358944,0.00422228045563793,0.024222006742844,0.0407733461289447,1.49562603154301e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,37388,0.0190938416915068,0.00248484123342064,0.0142235528740023,0.0239641305090112,1.64617048792433e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.0287680734288618,0.00375289717993673,0.0214123949561858,0.0361237519015378,1.88307046860289e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB6,Integrin beta-6,39587,0.0221301550950623,0.00288895398221764,0.0164678052899158,0.0277925049002089,1.96323901518513e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0299187569525757,0.00390673535370203,0.0222615556593197,0.0375759582458316,1.9922454586255e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,39666,0.0269840827768325,0.00352557419402942,0.0200739573565348,0.0338942081971302,2.06340894328465e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,37021,0.0892648995783769,0.0116749471562355,0.0663820031521553,0.112147796004599,2.2193559129859e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH5,Cadherin-5,40052,-0.0226968286733746,0.00296937811414621,-0.0285168097771012,-0.016876847569648,2.22979626617199e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0336038158903951,0.00440386599976301,-0.0422353932499306,-0.0249722385308596,2.46888203597448e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",39862,0.0695503715177935,0.00912016420027305,0.0516748496852583,0.0874258933503287,2.55716264738911e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX2,Sorting nexin-2,37368,0.0598373196265746,0.00785735030198275,0.0444369130346885,0.0752377262184608,2.80180108519105e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,37339,0.0357652963605364,0.00470155213609776,0.0265502541737848,0.044980338547288,2.98800149029137e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0379421903762766,0.00499235561083985,0.0281571733790305,0.0477272073735227,3.12768925126313e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MPO,Myeloperoxidase,39858,0.0335617561684413,0.00441657981673021,0.0249052597276501,0.0422182526092325,3.14822369360692e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0308597551677825,0.00407582042171159,0.0228711471412277,0.0388483631943372,3.89244987415709e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0243536293393486,0.00322035237350281,-0.0306655199914141,-0.018041738687283,4.21138364483104e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PVALB,Parvalbumin alpha,39971,0.0839595514605777,0.0111172759216307,0.0621696906541816,0.105749412266974,4.50966328656047e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP2,Retinol-binding protein 2,39788,-0.0560764716742073,0.00743707743680478,-0.0706531434503447,-0.04149979989807,4.94781622410374e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKK3,Dickkopf-related protein 3,40052,-0.0210513088427591,0.00279745261763304,-0.0265343159733199,-0.0155683017121983,5.54134232939155e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17D,Interleukin-17D,39587,0.0247713796139232,0.00329941366647901,0.0183045288276243,0.0312382304002221,6.33428133647271e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0395086862082783,0.00526260288062624,0.0291939845622509,0.0498233878543057,6.40469929531787e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN3,Calsyntenin-3,37388,0.0221207515123546,0.0029467757050442,0.016345071130468,0.0278964318942412,6.43918371503648e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI2,Serpin I2,37382,0.0418545653830632,0.00557972718163528,0.0309183001070581,0.0527908306590684,6.71833803940688e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0441916480219237,0.00589410362033873,0.0326392049260598,0.0557440911177876,6.91393548283896e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,39931,0.0475691357951788,0.00634861866259445,0.0351258432164937,0.0600124283738639,7.09047120040248e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0263300359257074,0.0035186696184576,0.0194334434735305,0.0332266283778843,7.64444319291945e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,37382,0.0368671873065307,0.00492967519763118,0.0272050239191735,0.0465293506938878,7.97269464267398e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0410479987741193,0.00549194846655546,0.0302837797796705,0.051812217768568,8.25694617889449e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,39489,0.0422271690842188,0.00565332144248662,0.031146659056945,0.0533076791114926,8.47854851256753e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0588887011509516,0.0078864899677803,0.0434311808141022,0.074346221487801,8.63491299056677e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0751065426909091,0.0100721378827075,0.0553651524408023,0.0948479329410159,9.39966264457169e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM3,Myomesin-3,37124,-0.0681087312229568,0.00913362047361524,-0.0860106273512427,-0.0502068350946709,9.40589436202874e-14
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,37021,0.0265280778003953,0.0035654995464732,0.0195396986893078,0.0335164569114828,1.06752431614192e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0261738988998883,0.00352540101055263,0.0192641129192051,0.0330836848805714,1.20097982716391e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPB2,Coatomer subunit beta',37021,0.0309251561687074,0.00416673199414954,0.0227583614601743,0.0390919508772405,1.22516487709112e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.031869435701356,0.00430910297706604,0.0234235938663066,0.0403152775364055,1.4901745139424e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0558524480429653,0.00758393845012087,0.0409879286807284,0.0707169674052022,1.88268387468974e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.0272795437106589,0.003704622148186,0.0200184843002143,0.0345406031211034,1.89461991251634e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL2,Fc receptor-like protein 2,39990,0.0331234719340849,0.00450515729235167,0.0242933636410756,0.0419535802270942,2.0410032133299e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,39858,-0.0201743305898053,0.00274609462207732,-0.0255566760490768,-0.0147919851305337,2.13189266273499e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD300C,CMRF35-like molecule 6,40009,0.0236479095526826,0.00324036199988361,0.0172968000329107,0.0299990190724545,3.05834516103024e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFHR4,Complement factor H-related protein 4,37409,0.0511872884144517,0.00701325032406154,0.0374413177792911,0.0649332590496123,3.06839647225892e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0240456590665456,0.00329672783086132,0.0175840725180575,0.0305072456150338,3.18123316040234e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,37445,-0.0181660787587817,0.00249324842795892,-0.0230528456775812,-0.0132793118399823,3.3662401411955e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,39564,0.0290683098672155,0.00399628460010129,0.021235592051017,0.0369010276834141,3.65923250322988e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0603752973568985,0.00831469239637591,0.0440785002600018,0.0766720944537953,4.0111456045377e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO3,R-spondin-3,40030,0.0190389840678274,0.00262446466027407,0.0138950333336902,0.0241829348019645,4.21656458109248e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,37453,0.0131070054411648,0.00180772129949283,0.00956387169415885,0.0166501391881707,4.37449075714036e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.0167981190402822,0.00231887581065197,-0.0213431156291601,-0.0122531224514044,4.55160223724096e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AFAP1,Actin filament-associated protein 1,37124,0.05993603483766,0.00827593167509268,0.0437152087544783,0.0761568609208416,4.65771024590772e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0377360686948952,0.00521452178138205,0.0275156060033863,0.047956531386404,4.84442184166994e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMD,Osteomodulin,39931,-0.0306191415980515,0.00423664116262851,-0.0389229582768034,-0.0223153249192996,5.1513146716306e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0546895349513783,0.00757902063170123,-0.0695444153895127,-0.0398346545132438,5.59763372399505e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0389496460912291,0.00539853075350466,0.0283685258143599,0.0495307663680982,5.68638512109826e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,39788,0.0419492660184446,0.00583065220459934,0.0305211876974299,0.0533773443394593,6.54294194650602e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1B,Interleukin-1 beta,39478,0.0389903155499942,0.00543303060719174,0.0283415755598984,0.04963905554009,7.47183794500927e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAX,Apoptosis regulator BAX,39456,0.0639958124348853,0.00892313782370479,0.0465064623004239,0.0814851625693467,7.72895989855008e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0389017602482358,0.0054294532729801,0.0282600318331948,0.0495434886632768,8.1170811903057e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,39866,0.0422334080881352,0.00590018250645126,0.0306690503754907,0.0537977658007796,8.54271338666654e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,39617,0.0203669656576987,0.00284900716662178,0.01478291161112,0.0259510197042774,9.13857757139101e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY75,Lymphocyte antigen 75,39866,0.0269039766845583,0.00376362830973615,0.0195272651974754,0.0342806881716411,9.15766403899043e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.0228743451768985,0.00320204995957626,0.0165983272561291,0.029150363097668,9.47939941723001e-13
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,39587,0.0250043855316244,0.00350589045493107,0.0181328402399595,0.0318759308232893,1.03150220785934e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0329091089683456,0.00461545179098668,0.0238628234580117,0.0419553944786795,1.04613689622884e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.068465252082888,0.00961181893590184,0.0496260869685203,0.0873044171972556,1.11070662401617e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0416948163922371,0.00585787872150394,0.0302133740980894,0.0531762586863849,1.14492102119837e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFIC,Nuclear factor 1 C-type,37411,0.0291001053420524,0.00408808539281651,0.0210874579721321,0.0371127527119728,1.14788031536416e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE3,Eosinophil cationic protein,39791,0.0744644452967523,0.0104716464888892,0.0539400181785295,0.0949888724149751,1.20053186433825e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYGD,Gamma-crystallin D,37388,0.0667228481134783,0.00938711764214252,0.048324097534879,0.0851215986920777,1.23712024438901e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.0255488752966268,0.0036061136695301,0.0184808925043478,0.0326168580889058,1.46039261473792e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0192962118829855,0.00272722003444557,0.0139508606154722,0.0246415631504988,1.56530404986461e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.0171763341935611,0.00243138204304463,0.0124108253891936,0.0219418429979285,1.69163242216355e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST5,Cystatin-D,39559,0.037307180009777,0.00528649418995862,0.0269456513974581,0.0476687086220959,1.77159128584875e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0577739179215074,0.00819754284993322,0.0417067339356383,0.0738411019073765,1.89487497806937e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CX3CL1,Fractalkine,39749,-0.0227385217444161,0.00323178426745142,-0.0290728189086209,-0.0164042245802113,2.06057881242709e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0433789196335744,0.0061675203791965,0.0312905796903493,0.0554672595767996,2.09661758258884e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR1,Complement receptor type 1,37420,0.0244206499754736,0.00347478349253668,0.0176100743301017,0.0312312256208454,2.1958306500408e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1A,Protein phosphatase 1A,39477,0.0208750961588117,0.00297618008495787,0.0150417831922943,0.0267084091253291,2.41007001856691e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0264972099775209,0.00377801068668518,0.019092309031618,0.0339021109234239,2.41715769880163e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.0472276681616791,0.00673450606993539,0.0340280362646057,0.0604273000587524,2.44722701229558e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCOR1,REST corepressor 1,39585,0.0307034801904127,0.00438102137234615,0.0221166783006143,0.0392902820802112,2.51043546577875e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRH,Corticoliberin,39455,0.0593516607858645,0.00847527428251261,0.0427401231921398,0.0759631983795892,2.60921775858276e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,37056,0.0281543281236791,0.00402019805320403,0.0202747399393992,0.036033916307959,2.6226248284694e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.034331531412941,0.00491922616898421,0.024689848121732,0.0439732147041501,3.11389671723863e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.0327477189145281,0.00470142326797807,0.0235329293092911,0.0419625085197651,3.40234220632157e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTL1,Cytokine-like protein 1,37437,0.0154959864853669,0.00223025008586687,0.0111246963170679,0.019867276653666,3.87131283678465e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GM2A,Ganglioside GM2 activator,37178,0.0244484658626642,0.00352263816533861,0.0175440950586005,0.0313528366667278,4.09128341562459e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0412372330064562,0.00594562893802959,0.0295838002879182,0.0528906657249941,4.22997837908028e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0384805230053829,0.0055527780690358,0.0275970779900727,0.0493639680206931,4.37312925452658e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0172413871679789,0.00248817625704174,0.0123645617041771,0.0221182126317807,4.3896874946103e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL3,Insulin-like 3,37388,0.0489417026866843,0.00706458525262979,0.0350951155915299,0.0627882897818387,4.46909519296651e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0246983338871871,0.00356774135020025,0.0177055608407946,0.0316911069335796,4.63185517954256e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0152899247819527,0.00221045634332457,0.0109574303490365,0.0196224192148689,4.78268012825045e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,39856,0.028775113314767,0.0041678461231218,0.0206061349134482,0.0369440917160857,5.24325634560488e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR2,Folate receptor beta,40009,-0.0193639466490036,0.00280880459576298,-0.024869203656699,-0.0138586896413081,5.62467558054306e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0269192926574353,0.0039080217310326,0.0192595700646114,0.0345790152502592,5.86009334504711e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0284810428673583,0.00414049732533578,0.0203656681097002,0.0365964176250164,6.3144639353675e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,39364,0.0671833600263997,0.0097721796600011,0.0480298878927975,0.0863368321600018,6.4373240666187e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0281950468586545,0.00410827018715539,0.02014283729183,0.0362472564254791,7.03561085122498e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH1,Protocadherin-1,40018,0.0138772229710155,0.00202532914810401,0.00990757784073163,0.0178468681012993,7.55408968782407e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSR,Insulin receptor,37056,0.0111225156234808,0.00162324881916463,0.00794094793791814,0.0143040833090435,7.60515588231819e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,37043,0.0399520493457926,0.00583591857837989,0.0285136489321681,0.0513904497594172,7.93667253510497e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,39868,0.0184492725590066,0.00269612503897526,0.0131648674826151,0.0237336776353981,8.04288112437755e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.0282725251973938,0.00413951168304034,0.0201590822986347,0.0363859680961528,8.80089834986736e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0239368989193036,0.00350931402477075,-0.0308151544078543,-0.017058643430753,9.36950966758479e-12
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0227917753270673,0.00334885690818676,0.0162280157870213,0.0293555348671134,1.04046670233014e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA4,Carbonic anhydrase 4,40052,-0.0154934850841046,0.00228155960793446,-0.0199653419156562,-0.0110216282525531,1.15436336349366e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHCY,Adenosylhomocysteinase,39868,0.0446001633449562,0.0066013685446474,0.0316614809974473,0.0575388456924651,1.46541094425974e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,39017,0.0235662723548603,0.00349409085545646,0.0167178542781657,0.030414690431555,1.58993515782633e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.0280529590190844,0.0041682827424272,-0.0362227931942417,-0.0198831248439271,1.75330839621918e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPQ,Carboxypeptidase Q,37430,0.0247733316916504,0.00368059342841989,0.0175593685719474,0.0319872948113534,1.7551193489013e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0459262435303954,0.00684173533527897,0.0325164422732486,0.0593360447875422,1.98928406998573e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0298415448119348,0.00444633212523833,0.0211267338464677,0.0385563557774019,2.00507401246627e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,39489,0.0228699623794426,0.00340917680116728,0.0161879758491548,0.0295519489097305,2.03590766261944e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN8,Septin-8,37357,0.0208251714226627,0.00310719774088678,0.0147350638505246,0.0269152789948008,2.13404523106687e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0228865634970604,0.00342138425822405,0.0161806503509412,0.0295924766431795,2.33352985693065e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0172339482846397,0.00258843838650854,0.0121606090470829,0.0223072875221964,2.86417230390149e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",37437,0.0318328298116672,0.00478152834145692,0.0224610342624117,0.0412046253609228,2.89307610373875e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LUZP2,Leucine zipper protein 2,37368,0.0283518026393417,0.00426201505165789,0.0199982531380922,0.0367053521405911,2.99849701755747e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD276,CD276 antigen,39862,-0.0226421324573209,0.00342859060408284,-0.0293621700413233,-0.0159220948733186,4.13041362130701e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAA4,Serum amyloid A-4 protein,37453,0.0212480504393,0.00321732669117802,0.0149420901245911,0.0275540107540089,4.14369176521428e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0345722236203717,0.0052403825388572,0.0243010738442116,0.0448433733965318,4.31993810521041e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.036056518194172,0.00547385209952279,0.0253277680791073,0.0467852683092366,4.65718859139558e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAS2,Growth arrest-specific protein 2,37169,0.0339886651366396,0.00516248036513559,0.0238702036209738,0.0441071266523053,4.75822062269369e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0200919673177412,0.00305549464289721,0.0141031978176627,0.0260807368178198,5.02536456404799e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSM,Oncostatin-M,39785,0.0454799530138121,0.00696199755831218,0.0318344377995202,0.059125468228104,6.6596518153561e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA12,Serpin A12,39405,0.0749912710972097,0.0115039708921804,0.0524434881485362,0.0975390540458832,7.30896848412741e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.0167987669006999,0.00257829866746908,0.0117453015124605,0.0218522322889393,7.46373295167881e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAT,Catalase,37252,0.0335282678174582,0.00515136358672306,0.023431595187481,0.0436249404474354,7.8545367289276e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYZL2,Lysozyme-like protein 2,36962,0.0228816805277845,0.00351560886916699,0.0159910871442172,0.0297722739113519,7.86181885227924e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN2,Calsyntenin-2,40058,-0.0249469301824937,0.0038368838754545,-0.0324672225783845,-0.0174266377866028,8.16461006297044e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSH,Pro-cathepsin H,39546,0.0458193388967174,0.00704997715019642,0.0320013836823324,0.0596372941111024,8.31738285964368e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0381344747311063,0.00588536054019475,0.0265991680723246,0.049669781389888,9.52697884747865e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHISA5,Protein shisa-5,37437,0.0144727144794882,0.00223433102987679,0.0100934256609297,0.0188520032980467,9.65151034467702e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0256200951405342,0.00395637081523756,0.0178656083426686,0.0333745819383998,9.7220315560524e-11
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0363357445088443,0.00561625851919529,0.0253278778112216,0.0473436112064671,1.01019037584782e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0237700628721434,0.0036903345220216,0.016537007208981,0.0310031185353057,1.22681064622731e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,37437,-0.0213708664153886,0.00332672989757591,-0.0278912570146374,-0.0148504758161398,1.3717742839368e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B2M,Beta-2-microglobulin,37453,0.0192779902903736,0.00300212407268692,0.0133938271079073,0.02516215347284,1.39470161938879e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,39868,0.0109860238550879,0.00171224973140074,0.00763001438154245,0.0143420333286333,1.43703233058316e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,37388,0.149506245409309,0.0233023046935825,0.103833728209887,0.195178762608731,1.44614439929322e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,37368,0.0371809560771842,0.00582159877141425,0.0257706224852123,0.0485912896691561,1.7502503034777e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0190483850659838,0.00298357355648917,-0.0248961892367026,-0.013200580895265,1.76872363815337e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0238963217049936,0.0037467767093501,0.0165526393546674,0.0312400040553198,1.85599344950831e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EBI3_IL27,Interleukin-27,40011,-0.0191226662738447,0.00299922896103476,-0.0250011550374729,-0.0132441775102166,1.86876450417804e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,40024,-0.0220139209177398,0.00345972638622133,-0.0287949846347336,-0.015232857200746,2.03295218747765e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH1,Neurexophilin-1,39489,0.023289571361066,0.00366092719248265,0.0161141540638001,0.030464988658332,2.05137041082507e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0200510484944188,0.00315829669676302,0.0138607869687633,0.0262413100200743,2.24064593140003e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOBR,Apolipoprotein B receptor,37043,-0.0262878765836867,0.00414700662187814,-0.0344160095625678,-0.0181597436048055,2.38795984948575e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL21,C-C motif chemokine 21,39931,0.0241467198781647,0.00381461019298415,0.0166700838999158,0.0316233558564136,2.51559550361495e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL34,Interleukin-34,39456,0.0220693892262597,0.00348786209783308,0.0152331795145069,0.0289055989380126,2.55991215896733e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0329089472897853,0.00520434478756181,0.0227084315061642,0.0431094630734065,2.6399221657282e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0186783188000021,0.0029542314558325,0.0128880251465704,0.0244686124534338,2.64240531311998e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCP1,Plastin-2,37437,0.0289101429278648,0.00457587657965086,0.0199414248317491,0.0378788610239805,2.73334754294399e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0380938954501224,0.00603386407857357,0.0262675218561182,0.0499202690441266,2.81588165999448e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0199767774757698,0.00316460933412632,0.0137741431808822,0.0261794117706574,2.83257928604732e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0334517523943378,0.00530101386850606,0.0230617652120659,0.0438417395766097,2.87143498928229e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYT1,Synaptotagmin-1,37388,0.022776213397544,0.00360980399968078,0.0157009975581696,0.0298514292369183,2.88581352146286e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANPEP,Aminopeptidase N,39891,0.0171396455601254,0.0027201576934861,0.0118081364808927,0.0224711546393582,3.03498892100763e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SBSN,Suprabasin,37420,-0.020827384455848,0.00331103992530798,-0.0273170227094516,-0.0143377462022443,3.26615996285641e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENSA,Alpha-endosulfine,37368,0.032215356628216,0.00512452841522011,0.0221712809343846,0.0422594323220474,3.34686698653095e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.0142699880370056,0.00227027305157322,0.00982025285592213,0.0187197232180891,3.35007610986253e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA7,Carbonic anhydrase 7,37169,-0.0206174498883255,0.00328269429929438,-0.0270515307149424,-0.0141833690617085,3.47652074050676e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0173199005269482,0.0027643157089758,-0.0227379593165408,-0.0119018417373557,3.81089286579272e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS4,Thrombospondin-4,39892,0.0272360617486573,0.00435354451147294,0.0187031145061703,0.0357690089911442,4.04826338487888e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPF,Centromere protein F,37169,0.0328682128584285,0.00526045462449055,0.022557721794427,0.04317870392243,4.27947422954298e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA1,Carbonic anhydrase 1,39531,0.0360747339241695,0.00578432264153442,0.024737461546762,0.047412006301577,4.58536178402708e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,37124,-0.0198202835815835,0.00318317200946524,-0.0260593007201354,-0.0135812664430317,4.9109945470113e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDC1,Syndecan-1,39868,0.0240203634419746,0.00387027281598664,0.0164346287226408,0.0316060981613084,5.55557926644844e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0184291748830306,0.00297046176241488,-0.0242512799373638,-0.0126070698286974,5.66510623163781e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,39991,0.0153300944109564,0.00247551161129592,0.0104780916528164,0.0201820971690964,6.05756352940065e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0346975144035391,0.00560759189326793,0.023706634292734,0.0456883945143443,6.25823073344135e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR15L,Protein GPR15L,37382,0.0370199640909854,0.00598622874931436,0.0252869557423293,0.0487529724396416,6.42203526289769e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDM1,Nuclear protein MDM1,37039,0.0188532313410153,0.00304973854622973,0.0128757437904051,0.0248307188916256,6.51965346054611e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB37,Ras-related protein Rab-37,39587,0.0501538283225901,0.00812171636786148,0.0342352642415816,0.0660723924035986,6.7671669538029e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPE,Carboxypeptidase E,39906,-0.0232098537249732,0.00375962900320634,-0.0305787265712577,-0.0158409808786888,6.84259654138105e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,39908,-0.0172774194386595,0.00280030802957475,-0.0227660231766261,-0.011788815700693,7.00045388044255e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.0214353139228178,0.00349001458780708,0.0145948853307159,0.0282757425149197,8.38897053617182e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A11,Protein S100-A11,39703,0.0271856714632758,0.00442742212014451,0.0185079241077926,0.0358634188187591,8.43337530491631e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0242840867361211,0.00395601195101724,0.0165303033121273,0.0320378701601149,8.53018769910855e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,37021,0.0272823009326949,0.00445870768463651,0.0185432338708073,0.0360213679945824,9.69090056009652e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH15,Cadherin-15,39973,0.0319696402644664,0.0052264253432373,0.0217258465917213,0.0422134339372115,9.76030915976878e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD93,Complement component C1q receptor,39238,-0.0183363232323279,0.00299931299022576,-0.0242149766931704,-0.0124576697714854,9.98193844716795e-10
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0240423472224265,0.00395660383621639,-0.0317972907414106,-0.0162874037034424,1.25621764797565e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0145889572816654,0.00240472861309174,0.00987568920000556,0.0193022253633252,1.33439382660953e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.0155309386404714,0.0025617814587731,0.0105098469812761,0.0205520302996667,1.36972223282553e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0202046963497159,0.00334489100445183,0.0136487099809904,0.0267606827184415,1.57030886891239e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FABP9,Fatty acid-binding protein 9,39866,0.032525473769869,0.00538955597075343,0.0219619440671923,0.0430890034725457,1.62560438984465e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LXN,Latexin,39682,-0.0392476554037899,0.00651502541334766,-0.0520171052139513,-0.0264782055936285,1.73739375232159e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,37124,0.0309668312012021,0.0051489601826359,0.0208748692432357,0.0410587931591685,1.85541748469638e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.025988613239481,0.00432816494074974,0.0175054099556115,0.0344718165233505,1.96805394864063e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0209626633477546,0.00349309902857402,0.0141161892517496,0.0278091374437597,2.00207881376912e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,39931,-0.0338538021379084,0.00564234873680879,-0.0449128056620536,-0.0227947986137632,2.01616409776729e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHAD,Chondroadherin,37124,0.0294854872679443,0.00491955601673861,0.0198431574751366,0.039127817060752,2.10666897250756e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0688818791659708,0.0114944230481634,0.0463528099915705,0.0914109483403712,2.10951311241239e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,39444,0.0164945958386833,0.00275279309591784,0.0110991213706844,0.0218900703066823,2.11907436178733e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTB,Lymphotoxin-beta,37368,0.0199315572553551,0.0033325167057737,0.0133998245120387,0.0264632899986716,2.27468541638324e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0151269956281909,0.00253445585118999,-0.0200945290965233,-0.0101594621598586,2.45536757657562e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,37318,0.0164793079483022,0.00276111886751216,0.0110675149679784,0.021891100928626,2.45700282864096e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.0192246126579844,0.00322368774845401,0.0129061846710145,0.0255430406449542,2.51960983964396e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF7,SLAM family member 7,39866,-0.0335200873174953,0.00562237536021269,-0.0445399430235121,-0.0225002316114784,2.54548829992956e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG4,Desmoglein-4,39725,0.0284688040775817,0.00478051967094389,0.0190989855225317,0.0378386226326317,2.65287833526216e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK4,Kallikrein-4,40030,-0.0348219865228584,0.00586301557217531,-0.046313497044322,-0.0233304760013948,2.92175371043223e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,-0.0192470489563993,0.00324139151993873,-0.0256001763354792,-0.0128939215773194,2.94666655184079e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0196417150499343,0.00332371333235786,0.0131272369185129,0.0261561931813557,3.5122508529618e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MATN3,Matrilin-3,39720,-0.0180329316479199,0.00305295351006756,-0.0240167205276523,-0.0120491427681874,3.56130551478539e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0446389405814115,0.00756115045568142,0.029819085688276,0.0594587954745471,3.64132826941128e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL3,Fc receptor-like protein 3,39587,0.0299878275286626,0.00508122036742196,0.0200286356085156,0.0399470194488097,3.67175683346887e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C8B,Complement component C8 beta chain,37453,0.0174246972443833,0.00295701610860583,0.0116289456715159,0.0232204488172508,3.89019372193651e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,37021,-0.0254964682367324,0.00432767288374951,-0.0339787070888815,-0.0170142293845834,3.92068210873519e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0246693691403419,0.00419424124090528,-0.0328900819725162,-0.0164486563081675,4.14073506585036e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.0411079305861682,0.00699756455088211,0.0273927040664393,0.0548231571058971,4.33979329228749e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA12,Carbonic anhydrase 12,39788,-0.0181685315132771,0.0031030051894478,-0.0242504216845948,-0.0120866413419594,4.85983546926007e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACAN,Aggrecan core protein,39730,0.0159989525950588,0.00274427157196109,0.0106201803140151,0.0213777248761025,5.65220904010718e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALY,RNA-binding protein Raly,37368,0.0276697764810593,0.00474876425499075,0.0183621985412775,0.0369773544208412,5.78116317113904e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,37411,0.0195536869850194,0.00336524819176326,0.0129578005291634,0.0261495734408754,6.36961446886139e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0226345789540611,0.00389771700312059,0.0149950536279447,0.0302741042801774,6.50180945818324e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKD1,Polycystin-1,37437,0.0148336676000794,0.00255483172742687,0.00982619741432275,0.0198411377858361,6.53657258295558e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRLB,Fc receptor-like B,39477,0.0327064802571374,0.00564310539993854,0.0216459936732578,0.0437669668410169,6.92949734311562e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0272599555795755,0.00470731927287712,0.0180336098047364,0.0364863013544147,7.15762957175452e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNC,Tenascin,39931,-0.0265481872993729,0.00458517134769888,-0.0355351231408627,-0.0175612514578831,7.16956275709046e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0268924274401068,0.00464936836891668,0.0177796654370301,0.0360051894431835,7.45574206808583e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,37271,0.0355472946430774,0.0061576503255011,0.0234783000050952,0.0476162892810595,7.96592908182712e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.014338125908063,0.00248810412668344,0.00946144181976342,0.0192148099963625,8.431122441941e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOB,Apolipoprotein B-100,37445,0.0127082414912701,0.00221022466654054,0.00837620114485064,0.0170402818376896,9.12973401904333e-09
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0210481325376064,0.00367627363002431,0.0138426362227587,0.028253628852454,1.05041720119305e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITM2A,Integral membrane protein 2A,39866,-0.0329621742397793,0.00576002511224743,-0.0442518234597843,-0.0216725250197744,1.0679924805778e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0271705094958871,0.00475813658657197,0.0178445617862061,0.0364964572055682,1.15132011790815e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CABP2,Calcium-binding protein 2,37039,0.0366120368180626,0.00641427576458748,0.0240400563194711,0.049184017316654,1.16844353744464e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE1,Ribonuclease pancreatic,37445,0.0124586141068713,0.0021843780692227,0.00817723309119475,0.0167399951225478,1.19813385102968e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALB1,Calbindin,39788,0.0231817413165554,0.004082001252297,0.0151810188620533,0.0311824637710575,1.37838000005279e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,39866,0.0255930106075212,0.00450869846878748,0.0167559616086977,0.0344300596063446,1.39973576182429e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST1,Cystatin-SN,35640,0.0558159282434282,0.00984291742574213,0.0365238100889736,0.0751080463978827,1.45586842016513e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0138696305559114,0.00245565599506149,0.00905654480559092,0.0186827163062319,1.6502299805347e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRL,Prolactin,40009,-0.0417391206811141,0.00739180143456505,-0.0562270514928616,-0.0272511898693666,1.66331361093454e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,37043,0.0133284279816487,0.0023604752489036,0.00870189649379765,0.0179549594694997,1.67126553622963e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSG3,Desmoglein-3,39964,0.0183369821793049,0.00324890361239687,0.0119691310990071,0.0247048332596028,1.68891939228839e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0212367991544214,0.00377055386626775,0.0138465135765366,0.0286270847323062,1.81391326441175e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSHB,Thyrotropin subunit beta,39868,0.041082320462615,0.00729629806812999,0.0267815762490803,0.0553830646761498,1.82630690125423e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0147400212886511,0.00262104550928217,-0.0198772704868441,-0.00960277209045804,1.90608675668409e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OBP2B,Odorant-binding protein 2b,39701,-0.0344249561991105,0.00613841834589938,-0.0464562561570732,-0.0223936562411477,2.0795942669646e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,39713,0.0164537209877449,0.00294729120418395,0.0106770302275444,0.0222304117479455,2.40753939149228e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0112458524620372,0.00201719643966015,0.00729214744030334,0.0151995574837711,2.5156116004677e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGA4,Pepsin A-4,37445,0.0336821024877644,0.00606795056044484,0.0217889193892925,0.0455752855862363,2.8965961641303e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBC1D17,TBC1 domain family member 17,39489,0.0238020105443421,0.00428958884160003,0.015394416414806,0.0322096046738782,2.92333204331147e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRC1,Macrophage mannose receptor 1,37445,0.014892894631635,0.00268635551599968,0.00962763782027565,0.0201581514429944,3.01317719232283e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,37410,-0.0261571540575506,0.00472169878704648,-0.0354116836801617,-0.0169026244349395,3.08503520139183e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.0183073618111414,0.00330937009775011,0.0118209964195512,0.0247937272027316,3.21627347790215e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD209,CD209 antigen,39885,-0.0208236305418297,0.00378806870921846,-0.0282482452118979,-0.0133990158717615,3.91845036796453e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,37411,0.0149734610171548,0.00272826647547656,0.00962605872522078,0.0203208633090889,4.13184349650566e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP4,Guanylate-binding protein 4,39489,0.0261583872201346,0.00476787930207699,0.0168133437880637,0.0355034306522055,4.16635694038914e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLC,Galectin-10,39841,-0.0355523084705346,0.00648889981804706,-0.0482705521139068,-0.0228340648271623,4.34344357140657e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.0266964804095569,0.00488851389399146,0.0171149931773337,0.0362779676417802,4.80495663357032e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD7,T-cell antigen CD7,37037,0.0227878870115733,0.00417590736806752,0.0146031085701609,0.0309726654529856,4.93024933180527e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRSS53,Serine protease 53,37388,0.0198336431181382,0.00363738505075212,0.012704368418664,0.0269629178176124,5.04755436795767e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0228894449865577,0.00419821898536453,0.0146609357752432,0.0311179541978722,5.05060775928842e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC16,Mucin-16,39788,0.0987243626000407,0.0181231312696552,0.0632030253115164,0.134245699888565,5.18627651656497e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.0137375279903299,0.00252215425971502,-0.0186809503393713,-0.00879410564128844,5.2193390164604e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDHR1,Cadherin-related family member 1,39489,0.0226587216727197,0.00416506984171388,0.0144951847829605,0.0308222585624789,5.40277915247874e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0223433341579763,0.00411184637613154,0.0142841152607585,0.0304025530551941,5.59578563412323e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0359399548844786,0.00662236750834205,0.0229601145681282,0.048919795200829,5.83106864746992e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0220599954978702,0.0040666003550141,0.0140894588020425,0.0300305321936978,5.90560643570377e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A14,Protein S100-A14,37411,0.0269920208375839,0.00498223063927877,0.0172268487845975,0.0367571928905703,6.14163332615433e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,40052,-0.0130496939323284,0.00241282037542354,-0.0177788218681585,-0.00832056599649828,6.44630530152402e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN2,Prefoldin subunit 2,39489,0.0293166716784595,0.00544430292569785,0.0186458379440917,0.0399875054128273,7.35590407917451e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.014036411604005,0.00260776639210792,0.00892518947547352,0.0191476337325366,7.46643931969752e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CR2,Complement receptor type 2,39931,0.0237216693743943,0.00441761598545447,0.0150631420429036,0.0323801967058851,7.99240303940915e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0164084524482489,0.00305775331747627,0.0104152559459954,0.0224016489505024,8.17813800162584e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDN1,Endothelin-1,37043,0.0146925748298443,0.00273933768219286,0.00932347297274632,0.0200616766869423,8.29800593919959e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0204599801637182,0.00381707665956724,0.0129785099109665,0.02794145041647,8.45347935698825e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,39456,0.0267547350515937,0.0049937130997656,0.0169670573760531,0.0365424127271343,8.54925393894284e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0132581571291739,0.00247521417086834,0.00840673735427195,0.0181095769040759,8.60856701391749e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN1,Contactin-1,40052,-0.0138895782801526,0.00259689156712051,-0.0189794857517088,-0.00879967080859642,8.98709008115112e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,39477,0.0268464752103633,0.005027572590566,0.0169924329328539,0.0367005174878726,9.4326354742612e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.0223144866311889,0.00418022840608708,-0.0305077343071196,-0.0141212389552582,9.52059655041592e-08
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN10,Ataxin-10,39489,0.0378759669163481,0.00713648653940261,0.023888453299119,0.0518634805335773,1.12737841554262e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.0155580687913133,0.00294986983311309,0.00977632391841164,0.0213398136642149,1.35090184991544e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0187338314281116,0.00357251916910469,0.0117316938566664,0.0257359689995568,1.59278322380018e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0187460475620474,0.00357542734469892,0.0117382099664375,0.0257538851576573,1.59951572475369e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLMP,CXADR-like membrane protein,40030,0.0104185871741502,0.00199608242002511,0.00650626563090096,0.0143309087173994,1.81608485548483e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,39587,0.0145590599297877,0.00278941340297592,0.00909180965995489,0.0200263101996205,1.81787957353927e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPC1,Glypican-1,40030,0.0147450644575216,0.00282608169037479,0.00920594434438705,0.0202841845706562,1.83599662847391e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,39931,0.0132531612422917,0.00254394193786844,0.00826703504406959,0.0182392874405139,1.91488139451203e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,0.021010347111126,0.00405150109332003,0.0130694049682187,0.0289512892540332,2.17690622428805e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,40038,0.0264190276921356,0.00509565097440854,0.0164315517822949,0.0364065036019763,2.19059445807786e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX1,Neuronal pentraxin-1,39858,0.0206153498719877,0.00398447782005925,0.0128057733446716,0.0284249263993039,2.32008751900132e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,39931,0.0131916419563114,0.0025544492647669,0.00818492139736823,0.0181983625152545,2.44375379186781e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0137259260404635,0.00265931484661308,0.00851366894110189,0.0189381831398252,2.48044292349291e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,37445,0.012928119932904,0.0025071345627021,0.00801413619000786,0.0178421036758001,2.55101211726144e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INHBB,Inhibin beta B chain,37124,0.024891726817847,0.0048309742243416,0.0154230173381375,0.0343604362975566,2.60688146881266e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL3,Follistatin-related protein 3,39803,0.0149820272108492,0.00292167985515255,0.00925553469475026,0.0207085197269482,2.96452645578501e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0149944333955705,0.002926223039961,0.0092590362372469,0.020729830553894,3.02431246153588e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.024459289006207,0.00478595013117489,-0.0338397512633098,-0.0150788267491042,3.24747522950045e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB2A2,Mammaglobin-A,37021,-0.0156604391349003,0.003064044995638,-0.0216659673263507,-0.00965491094344978,3.24891646694272e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD1,Bromodomain-containing protein 1,37169,-0.0153301485396845,0.00300130515160472,-0.0212127066368298,-0.00944759044253928,3.30390883251732e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.0176633119596259,0.00345974674249203,0.0108822083443415,0.0244444155749102,3.33928349761464e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0178810982935033,0.00350461756742348,0.0110120478613532,0.0247501487256533,3.40473184330137e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MILR1,Allergin-1,39587,-0.0245709297800146,0.00482556225903232,-0.034029031807718,-0.0151128277523113,3.58725431661917e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0190316755707777,0.00375226027152978,0.0116772454385793,0.0263861057029761,3.98045804615345e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLGN,Calmegin,37039,0.0215799405989057,0.00425705278240217,0.0132361171453974,0.0299237640524139,4.04864373829807e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0125323715218855,0.00247365237963222,0.00768401285780631,0.0173807301859646,4.1005729105895e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,39456,0.0345115886090471,0.00685762648162174,0.0210706407050685,0.0479525365130257,4.89296596012223e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICOSLG,ICOS ligand,39788,0.00924171066473227,0.00183680719724221,0.00564156855813753,0.012841852771327,4.92214473956588e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AZU1,Azurocidin,39344,0.03760838740816,0.00747647804431249,0.0229544904413075,0.0522622843750125,4.95380672813549e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD1,Leiomodin-1,37411,-0.0172476826201993,0.00343551210801286,-0.0239812863519045,-0.0105140788884941,5.22159049168751e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLN,Mesothelin,39766,0.0256577758430199,0.00511626646433516,0.015629893572923,0.0356856581131169,5.36208229501323e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.0196179505581282,0.00391413884017348,0.0119462384313882,0.0272896626848682,5.4421811010628e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0257276375807837,0.00513314656772399,0.0156666703080447,0.0357886048535227,5.45321659643862e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,37056,0.0138118957941502,0.00276807501049201,0.00838646877358587,0.0192373228147145,6.12397522649157e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0178965325508994,0.00359138916824429,0.0108574097811406,0.0249356553206582,6.33224199322602e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF4,Neurotrophin-4,39477,0.0193230618195552,0.00387855289568931,0.0117210981440042,0.0269250254951063,6.35937489605797e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,0.0159260629729211,0.00319733248973969,0.00965929129303132,0.0221928346528109,6.39002878536675e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEPACAM2,HEPACAM family member 2,37388,-0.0203132096971052,0.00408593761318555,-0.0283216474189489,-0.0123047719752615,6.72530842316902e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMPD3,AMP deaminase 3,37388,0.0343296891455418,0.00690778621840924,0.0207904281574597,0.0478689501336239,6.78735236948689e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0297362220700055,0.0059869934906487,0.018001714828334,0.0414707293116769,6.87794946062417e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINI1,Neuroserpin,37088,0.014933711452416,0.00300788574840135,0.00903825538554939,0.0208291675192827,6.96098822526172e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNPY2,Protein canopy homolog 2,39585,0.0291512247247157,0.00587842808101256,0.0176295056859311,0.0406729437635004,7.15896016733689e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.0246539016718202,0.00498035084717729,0.0148924140113527,0.0344153893322877,7.48973483462479e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST7,Cystatin-F,39882,0.0444505756165817,0.00899999244903026,0.0268105904164824,0.0620905608166811,7.93328049923058e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRUNE2,Protein prune homolog 2,37169,0.0137168314913872,0.00278007825789944,0.00826787810590431,0.0191657848768701,8.15477200951004e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0186450986555124,0.00379216906749134,0.0112124472832294,0.0260777500277954,8.88917780652515e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.0230648401765971,0.0047101385173229,0.0138329686826442,0.03229671167055,9.83584042235972e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH3,Cadherin-3,40009,0.0165323205002338,0.00337809395279984,0.00991125635274614,0.0231533846477215,9.9770787407062e-07
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR1,Folate receptor alpha,39809,0.0130584297409052,0.00267012490983032,0.00782498491763775,0.0182918745641726,1.01524554750388e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM2,Myomesin-2,37021,-0.0245681902833133,0.00502576089896082,-0.0344186816452765,-0.0147176989213501,1.02830935201245e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0131358411647195,0.00269670667496881,-0.0184213862476584,-0.00785029608178061,1.12273735427148e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA1,Annexin A1,37072,0.0207884204761389,0.00427000911053744,0.0124192026194856,0.0291576383327923,1.13765125709051e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0165215625079135,0.00339897131128942,0.00985957873778627,0.0231835462780408,1.18035583779111e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNX18,Sorting nexin-18,37382,0.0214164374037704,0.00441165532157481,0.0127695929734837,0.030063281834057,1.22031668696737e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN8,Tetraspanin-8,37382,0.0463908202095201,0.0095598523117539,0.0276535096784825,0.0651281307405577,1.2316874783692e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL6,Interleukin-6,39788,0.0334676618634287,0.00689919535297518,0.0199452389715974,0.04699008475526,1.24032187472732e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,37021,0.0208599147819923,0.00430099035185972,0.0124299736923472,0.0292898558716373,1.24857765064606e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK8,Kallikrein-8,39315,0.0164459364270321,0.00339197306915103,0.00979766921149604,0.0230942036425681,1.25616706497842e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.066697490068352,0.0137993706718868,0.0396507235514539,0.0937442565852501,1.35515104437971e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFAP,Glial fibrillary acidic protein,39453,0.0205260051262943,0.00426309493362894,0.0121703390563816,0.0288816711962071,1.48720170955923e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMBS,Porphobilinogen deaminase,40030,0.0201673524420057,0.0041894242771027,0.0119560808588844,0.028378624025127,1.49371798056557e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPA4,Carboxypeptidase A4,36868,0.0204742505769376,0.00425758930550075,0.0121293755381562,0.0288191256157191,1.53475876192501e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0246951784469254,0.00514975937918767,0.0146016500637175,0.0347887068301332,1.638340687327e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.033244421105131,0.00694268311148222,0.0196367622066259,0.0468520800036362,1.69917248718417e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.0147120093935367,0.00308053933562696,0.00867415229570785,0.0207498664913655,1.80590419425419e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRP2,Neuropilin-2,39858,-0.0132712083650146,0.00278230472004422,-0.0187245256163013,-0.00781789111372798,1.85978388231248e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,37039,0.0318333199495026,0.0066849861087102,0.0187307471764306,0.0449358927225746,1.93807986149583e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLFM4,Olfactomedin-4,36654,0.0571188995956659,0.0120208526064115,0.0335580284870994,0.0806797707042324,2.03956383478329e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,39545,0.0347555370504475,0.00733602307989774,0.0203769318138479,0.049134142287047,2.18101613886771e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0298205564323405,0.00630269444383637,0.0174672753224212,0.0421738375422597,2.25271431258675e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,37043,0.0182436292895791,0.00386042278477546,0.0106772006314192,0.025810057947739,2.31566933384123e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0136495778459782,0.00289293551135857,0.00797942424371543,0.019319731448241,2.40346407835885e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN2,Alpha-actinin-2,37021,-0.0271571669049652,0.00576245942216704,-0.0384515873724126,-0.0158627464375178,2.46870193731699e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0122878514135383,0.00260954516014709,0.00717314289964997,0.0174025599274266,2.51632887801304e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.0120539838888921,0.00256239302195318,-0.0170762742119203,-0.00703169356586385,2.57479330976547e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0171151885584341,0.00364017035857507,0.00998045465562698,0.0242499224612413,2.60087167901615e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGB1A1,Uteroglobin,39903,0.0250677242534646,0.00533376291813864,0.0146135489339129,0.0355218995730164,2.62554249973417e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLVRB,Flavin reductase,39858,0.0294808340927538,0.00628990772125652,0.0171526149590911,0.0418090532264166,2.79516328150425e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,40009,-0.0128480089507188,0.00274417942457815,-0.018226600622892,-0.00746941727854565,2.86521392351896e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUC2,Mucin-2,37437,0.0411506120362951,0.00879973678886175,0.0239031279301261,0.0583980961424642,2.94845354281e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00978935968695882,0.00209451138176325,-0.0138946019952148,-0.00568411737870286,2.98107796075416e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRELP,Prolargin,39862,0.0101045756798765,0.0021625566755509,0.00586596459579671,0.0143431867639562,2.99958602960475e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0408312669823256,0.008741662424858,0.0236976086296039,0.0579649253350472,3.02342281787978e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAP,Cartilage-associated protein,37039,0.0225058927915614,0.00481911778460233,0.0130604219337408,0.031951363649382,3.03985846289712e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SATB1,DNA-binding protein SATB1,37411,0.0136456728871257,0.00292645967869662,0.00790981191688032,0.0193815338573711,3.14821006128375e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSTN1,Calsyntenin-1,39489,0.0227968900889916,0.00491246403674924,0.0131684605769631,0.0324253196010201,3.50182583477534e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATXN2,Ataxin-2,36991,0.0503819001406421,0.0108606743203869,0.0290949784726839,0.0716688218086004,3.53601449948932e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,37388,0.0200681128465423,0.00433221387104108,0.0115769736593018,0.0285592520337828,3.64997499973496e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0316028806660181,0.00685901259438056,0.0181592159810322,0.045046545351004,4.11260204952147e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTX2,Neuronal pentraxin-2,37437,-0.0151457883566985,0.0032882225991032,-0.0215907046509408,-0.00870087206245624,4.14076615682727e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLPS,Colipase,39836,0.0310830874660864,0.00675303651436967,0.0178471358979218,0.0443190390342509,4.19994520192137e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LGALS4,Galectin-4,39862,0.0235164478414183,0.00514271813003682,0.0134367203065462,0.0335961753762905,4.8493442071833e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCN,Decorin,39585,-0.00967049656807381,0.00211982965057938,-0.0138253626832094,-0.00551563045293822,5.10706735483438e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0215732213934583,0.004738500677211,-0.0308606827207919,-0.0122857600661247,5.33391121220209e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0168271876606471,0.00369781252756211,-0.0240749002146688,-0.00957947510662536,5.39783906591259e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CFD,Complement factor D,37453,0.00809378046689262,0.00178162209394208,0.00460180116276613,0.0115857597710191,5.59558269911597e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,37043,0.042649730946027,0.00942549196983953,0.0241757666851415,0.0611236952069125,6.09424616224108e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROCR,Endothelial protein C receptor,37021,-0.016123791834307,0.00356567953399352,-0.0231125237209343,-0.00913505994767974,6.18104173828738e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTPN,Myotrophin,39585,0.0143076040455972,0.00316505232466738,0.00810410148924916,0.0205111066019453,6.21453514733705e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,37368,0.0263584555331879,0.00583549810988384,0.0149208792378156,0.0377960318285602,6.3278421002105e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QL2,Complement C1q-like protein 2,37056,0.0184502039135119,0.00409750937973663,0.0104190855292281,0.0264813222977957,6.76435355078654e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0148030626535757,0.00329466087998131,-0.021260597978339,-0.00834552732881229,7.08113747311923e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0222519442935212,0.00497688338867405,0.0124972528517201,0.0320066357353224,7.84670269000227e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HYAL1,Hyaluronidase-1,39747,0.00993455719951958,0.00222279219578451,0.00557788449578195,0.0142912299032572,7.89800880978488e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0138733167660839,0.00311011794321521,-0.0199691479347858,-0.00777748559738212,8.23625927943799e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOSB,Protein fosB,39489,0.0169903653582219,0.00381147163991319,0.00951988094399207,0.0244608497724518,8.34234702503041e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00966482034936814,0.00216821299732123,0.00541512287461853,0.0139145178241178,8.34831718269415e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.0218263849277964,0.00491076166415398,0.0122012920660547,0.0314514777895382,8.87549878938026e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.025020472621965,0.00563996781978221,0.0139661356951918,0.0360748095487381,9.2152826160277e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMB,Granzyme B,39866,0.0276547305194181,0.00624641179807665,0.0154117633951879,0.0398976976436484,9.60521325744002e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARTN,Artemin,39587,0.0193403437533291,0.00436887068166601,0.0107773572172637,0.0279033302893944,9.62621793474366e-06
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,39788,-0.0103137310034724,0.002339973678189,-0.0149000794127228,-0.00572738259422195,1.05192708374048e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP1,Caspase-1,39489,0.0286641453326903,0.00652418061804998,0.0158767513213124,0.0414515393440683,1.12261941292447e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MBL2,Mannose-binding protein C,37257,-0.0460594233792487,0.0104857711695137,-0.0666115348714955,-0.0255073118870019,1.12881426654903e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0300175588720751,0.00686962921831428,-0.0434820321399711,-0.0165530856041791,1.25399902345147e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSPN,Persephin,39866,0.0401124905523755,0.00918559386246782,0.0221087265819386,0.0581162545228124,1.26818761425742e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0160836741202387,0.00369244842826183,0.0088464752008455,0.0233208730396319,1.33564661423573e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0187401377001984,0.00431741344216564,0.0102780073535538,0.0272022680468431,1.42974453033549e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIF,Leukemia inhibitory factor,39489,0.0217357879365181,0.00501062401705843,0.0119149648630836,0.0315566110099526,1.44725945836485e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL,Podocalyxin,39788,0.00634925721332093,0.00146531722423274,0.00347723545382475,0.0092212789728171,1.47974785796906e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDS,Iduronate 2-sulfatase,40058,0.00380125734097741,0.000877696756045701,0.00208097169912783,0.00552154298282698,1.49362608039092e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MET,Hepatocyte growth factor receptor,39879,-0.00823606493578521,0.00190311679908373,-0.0119661738619893,-0.00450595600958109,1.51607233570493e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF16,Fibroblast growth factor 16,37056,0.0203870441769031,0.00471545338923428,0.0111447555340039,0.0296293328198023,1.54732047023797e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",37169,0.0194152441968924,0.00449510551505215,0.0106048373873902,0.0282256510063946,1.57732792128181e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP4,Bone morphogenetic protein 4,39720,-0.0193310050788385,0.00448079381997458,-0.0281133609659887,-0.0105486491916883,1.61156782279622e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0174174819083709,0.00403887258107398,0.00950129164946587,0.0253336721672759,1.62592624491087e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,39489,0.0355215305492506,0.00827804501667604,0.0192965623165656,0.0517464987819356,1.78897387140293e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,39587,0.0200528146892324,0.00467617945940201,0.0108875029488045,0.0292181264296604,1.8112729873836e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEFL,Neurofilament light polypeptide,39438,0.0181550332812912,0.00424072671056615,0.00984320892858152,0.0264668576340008,1.87072574087528e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,39931,0.0117393763440072,0.00274629479584092,0.00635663854415896,0.0171221141438554,1.92564091800655e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMS1,PMS1 protein homolog 1,37039,0.020734874980366,0.00485253442739202,0.0112239075026776,0.0302458424580544,1.94215518507619e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.0245421983701877,0.00574914809638777,0.0132738681012677,0.0358105286391077,1.97852521258578e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI3,Elafin,39594,0.0219295502422201,0.00516872044801114,0.0117988581641182,0.0320602423203219,2.22068072012748e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,39248,0.0121224771330832,0.00286226643750472,0.00651243491557392,0.0177325193505924,2.29601757123086e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.0141509572762661,0.00334423589305139,0.00759625492588542,0.0207056596266469,2.3350830327192e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0413318431381593,0.00978569959716865,0.0221518719277088,0.0605118143486099,2.41940069959527e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0254203588624129,0.00602099297078561,0.0136192126396731,0.0372215050851527,2.43823244830653e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK11,Kallikrein-11,39779,0.0119705694382484,0.00283885581235107,0.00640641204604033,0.0175347268304565,2.4928598037671e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNLY,Granulysin,39858,0.0209383751633114,0.00497125173306923,0.0111947217664957,0.0306820285601271,2.54626586233945e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH6,Cadherin-6,39868,-0.0156127007357114,0.00370783134699115,-0.0228800501758141,-0.00834535129560879,2.5593020464677e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLASP1,CLIP-associating protein 1,36962,0.0300668531475537,0.00714902399135059,0.0160547661245065,0.0440789401706008,2.61972744071355e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,37437,-0.016080234602318,0.00382575598677631,-0.0235787163363996,-0.00858175286823646,2.64908122025437e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAM,Basal cell adhesion molecule,39858,-0.00963122793306745,0.00229701126497526,-0.014133370012419,-0.00512908585371594,2.76844901577364e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECM1,Extracellular matrix protein 1,37106,0.0148053508954229,0.00353280798590604,0.00788104724304707,0.0217296545477988,2.79755206797071e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0191133428253519,0.00456874035575834,-0.0280680739226382,-0.0101586117280655,2.88567521636818e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0159447119857724,0.00382028358719435,0.00845695615487144,0.0234324678166733,3.0161810064952e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,36962,0.0249984214474537,0.00599519658994634,0.0132478361311589,0.0367490067637485,3.06906971702346e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,37388,0.0240124217086777,0.00576530350506622,0.0127124268387479,0.0353124165786075,3.13300168774085e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FSTL1,Follistatin-related protein 1,37043,-0.00931219757531155,0.00223691701430848,-0.0136965549233562,-0.00492784022726694,3.16143786546807e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.0154954361632655,0.00373155497912461,0.00818158840418124,0.0228092839223497,3.30515634654352e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0342866147019136,0.00829966540391011,-0.0505539588935774,-0.0180192705102498,3.62952253309273e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.015916169116053,0.00385300525535853,0.00836427881555024,0.0234680594165557,3.63595465992887e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,40058,0.0101897756307415,0.00247089331404551,0.00534682473521227,0.0150327265262707,3.74329959251752e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SNU13,NHP2-like protein 1,37021,0.0249019958347451,0.00604062721551584,0.0130623664923341,0.0367416251771562,3.77213774811903e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,39868,0.0176685420131928,0.00430130650414533,0.00923798126506792,0.0260991027613176,4.01579144180986e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.00838376620876955,0.00204345070974622,-0.0123889295998721,-0.00437860281766696,4.10723801669673e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.0192842646132156,0.00470877213755935,0.0100550712235992,0.0285134580028319,4.239038728205e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN4,Contactin-4,39858,-0.00952584585951152,0.00232819060661097,-0.014089099448469,-0.00496259227055401,4.30649309047275e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.00958369132838973,0.00234409245877669,0.00498927010918741,0.014178112547592,4.36386603273054e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLIN3,Perilipin-3,39868,0.017114570923756,0.00418635244993045,0.00890932012189232,0.0253198217256197,4.36889686727244e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,F3,Tissue factor,39931,-0.0108142457159418,0.00264823935031336,-0.016004794842556,-0.00562369658932762,4.45656369161054e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD55,Complement decay-accelerating factor,39315,0.0100880082693437,0.00247613788335983,0.00523477801795846,0.014941238520729,4.64252280750878e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTG,Protogenin,40030,0.0098879474908271,0.00242730358035558,0.00513043247333016,0.014645462508324,4.65058212093008e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,37021,-0.0131425977123535,0.00322630550852335,-0.0194661565090593,-0.00681903891564777,4.65682497416604e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.0163295488158933,0.00402189788421111,0.00844662896283948,0.024212468668947,4.93224529186431e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.0127809740166428,0.00315297163211928,-0.0189607984155966,-0.00660114961768903,5.06737811147539e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,0.0223541763050882,0.00553501177109537,0.0115055532337412,0.0332027993764351,5.40019666470522e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.0120811428312698,0.00299787869119351,0.00620530059653052,0.0179569850660091,5.60605492000108e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0110416278171257,0.00274420676885987,-0.0164202730840911,-0.00566298255016036,5.75772947421572e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLSPN,Claspin,39453,0.0135179931839945,0.00336101689649945,0.00693040006685557,0.0201055863011334,5.7979164775985e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SDK2,Protein sidekick-2,37124,0.0145885409299151,0.00362890195843617,0.00747589309138021,0.02170118876845,5.84957026931601e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0170038726464789,0.00423874702101426,0.008695928485291,0.0253118168076669,6.06584432754938e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPO,Erythropoietin,39866,0.0301793322188022,0.00752483682938002,0.0154306520332173,0.044928012404387,6.08320554063617e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0340787475812988,0.00850230253520078,0.0174142346123053,0.0507432605502924,6.15260562188241e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEO1,Neogenin,37411,0.00844612946122121,0.00210802463427837,0.0043144011780356,0.0125778577444068,6.1913617075298e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00728130657248361,0.00181797399241415,0.00371807754735187,0.0108445355976153,6.230094168527e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD3,Bromodomain-containing protein 3,37021,0.0181198907114312,0.00452696018127897,0.00924704875612437,0.0269927326667379,6.2977194604994e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,37043,0.0130227745964529,0.00325642981617197,0.00664017215675587,0.01940537703615,6.39318109098814e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.0155995165453461,0.00390913792970299,0.00793760620312823,0.023261426887564,6.62279499445093e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN1,Tetraspanin-1,39585,0.0157009969717818,0.00393874646487642,0.00798105390062401,0.0234209400429396,6.74167790568709e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ASPN,Asporin,37437,0.0104696195927726,0.00263224165027283,0.00531042595823782,0.0156288132273073,7.00185626642388e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.0210889363668058,0.00531224118152122,-0.0315009290825874,-0.0106769436510242,7.22250891818357e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL3,Myosin light chain 3,37043,-0.0281416726784742,0.00710619783133312,-0.0420698204278871,-0.0142135249290613,7.5293601834337e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNG,Interferon gamma,39587,0.0441210067903502,0.0111517548127998,0.0222635673572625,0.0659784462234378,7.64158160851464e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CST6,Cystatin-M,39524,0.0180661189346994,0.00457473282352995,0.00909964260058067,0.0270325952688181,7.87858613104458e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,40052,-0.00898953367462159,0.00229070330720411,-0.0134793121567416,-0.00449975519250154,8.73217638587293e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GZMH,Granzyme H,39585,0.0287919949217889,0.0073485295931785,0.014388876919159,0.0431951129244187,8.9641372406415e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.0073240949986799,0.00186987648804756,-0.0109890529152531,-0.00365913708210668,9.0138360296465e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPS10,40S ribosomal protein S10,37021,-0.0163929719953852,0.00418892154100721,-0.0246032582157593,-0.00818268577501104,9.14594833139908e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHNAK2,Protein AHNAK2,37043,0.0111630721917243,0.00286327712673319,0.00555104902332727,0.0167750953601214,9.71877043362603e-05
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCAN,Versican core protein,40009,-0.0111800370865944,0.00288392471573727,-0.0168325295294394,-0.00552754464374931,0.00010631296894553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWF,von Willebrand factor,40052,-0.0276093520638234,0.00712536729200214,-0.0415750719561476,-0.0136436321714992,0.000107134004874783
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,40052,-0.00951736077518363,0.00246941357540079,-0.0143574113829692,-0.00467731016739807,0.000116605723150749
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,39477,0.0174234421512929,0.00453379410397414,0.00853720570750358,0.0263096785950822,0.0001220128895532
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD160,CD160 antigen,40058,0.0167921329965817,0.00437143711925241,0.00822411624284696,0.0253601497503164,0.000122835785182445
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0253099345398989,0.00659354053167333,0.0123865950978191,0.0382332739819786,0.00012430425325212
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0140326128938206,0.00365651542627081,-0.0211993831293114,-0.00686584265832982,0.000124771406957854
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.00909434349350501,0.00238182471856164,-0.0137627199418858,-0.00442596704512419,0.000134916050776736
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCD6,Programmed cell death protein 6,39868,-0.0259162969951366,0.00679304155475767,-0.0392306584424617,-0.0126019355478116,0.000136626003188704
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL5,Fc receptor-like protein 5,39858,-0.0207647095084869,0.00545203012631489,-0.0314506885560641,-0.0100787304609097,0.000140266805083045
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,39962,0.0155654677112243,0.00409496707325382,0.00753933224764683,0.0235916031748018,0.000144573345491419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,39729,0.0123790710971448,0.00326547637699332,0.00597873739823793,0.0187794047960517,0.000150662247357457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0201943306951902,0.00533495987934378,0.00973780933167642,0.030650852058704,0.000154108218646992
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,37382,0.0108171857077203,0.00286061847362739,0.00521037349941062,0.01642399791603,0.000156610540799954
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,39826,-0.00828678122894294,0.00219284527872029,-0.0125847579752347,-0.00398880448265117,0.000158026353779409
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.0120424779304389,0.00318945687748046,0.00579114245057721,0.0182938134103006,0.000160232222811056
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY6D,Lymphocyte antigen 6D,39761,0.0133132530860543,0.00352804598409644,0.00639828295722529,0.0202282232148833,0.000161526098068949
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0133998044541422,0.00355328434759599,0.00643536713285405,0.0203642417754303,0.000163219985438043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NTF3,Neurotrophin-3,39866,0.0123403993543807,0.00328199287991205,0.00590769330975305,0.0187731053990083,0.000170495876162307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,37056,0.0207495934807378,0.00552238553110988,0.00992571783976245,0.0315734691217132,0.000172454286451934
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,39900,-0.011386665580923,0.00303769739575556,-0.0173405524766039,-0.00543277868524208,0.000178553189976586
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,37056,0.040069453078533,0.0107015809312525,0.0190943544532781,0.0610445517037879,0.000181698246715481
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPON1,Spondin-1,39885,0.011624305905039,0.00310626928388253,0.00553601810862927,0.0177125937014488,0.000183047158718122
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,39868,0.0124027737487903,0.00331499283162718,0.00590538779880105,0.0189001596987796,0.00018362384163707
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL15,Interleukin-15,39866,0.011831399502677,0.00316461933207482,0.00562874561181037,0.0180340533935437,0.000185656449562142
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERC2,ERC protein 2,37039,0.0273002072881992,0.00731460045426618,0.0129635903978375,0.0416368241785609,0.000190544767825622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,39868,0.0115290479671224,0.00309057325937107,0.00547152437875508,0.0175865715554897,0.000191842710578538
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,36942,-0.0226425957997062,0.00607012878862241,-0.0345400482254061,-0.0107451433740062,0.000192161277264917
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0183827810697566,0.00493442288419105,0.00871131221674218,0.0280542499227711,0.000195807998405096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0212202437476979,0.00569724212064949,0.0100536491912249,0.0323868383041709,0.000196268408500197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROBO4,Roundabout homolog 4,37043,-0.00647717353278324,0.00174056442826196,-0.00988867981217669,-0.00306566725338979,0.000199018466569764
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00831952734463376,0.00223991614906684,0.00392929169246275,0.0127097629968048,0.000204534119376372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0158568556196448,0.00427114358080354,0.00748541420126991,0.0242282970380198,0.000206014588614784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DSC2,Desmocollin-2,39673,-0.012034315172477,0.0032481608027453,-0.0184007103458578,-0.00566791999909622,0.000212142019776226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,39489,0.0143067804160358,0.00386434873372476,0.00673265689793531,0.0218809039341364,0.000214431539657003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,39835,0.0159812468878611,0.00431827236873836,0.00751743304513391,0.0244450607305883,0.00021560629560671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.0124279317778386,0.00335867203887513,0.00584493458164339,0.0190109289740339,0.000216102970100543
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0123801487662983,0.00335889200712482,0.00579672043233362,0.0189635771002629,0.000228756115906332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,39699,0.0101796875163319,0.00276342013425213,0.0047633840531977,0.0155959909794661,0.000230612807189342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYO6,Unconventional myosin-VI,37411,0.0136743191276915,0.00372350277266391,0.00637625369327021,0.0209723845621128,0.000241175188268508
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17RA,Interleukin-17 receptor A,39858,0.0157829615374741,0.0042995837465829,0.00735577739417166,0.0242101456807766,0.000242567969514224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DRAXIN,Draxin,39749,0.0150337654172114,0.00410055845187455,0.00699667085153724,0.0230708599828855,0.000246913717995253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX3,Syntaxin-3,37388,0.0135806795233699,0.00370924688644756,0.00631055562593274,0.0208508034208072,0.000251891040664312
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EGFLAM,Pikachurin,37382,0.0109446405619218,0.00299108909541301,0.00508210593491228,0.0168071751889313,0.000254082803982079
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP2,Guanylate-binding protein 2,39587,0.0210948733121475,0.00578176169450552,0.00976262039091666,0.0324271262333783,0.000264608266728638
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LHB,Lutropin subunit beta,39477,0.0314284095584324,0.00863308523190886,0.014507562503891,0.0483492566129737,0.000273029343389233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,37056,-0.0103750301873566,0.00285323367467169,-0.0159673681897132,-0.00478269218500011,0.000277704213970629
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,39754,0.0212959447610438,0.00586245124263849,0.00980554032547239,0.0327863491966153,0.000281462143734086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0130269047526867,0.00358885242527945,-0.0200610555062344,-0.00599275399913894,0.000284658160720736
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.00994732368204422,0.00274548370695926,0.00456617561640407,0.0153284717476844,0.000291927624153599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,39477,0.0275620933639464,0.00760727092562173,0.0126518423497278,0.0424723443781649,0.000291988444595299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAFB2,Scaffold attachment factor B2,37411,0.00966789877711638,0.00267409947198839,0.00442666381201914,0.0149091337422136,0.000300989588887832
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.0129454674713349,0.00358241180465762,-0.0199669946084638,-0.00592394033420596,0.000303078130408448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,36991,-0.0220945665065492,0.0061155883667383,-0.0340811197053563,-0.0101080133077422,0.000304006897662041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPH3,Neurexophilin-3,37056,0.0104740906615001,0.00290195961771937,0.00478624981077018,0.0161619315122301,0.00030814131794714
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSB,Lupus La protein,39489,0.0213418875298773,0.00592397273471514,0.00973090096983568,0.032952874089919,0.000315990167420131
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXTL1,Exostosin-like 1,37021,0.0167710929648432,0.00465949806207581,0.00763847676317458,0.0259037091665118,0.000320204253957537
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOA4,Apolipoprotein A-IV,37453,0.0124349241515591,0.00345487593633342,0.00566336731634563,0.0192064809867726,0.00032028468681564
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.0655439103587115,0.0182117845730691,0.0298488125954961,0.101239008121927,0.000320431839247729
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,39866,-0.00848196089470115,0.00237838586961897,-0.0131435971991543,-0.00382032459024796,0.000363157672230256
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANGPT2,Angiopoietin-2,40030,-0.0132357099055166,0.00371478000063929,-0.0205166787067696,-0.00595474110426354,0.000367715041951872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM3D,Protein FAM3D,37382,0.0289433841023861,0.00814577669813633,0.0129776617740389,0.0449091064307333,0.000381905193546598
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPARCL1,SPARC-like protein 1,39871,-0.00943190258092999,0.00265514927157935,-0.0146359951532255,-0.00422781000863447,0.000382967940943238
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAG,S-arrestin,36991,-0.0184203186915519,0.00518664545145746,-0.0285861437764086,-0.0082544936066953,0.000384398116780372
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,37043,0.0125634402446928,0.00353824681301653,0.00562847649118037,0.0194984039982052,0.000385469599760344
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0311299476654902,0.0087772192268911,0.0139265979807836,0.0483332973501967,0.00039147741038849
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.035295331065394,0.00997409362694283,0.015746107556586,0.0548445545742019,0.000403249461190996
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0206269543165317,0.00584860404322981,0.00916369039180123,0.0320902182412621,0.000422015660044985
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.010582433898156,0.00300134643130745,-0.0164650729035186,-0.00469979489279338,0.000423488651330424
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.016838870041809,0.00478137787095571,0.00746736941473584,0.0262103706688822,0.000429912449852507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,37056,0.0223036569393479,0.00633959566218171,0.00987804944147176,0.0347292644372241,0.000436026215600285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP1,Dipeptidase 1,39713,-0.0162181277104685,0.00461994861523572,-0.0252732269963305,-0.00716302842460644,0.000448580435562036
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,39931,0.00688145508720415,0.00196926905507448,0.00302168773925816,0.0107412224351501,0.000476370438466189
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NINJ1,Ninjurin-1,39477,0.0191376323099387,0.0055064372584313,0.00834501528341335,0.0299302493364641,0.000511283208908005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAL,Galanin peptides,39931,-0.0217782778513771,0.00627844672982037,-0.034084033441825,-0.00947252226092912,0.000524281632016693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0236408978035126,0.00683610240858149,0.0102421370826929,0.0370396585243323,0.000545136733001539
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0222181616055122,0.00642497528445992,-0.0348111131630536,-0.00962521004797074,0.000545687560060354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPS,Calcyphosin,37388,0.0293466403230069,0.00849009035820374,0.0127060632209276,0.0459872174250862,0.000548766010328214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0236887228629214,0.00685546193344315,0.0102520174733729,0.03712542825247,0.000551083342519382
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0200527727050465,0.00581871254798778,0.00864809611099048,0.0314574492991026,0.000570194652454507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0146244619789744,0.00425118331527671,0.00629214268103206,0.0229567812769167,0.000583035044349597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD109,CD109 antigen,39858,-0.0112781454623943,0.00329203154548216,-0.0177305272915393,-0.00482576363324928,0.000614322871364064
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,37411,0.011921623070146,0.00348121547529772,0.00509844073856242,0.0187448054017295,0.000617625272073226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,39788,0.00693935264278325,0.00202891305630075,0.00296268305243379,0.0109160222331327,0.000627247468943038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0131284919615723,0.00387433650811286,-0.0207221915174735,-0.0055347924056711,0.000704557153085484
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC1,Sialoadhesin,39931,0.0137879951694317,0.00407508388203076,0.00580083076065138,0.021775159578212,0.000717423702336799
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RETN,Resistin,39790,0.0134196920069182,0.00397708765808356,0.0056246001970744,0.021214783816762,0.000741933385936804
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.0136650249542875,0.00405215418213368,-0.0216072471512696,-0.00572280275730552,0.000747615757026992
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB44,Ras-related protein Rab-44,37368,0.0138547558304143,0.00412337659957381,0.00577293769524962,0.021936573965579,0.000781438347063338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMNB1,Lamin-B1,37348,0.0189987471068969,0.005658911331011,0.00790728089811536,0.0300902133156785,0.000789210031199328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKCQ,Protein kinase C theta type,39587,0.0141648393483635,0.00422972178968664,0.00587458464057764,0.0224550940561493,0.000813288903975895
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGA,Chromogranin-A,37437,-0.0255797107677218,0.00764836997912595,-0.0405705159268086,-0.0105889056086349,0.00082664443305353
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN1,Nectin-1,37056,0.0104678450159481,0.0031334246593352,0.00432633268365108,0.016609357348245,0.000837980169632802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0231089752573247,0.00691989306774454,0.00954598484454538,0.036671965670104,0.000841196566549462
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ELAVL4,ELAV-like protein 4,36991,0.0274734235256184,0.00824722303737923,0.0113088663723551,0.0436379806788817,0.000867006437343123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,39928,0.0261470579833666,0.00785288996276931,0.0107553936563388,0.0415387223103945,0.000871634996042298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCL28,C-C motif chemokine 28,39815,0.0193221409858692,0.0058089016368013,0.00793669377773868,0.0307075881939998,0.000882063014055593
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0240352376297199,0.00722626862837436,0.00987175111810615,0.0381987241413336,0.000883148166372442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,37039,-0.0104040648864349,0.00312811822709777,-0.0165351766115465,-0.00427295316132326,0.000883483810370805
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,37124,0.00920530395250524,0.00277077790618848,0.00377457925637581,0.0146360286486347,0.000895260070465782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.01901161548825,0.00572274601675235,0.00779503329541542,0.0302281976810846,0.000895400802800113
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TYMP,Thymidine phosphorylase,39764,0.0218550168408631,0.00660592385131339,0.0089074060922888,0.0348026275894373,0.000940400907159364
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL4,Delta-like protein 4,37043,0.0277470951312558,0.00840196663367533,0.0112792405292522,0.0442149497332594,0.0009609836134809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0190920039595272,0.00579134209322977,0.00774097345679684,0.0304430344622576,0.000980979368453935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMOD4,Tropomodulin-4,36962,-0.0131263847335788,0.00398279632451142,-0.0209326655296212,-0.00532010393753645,0.000984127904131604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.0111063037472138,0.00337152031358516,-0.0177144835618407,-0.00449812393258687,0.000989800130239855
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,40058,0.0182958535983153,0.00558081013182146,0.00735746573994529,0.0292342414566854,0.00104635562274912
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00947085131728596,0.00290327036671911,0.0037804413985165,0.0151612612360554,0.00110858487273639
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00862409821908403,0.00264606384397572,0.00343781308489162,0.0138103833532764,0.00111995896506396
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,37021,0.0198171972974534,0.00608053061374647,0.00789935729451028,0.0317350373003964,0.00112040844802248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,40030,0.018519894660772,0.00571699808898405,0.00731457840636329,0.0297252109151808,0.00120004912635244
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOD3,Extracellular superoxide dismutase,37445,-0.0192266544743027,0.00594560891977313,-0.030880047957058,-0.00757326099154735,0.00122465207983041
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0174483520979262,0.00539669083900158,0.00687083805348314,0.0280258661423693,0.0012272348900644
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.0114670563736956,0.00355724872954059,0.00449484886379604,0.0184392638835951,0.00126909494033141
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0219981053427124,0.00683624716275986,0.00859906090370308,0.0353971497817217,0.00129412894273115
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.018000379131684,0.00562432669759541,-0.029024059458971,-0.00697669880439701,0.00137538600662206
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0182288764831213,0.00569638499270296,0.0070639618974235,0.0293937910688191,0.00137712698470989
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00451802617430651,0.00141256794269764,0.00174939300661912,0.00728665934199389,0.00138486932937739
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VIM,Vimentin,39585,0.0365333782155608,0.0114403620246822,0.0141102686471837,0.058956487783938,0.00140896713220362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,37056,0.00996040472098912,0.00311898191520608,0.0038472001671852,0.016073609274793,0.00140899406719361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,37169,0.0161517042629519,0.00506368877745065,0.00622687425914865,0.0260765342667552,0.00142745215894891
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.03761274642261,0.011817554836028,0.0144503389439951,0.0607751539012249,0.00146149278034628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,0.0102574765658838,0.00322926712895214,0.00392811299313758,0.01658684013863,0.00149392669545203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0126575919598287,0.00398635720608532,-0.020470852083756,-0.00484433183590152,0.00150065631452404
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNXB,Tenascin-X,39858,-0.00795879413982578,0.00250954588834806,-0.012877504080988,-0.00304008419866358,0.00151988241829182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.0133672448012494,0.00421991721473583,0.00509620706036721,0.0216382825421317,0.0015402063304137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH12,Protocadherin-12,37411,0.00781166074029523,0.00246970855891389,0.00297103196482401,0.0126522895157664,0.00156502956975987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,39788,0.00799317480440541,0.00253823025861548,0.00301824349751906,0.0129681061112918,0.00164069212903688
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,37056,-0.00668607057411849,0.00213211254592419,-0.0108650111641299,-0.00250712998410708,0.00171709648840776
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDHB15,Protocadherin beta-15,37368,-0.0121594945743064,0.00387955673298343,-0.0197634257709539,-0.00455556337765885,0.0017266381898565
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,39835,-0.00531821260118497,0.00169833366324472,-0.00864694658114462,-0.00198947862122531,0.00174271252157171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.0183696713016944,0.00587489082837277,0.00685488527808382,0.0298844573253051,0.00177032524898273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EP300,Histone acetyltransferase p300,37056,0.00902137403132573,0.00289016279213265,0.00335665495874574,0.0146860931039057,0.00180377738407519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RCC1,Regulator of chromosome condensation,37368,0.0153540988251177,0.00494448484530301,0.00566290852832379,0.0250452891219116,0.00190480766325493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0129585776942206,0.00417991580297542,-0.0211512126680524,-0.00476594272038879,0.00193798787882053
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00827046731439447,0.00267112369797969,0.00303506486635428,0.0135058697624347,0.00196319599788492
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,37437,0.0107868751686447,0.00348627523612213,0.00395377570584529,0.017619974631444,0.00197813734838278
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BOC,Brother of CDO,39585,-0.00707260984968107,0.00228609367682345,-0.011553353456255,-0.0025918662431071,0.00197988281658038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,36962,0.0109295194369304,0.00353452460118169,0.00400185121861424,0.0178571876552465,0.00199084445178401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",39788,0.0317049566422031,0.0102914119349842,0.011533789249634,0.0518761240347722,0.00206852814989913
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH7B,Myosin-7B,36962,-0.0132135321028313,0.00429573990639865,-0.0216331823193726,-0.00479388188628991,0.0021025701668605
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAN,Neurocan core protein,40009,0.0109950650958177,0.00358148761394603,0.00397534937248347,0.0180147808191519,0.00214434445535111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.0118561120921283,0.00387456458633381,0.00426196550291408,0.0194502586813426,0.0022179303197126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,39858,-0.00901213305637863,0.00294892075849697,-0.0147920177430327,-0.00323224836972456,0.00224622097719207
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00674493631879924,0.00220774196852547,0.00241776206048933,0.0110721105771092,0.00225329609675819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,39757,0.00796687543631637,0.0026141294471689,0.00284318171986532,0.0130905691527674,0.0023103935486779
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,37039,-0.0128418453568524,0.00422826857568393,-0.0211292517651929,-0.00455443894851189,0.00239301166138704
NMR metabolomics,X23495.Concentration of Large VLDL Particles,METAP1,Methionine aminopeptidase 1,39489,0.00901917959753874,0.00297494603750879,0.00318828536402152,0.014850073831056,0.00243569382643721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171B,Protein FAM171B,37368,0.00818494865275463,0.00270581025099671,0.00288156056080107,0.0134883367447082,0.0024913927449448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00837427956700396,0.00277582454432854,0.00293366346012002,0.0138148956738879,0.0025588149486378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNN,Tenascin-N,37437,0.0126429619282802,0.00419438884669906,0.00442195978875008,0.0208639640678104,0.00258085889769828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,37388,0.00843823672534677,0.00280146715358538,0.00294736110431943,0.0139291123463741,0.00259945665803301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.0132942877208937,0.00442404515190924,0.0046231592231516,0.0219654162186358,0.00266061825855689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0215090208537723,0.00716044202018027,0.00747455449421897,0.0355434872133256,0.0026705713988089
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.0154252890314605,0.00514283558163303,-0.0255052467714612,-0.00534533129145971,0.00271041874266632
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP9,Matrix metalloproteinase-9,39843,0.0176491811106247,0.0059116596104649,0.00606232827411345,0.0292360339471359,0.00283556160786159
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0103079780833322,0.0034646544814644,-0.0170987008670025,-0.00351725529966202,0.00293247398797841
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF8,SLAM family member 8,39477,0.0151037958719846,0.00507697392960012,0.00515292696996839,0.0250546647740009,0.00293474754992355
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.0152343451079738,0.00512347417985106,0.00519233571546568,0.0252763545004818,0.00294931264045976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF3,Trefoil factor 3,39839,0.0140333127697408,0.00472911222155856,0.00476425281548597,0.0233023727239955,0.00300744845086315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,37039,0.0152283780181086,0.00514030464263234,0.00515338091854923,0.025303375117668,0.00305653113033315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP8,Neutrophil collagenase,39985,0.0207033075775898,0.00699035461769013,0.00700221252691711,0.0344044026282624,0.00306395353244249
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,37388,0.0113589799533655,0.0038411508348048,0.00383032431714811,0.0188876355895829,0.00311001861440768
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCLRE1C,Protein artemis,36962,-0.00895416818037004,0.00303020659031932,-0.0148933730973959,-0.00301496326334417,0.00313256331084966
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,39866,0.0134719719347572,0.00456238348182733,0.00452970031037568,0.0224142435591388,0.00315326181507267
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,39372,0.0104391137513088,0.00355034594150286,0.00348043570596322,0.0173977917966544,0.00328369101499086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.0156915326453026,0.00533940498233045,0.00522629887993497,0.0261567664106703,0.00329949551440319
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,37124,0.00807770116266779,0.00275028613233738,0.00268714034328653,0.0134682619820491,0.00331930704801163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN2,Contactin-2,40030,0.0126916000739009,0.00432143432334629,0.00422158880014216,0.0211616113476596,0.00331983398607339
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYH4,Myosin-4,37021,-0.0136923037060242,0.00466404839188471,-0.0228338385541182,-0.00455076885793015,0.00333358550990533
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.00855451769126954,0.00292680571130494,-0.0142910568854272,-0.00281797849711186,0.00347473381256043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0186195528309344,0.00639807031532035,-0.0311597706489623,-0.00607933501290651,0.00361717094826951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.019753440290284,0.00680473405296576,0.00641616154647115,0.0330907190340969,0.00370227483429377
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA7A,Semaphorin-7A,40002,0.00758895182583556,0.00262756122326258,0.00243893182824091,0.0127389718234302,0.0038795451176551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0164072695727397,0.00570029364897327,0.00523469402075212,0.0275798451247273,0.00400444434674683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,37186,0.0117960181914499,0.00410248316755618,0.00375515118303977,0.01983688519986,0.00404236884336689
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00889340710021365,0.00309852860857443,-0.0149665231730195,-0.00282029102740777,0.00410860753477323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LEG1,Protein LEG1 homolog,36703,-0.0195430987611599,0.00683306748984128,-0.0329359110412488,-0.00615028648107103,0.00424221104123864
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00826844129703497,0.00289472269547799,0.00259478481389811,0.0139420977801718,0.00429047596812103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,36962,0.0116039874802383,0.00407545997912288,0.00361608592115742,0.0195918890393191,0.0044162723630588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0113316851667076,0.00398455240608448,-0.0191414078826332,-0.00352196245078202,0.00446331393134685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CENPJ,Centromere protein J,37169,0.0200998082800549,0.00708757236880703,0.00620816643719316,0.0339914501229167,0.00457624266227211
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELENOP,Selenoprotein P,37453,0.00614582301363255,0.00216932729006304,0.00189394152510898,0.0103977045021561,0.00461733464001467
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COMMD9,COMM domain-containing protein 9,37368,0.0108156725039539,0.00383233181755195,0.00330430214155212,0.0183270428663558,0.00477625408485639
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN1,Prorelaxin H1,37411,-0.0222113860105708,0.00787193981899329,-0.0376403880557977,-0.00678238396534398,0.00478557644048039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTP1,Glutathione S-transferase P,39393,-0.0191020186458824,0.00677482220243781,-0.0323806701626605,-0.00582336712910428,0.00481503957389503
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.0100557762142291,0.00356730546213535,-0.0170476949200144,-0.0030638575084438,0.00482647291009127
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,37039,-0.00792795839515178,0.00281272887783171,-0.0134409069957019,-0.00241500979460162,0.00483054236494852
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00812708489413905,0.0029009348628366,0.00244125256297932,0.0138129172252988,0.00509333994250515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.00828238991568188,0.00295688753676916,0.00248689034361433,0.0140778894877494,0.00510089229843741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RYR1,Ryanodine receptor 1,37021,-0.00924561092588291,0.00330399977536909,-0.0157214504856063,-0.0027697713661595,0.00514456955325845
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH17,Cadherin-17,39868,-0.018078290003416,0.00647728994960475,-0.0307737783046413,-0.00538280170219069,0.00526033289398698
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD200,OX-2 membrane glycoprotein,39866,-0.00697928465955656,0.00250851734578984,-0.0118959786573046,-0.00206259066180848,0.00540491468495974
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RALB,Ras-related protein Ral-B,37056,0.00787936921793645,0.00285676679557554,0.00228010629860838,0.0134786321372645,0.00582109049149566
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,37247,-0.00217814934337561,0.00078977941357586,-0.0037261169939843,-0.000630181692766927,0.0058249128074976
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0790191841903083,0.0286817132904521,0.0228030261410222,0.135235342239595,0.00587518175622311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDI2,Protein DDI1 homolog 2,37124,0.0201642194907301,0.00734180508230476,0.00577428152941279,0.0345541574520475,0.00603173271851248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH23,Cadherin-23,37388,-0.0071872003626021,0.00262103028306769,-0.0123244197174148,-0.00204998100778943,0.00611228174428098
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK14,Kallikrein-14,40030,-0.0120427274086078,0.00440200240898379,-0.020670652130216,-0.00341480268699957,0.00623083534342405
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00708951139640328,0.00259309001509591,-0.0121719678259913,-0.00200705496681529,0.00626533249564348
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM25,Transmembrane protein 25,37411,-0.0119400455813044,0.00436775567635788,-0.0205008467069658,-0.00337924445564291,0.006271221103419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AREG,Amphiregulin,39788,-0.0124356674235893,0.004558358128847,-0.0213700493561294,-0.00350128549104918,0.00637696730439411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.0056919743904412,0.00208661484705377,0.00160220929021581,0.0097817394906666,0.0063830689043101
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,40009,0.00718095219099981,0.0026349517636582,0.00201644673422974,0.0123454576477699,0.00643183377505005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHGB,Secretogranin-1,39952,0.0104785204067575,0.00384832179272718,0.00293580969301224,0.0180212311205028,0.00647851971882433
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM19,Probable RNA-binding protein 19,37021,-0.0126285769928843,0.00464074805521694,-0.0217244431811095,-0.00353271080465909,0.00651235554731734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,37169,0.0122480154266632,0.00450252341087056,0.00342306954135688,0.0210729613119695,0.00653161355091302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,39477,0.0094136575298263,0.00347437723551871,0.00260387814820963,0.016223436911443,0.00674680213642093
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEDD9,Enhancer of filamentation 1,37056,0.0088201678919283,0.00326224264445448,0.00242617230879751,0.0152141634750591,0.00686573376590803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSC1,Hamartin,37056,0.0201650264409011,0.00746378531439593,0.00553600722468506,0.0347940456571171,0.0069070856740675
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMBN,Ameloblastin,39587,-0.00751713890855291,0.00278328301401758,-0.0129723736160274,-0.00206190420107846,0.00692433963694515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THBS2,Thrombospondin-2,39858,-0.00946296168773705,0.00351652456089892,-0.0163553498270989,-0.00257057354837517,0.00713125766075298
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD99,CD99 antigen,39858,-0.00501868595695301,0.00186826444998551,-0.00868048427892462,-0.0013568876349814,0.00723265936405604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,36962,0.0111838522792607,0.00416504847683459,0.00302035726466488,0.0193473472938565,0.00725847625327417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,37169,0.0180098292535947,0.00670849445103848,0.00486118012955932,0.0311584783776302,0.00726999460439879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100G,Protein S100-G,37411,-0.0116934437159029,0.00438511558257794,-0.0202882702577556,-0.00309861717405011,0.00767088744549941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SH3GL3,Endophilin-A3,37083,0.0214673205566792,0.00805716414889325,0.0056752788248484,0.0372593622885099,0.00772247119095713
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,36962,0.0145301992733713,0.00545454974173758,0.00383928177956561,0.0252211167671769,0.00773424423060279
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,37169,0.0136846452800681,0.00514523179751611,0.00359999095693648,0.0237692996031996,0.00783097329845596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0159436035937906,0.00599575327176065,0.00419192718113973,0.0276952800064415,0.00784193234935762
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOM1,Myomesin-1,36991,0.0122990184848905,0.00462645758810239,0.00323116161220983,0.0213668753575712,0.00786056036222029
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,39489,0.00843794144471377,0.00318730310207782,0.00219082736464124,0.0146850555247863,0.00812041201520471
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.0134724694010461,0.00510095368513815,0.00347460017817532,0.0234703386239168,0.00827032948984233
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0136587390677421,0.00517949332311797,0.00350693215443089,0.0238105459810533,0.00837211855359847
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPP1,Osteopontin,40012,-0.0115374877093511,0.00439049730762348,-0.0201428624322932,-0.00293211298640911,0.0086012273244163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6L,Seizure 6-like protein,39913,0.00688832701767149,0.0026267320019495,0.00173993229385048,0.0120367217414925,0.00873967920440676
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPA,Apolipoprotein(a),37186,-0.0449002321581093,0.0171699031706602,-0.0785532423726033,-0.0112472219436152,0.00893136943793869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB1,Integrin beta-1,39862,0.00551682148843549,0.00211853441041746,0.00136449404401727,0.0096691489328537,0.00922078308807959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0173541394061523,0.00668022275887522,0.00426090279875687,0.0304473760135477,0.00939168333111767
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GDF15,Growth/differentiation factor 15,40052,0.0107411987999594,0.00413627939582125,0.00263409118414972,0.018848306415769,0.00941745690460524
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,37453,0.00445813525991092,0.00171833334694034,0.00109020189990784,0.00782606861991399,0.00948432353857682
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK15,Kallikrein-15,37351,0.0127217263987439,0.00491968983056153,0.00307913433084326,0.0223643184666444,0.00972346225952229
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA3G,Semaphorin-3G,37124,0.0110506191154722,0.00428059971491597,0.00266064367423685,0.0194405945567074,0.00984615761617986
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR4,Proline-rich protein 4,37031,-0.0176133244045291,0.00682837077636465,-0.0309969311262038,-0.00422971768285437,0.00990700636139144
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,37169,0.00924044428794704,0.00359067890646713,0.00220271363127147,0.0162781749446226,0.0100796490546759
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0179020974380547,0.00696980102502592,-0.0315629074471055,-0.00424128742900393,0.0102242303499575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00737675691222646,0.00287396695928591,0.00174378167202607,0.0130097321524268,0.0102765762839228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSMB,Beta-microseminoprotein,39780,0.0167894859689453,0.00654485708973516,0.00396156607306444,0.0296174058648262,0.0103179018628224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00825709711007665,0.00322553271122685,-0.0145791412240813,-0.00193505299607202,0.0104788505394611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BEX3,Protein BEX3,36962,-0.0116925317948196,0.00457030626489089,-0.0206503320740057,-0.00273473151563342,0.0105275733695369
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,39587,0.015096441763965,0.00590640343470168,0.00351989103194974,0.0266729924959803,0.0105993045239151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGMA,Repulsive guidance molecule A,40009,-0.00771437496698738,0.00302106302941848,-0.0136356585046476,-0.00179309142932716,0.0106728154136804
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,40009,-0.0317414382773997,0.0125886347731158,-0.0564151624327066,-0.00706771412209278,0.0116972319683766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.00876180315999273,0.00347559057532519,0.00194964563235537,0.0155739606876301,0.0117150807808487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.0154208802362842,0.0061224159982138,-0.0274208155927833,-0.00342094487978521,0.0117887169491929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,0.00891752625083345,0.00354047917735746,0.00197818706321284,0.0158568654384541,0.0117894736796297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GKN1,Gastrokine-1,39123,0.00689522092500046,0.00274251200125563,0.00151989740253942,0.0122705444474615,0.0119405109728797
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG1,Arginase-1,39754,0.0126218495122828,0.00504402136952205,0.00273556762801962,0.0225081313965461,0.012347548525174
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.0123895842682138,0.00495628048127515,0.00267527452491455,0.0221038940115131,0.012439363377125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUK1,Guanylate kinase,37021,-0.0100957696314321,0.00404451841235373,-0.0180230257196454,-0.00216851354321876,0.0125666934746291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX5,Syntaxin-5,37056,0.00985634715713029,0.00397729085245175,0.00206085708632486,0.0176518372279357,0.0132187518324787
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,39866,0.00834730675783322,0.00337856750734709,0.00172531444343292,0.0149692990722335,0.0134965671963611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,0.0100388989882722,0.00408101247660115,0.00204011453413398,0.0180376834424105,0.0139077851113264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",37021,0.0135044929706133,0.00550132737403547,0.00272189131750375,0.0242870946237228,0.0141103273970357
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17C,Interleukin-17C,39587,-0.0159041847861266,0.00647967337383125,-0.0286043445988358,-0.00320402497341732,0.0141198738010809
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.0155320318999784,0.00632794403000446,0.00312926160116966,0.0279348021987871,0.0141199714851927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.0121476160932266,0.00495599001651745,-0.0218613565256008,-0.00243387566085237,0.0142550388182708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.007535939379143,0.0030827428400378,-0.0135781153456171,-0.00149376341266892,0.0145136194179085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX33,Testis-expressed protein 33,37169,-0.00946272655178821,0.003875711836956,-0.017059121752222,-0.00186633135135444,0.0146374809716982
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,40030,-0.0142656966913565,0.00584916063398408,-0.0257300515339653,-0.00280134184874774,0.0147414796663134
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,39587,0.0135353686798926,0.00555917832393903,0.00263937916497209,0.0244313581948131,0.0149119449907209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.0108136435420703,0.00444581500822874,0.00209984612594196,0.0195274409581986,0.0150135365450096
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENO1,Alpha-enolase,39830,0.0186664567927222,0.00771366420595596,0.00354767494904857,0.0337852386363959,0.0155349747391357
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0151360255736954,0.00629173745243063,-0.0274678309804594,-0.00280422016693134,0.0161551478839947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,37021,0.0207655373650767,0.00866109512711763,0.00378979091592617,0.0377412838142273,0.0165183065453326
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00593068781456653,0.00247419321763172,-0.0107801065211247,-0.00108126910800837,0.0165425543971387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDRG1,Protein NDRG1,39489,0.0161650080850335,0.00676134326802488,0.0029127752797047,0.0294172408903622,0.0168235465452628
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00626707430897433,0.00262525764527971,0.00112156932422609,0.0114125792937226,0.0169879522684457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD48,CD48 antigen,39908,0.00673695868062291,0.00282368225439014,0.00120254146201824,0.0122713758992276,0.0170499716339784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0103031620884297,0.00432056634404895,-0.0187714721227657,-0.00183485205409381,0.0171079666937772
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0144074018364764,0.00605505827098304,0.00253948762534962,0.0262753160476032,0.0173527345038224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TUBB3,Tubulin beta-3 chain,36991,-0.0065359500436542,0.00274783144521326,-0.0119216996762722,-0.0011502004110362,0.0173934547704151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,37411,-0.0176899286717998,0.0074488706445994,-0.0322897151352147,-0.003090142208385,0.0175700601271183
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00785199632748397,0.00331427422467296,0.00135601884712497,0.014347973807843,0.0178409719647204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,37021,-0.00641978763682014,0.00271916030165589,-0.0117493418280657,-0.00109023344557461,0.0182429325069693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL11,Interleukin-11,39587,0.0142984380264675,0.00606960848491884,0.00240200539602653,0.0261948706569084,0.0184979048227195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VASN,Vasorin,39642,0.00627078161367327,0.00266750783375054,0.00104246625952222,0.0114990969678243,0.0187452563625529
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0108714012145298,0.00464607306609968,0.00176509800497448,0.0199777044240852,0.019302731601371
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,39913,0.0178276264437627,0.00765634734066141,0.00282118565606631,0.032834067231459,0.0198991574964933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00851651972964208,0.00366090127705807,0.00134115322660826,0.0156918862326759,0.0200152132853215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESPL1,Separin,36962,-0.0121941584731331,0.00525410364434452,-0.0224922016160484,-0.00189611533021783,0.0203084434792272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00681293656693517,0.00293961706164774,0.00105128712610561,0.0125745860077647,0.0204823580487527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,36971,0.0221212071587206,0.00955098264962495,0.00340128116545575,0.0408411331519855,0.0205671463444535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PXDNL,Peroxidasin-like protein,37368,0.0134496144487961,0.00581092357325301,0.00206020424522018,0.024839024652372,0.020653045866724
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00928523120888428,0.00401871124751234,-0.0171619052540085,-0.00140855716376009,0.0208758893625937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNLZ,DNL-type zinc finger protein,36991,-0.0201462653983093,0.00876792596225181,-0.0373314002843229,-0.00296113051229578,0.0215932045778826
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRDX2,Peroxiredoxin-2,37249,0.0136422875546189,0.0059425521762021,0.00199488528926278,0.025289689819975,0.0217087044729349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,37056,0.00451442527413363,0.00196766524554861,0.000657801392858354,0.00837104915540891,0.0217885841975293
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,-0.00586917688206096,0.00258295696228085,-0.0109317725281314,-0.000806581235990498,0.0230834472471654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PROK1,Prokineticin-1,39866,0.0143116919650094,0.00631508556650468,0.00193412425466028,0.0266892596753586,0.023448119205734
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.0135784322047923,0.00601332644167362,-0.0253645520304726,-0.00179231237911201,0.0239584691760089
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00816524511348833,0.00362714356062872,-0.0152744464923206,-0.00105604373465604,0.0243925266105046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STX1B,Syntaxin-1B,37039,0.00932767056068452,0.00414733951008114,0.00119888512092549,0.0174564560004435,0.0245242763428782
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,37437,-0.00725559985339601,0.00322635965707199,-0.0135792647812571,-0.000931934925534903,0.0245379876505322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00666810983553801,0.00297327821013459,-0.0124957351274018,-0.000840484543674209,0.0249314653643215
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF1,Trefoil factor 1,39789,0.0164470946641965,0.00734229384913633,0.00205619871988929,0.0308379906085037,0.025101505974906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0086751917965248,0.0038768724691958,-0.0162738618361486,-0.00107652175690104,0.0252587330871251
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSAP,Gamma-secretase-activating protein,39477,0.0191525887926423,0.00858666984607349,0.00232271589433826,0.0359824616909463,0.0257282489283039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00820136264672088,0.00368588624343848,0.000977025609581465,0.0154256996838603,0.0260908705966217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_DRA,,39799,-0.0076878122047139,0.00345941330568361,-0.0144682622838538,-0.000907362125574015,0.0262778387435516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00700374456563284,0.00316440536658819,-0.0132059790841457,-0.000801510047119982,0.0268948332586983
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,37368,0.0081110390262293,0.00367972598251711,0.000898776100495774,0.0153233019519628,0.027523510097595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",37021,0.0136443696459649,0.00619858942588553,0.00149513437122921,0.0257936049207005,0.0277387694529167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0152717445993224,0.00699489457405844,-0.028981737964477,-0.00156175123416788,0.0290335236906683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.0100556970462096,0.00460638394542437,-0.0190842095792413,-0.0010271845131778,0.0290540189616163
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPN1,Epsin-1,37169,0.00917695176562818,0.00420386140924356,0.000937383403510794,0.0174165201277456,0.0290545831542879
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,37039,-0.0141467126049615,0.00648502634491327,-0.0268573642409915,-0.00143606096893146,0.0291683071662778
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COPE,Coatomer subunit epsilon,39489,0.00994312550894633,0.00461836313573183,0.000891133762911936,0.0189951172549807,0.0313375122010839
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,0.00564589527957017,0.00262429958832408,0.000502268086454971,0.0107895224726854,0.0314629134478255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.017871254554478,0.00831130127970886,-0.0341614050627073,-0.00158110404624861,0.0315547266052302
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.0102144451382621,0.00476981089070631,0.000865615792477762,0.0195632744840465,0.0322533461609078
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.00970044116981541,0.00453594193196293,0.000809994983168064,0.0185908873564628,0.0324852563427505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,37039,0.0104108243288077,0.00487393616825845,0.000857909439021108,0.0199637392185942,0.0326961690925305
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.0059944780503972,0.00281129742879458,-0.0115046210108346,-0.000484335089959817,0.0330021968783793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACE,Angiotensin-converting enzyme,37445,-0.00532940676331976,0.00250393231135316,-0.010237114093572,-0.000421699433067567,0.0333206458468587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.00816857711222104,0.00385124134231828,0.000620144081277209,0.0157170101431649,0.0339378508605038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.0308722970603624,0.0145579999297382,0.00233861719807559,0.0594059769226491,0.0339673280815682
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.0120739832511346,0.00571311125343213,0.00087628519440764,0.0232716813078616,0.0345836184321706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,39489,0.01321890735796,0.00626159777972104,0.000946175709706759,0.0254916390062133,0.0347788905881935
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",39842,0.0134403506584756,0.00637580686577089,0.000943769201564609,0.0259369321153865,0.0350444845943457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00688294388349253,0.00326607860639316,-0.0132844579520231,-0.000481429814961937,0.0351015266306928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MN1,Transcriptional activator MN1,37039,-0.0121255907754801,0.00577515545692627,-0.0234448954710556,-0.000806286079904633,0.0357818743028502
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLA2G1B,Phospholipase A2,40031,-0.00834331544308995,0.00398549299591714,-0.0161548817150875,-0.000531749171092352,0.0363271105366126
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA5,Annexin A5,39415,0.00615024902180339,0.00295310544101187,0.000362162357420112,0.0119383356861867,0.037300548384055
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MELTF,Melanotransferrin,37437,0.00590481262433246,0.00283578959625005,0.000346665015682357,0.0114629602329826,0.037338648721827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA4C,Semaphorin-4C,39788,0.00573398494954979,0.00276187144445121,0.000320716918425417,0.0111472529806742,0.0378985732014102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D2,DCN1-like protein 2,36962,-0.0162927571742882,0.00785266753715154,-0.0316839855471052,-0.000901528801471194,0.0380240449989871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JCHAIN,Immunoglobulin J chain,39587,-0.0122487700953083,0.00590578013074042,-0.0238240991515595,-0.000673441039057025,0.0380926800493438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,39868,-0.00542431127723753,0.00261650691586202,-0.0105526648323271,-0.000295957722147976,0.0381778388132354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,39913,0.0055555513216891,0.00268037450317118,0.000302017295473583,0.0108090853479046,0.0382182445883584
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36A,Interleukin-36 alpha,37056,-0.0119136197361796,0.00574802323340725,-0.0231797452736579,-0.000647494198701436,0.0382245663350735
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,39489,0.0108572684768077,0.00526888144532161,0.000530260843977354,0.0211842761096381,0.0393538969349133
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCUN1D1,DCN1-like protein 1,36991,-0.0150673379678289,0.00731946278177032,-0.0294134850200987,-0.000721190915559044,0.0395589129997149
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFF2,Trefoil factor 2,39908,0.0114524547918747,0.0055658515551402,0.000543385743799927,0.0223615238399495,0.0396419260699413
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.00717118092752248,0.00349827064123049,0.000314570470710724,0.0140277913843342,0.0403916232166855
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0120220821982029,0.0058758083936113,-0.023538666649681,-0.00050549774672474,0.0407731649134528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAT1,Diamine acetyltransferase 1,37021,-0.00991279782066618,0.00484932821517013,-0.0194174811223996,-0.000408114518932735,0.0409577035024929
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.00776869800852664,0.00380295493030924,0.000314906345120524,0.0152224896719327,0.0410915546130856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.0103772096566953,0.0050829255361945,0.000414675605754103,0.0203397437076366,0.0412126822875576
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,36430,0.010291421046812,0.00505591141283074,0.000381834677663756,0.0202010074159603,0.0418192647351016
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANXA10,Annexin A10,39489,0.0155687781607763,0.00764915168147975,0.000576440865076015,0.0305611154564766,0.041831487947247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOP56,Nucleolar protein 56,37021,0.021921179011263,0.0107732503778374,0.000805608270701676,0.0430367497518243,0.041893159436129
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.0171663744053182,0.00844338966710261,0.000617330657797052,0.0337154181528393,0.0420611153708701
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCGN,Secretagogin,39587,-0.00852082893214047,0.00420412658776753,-0.0167609170441648,-0.000280740820116103,0.0427020163187307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00761265139765655,0.00375876119492002,0.000245479455613301,0.0149798233396998,0.0428552816305572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN15,Tetraspanin-15,37021,-0.00966774186656011,0.00482031528721132,-0.0191155598294943,-0.000219923903625917,0.0449167699832038
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL31,Interleukin-31,37056,-0.0112215825379737,0.00561199746921406,-0.0222210975776333,-0.000222067498314167,0.0455671657029818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYOC,Myocilin,39858,-0.00888242866973406,0.00448424571856376,-0.017671550278119,-9.33070613490846e-05,0.0476299357079297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00444794895993665,0.00225493317125583,2.82799442752179e-05,0.00886761797559809,0.0485651427853477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.00567123024832532,0.00287919341951693,-0.0113144493505785,-2.80111460721245e-05,0.0488898368173717
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGN,Mimecan,39858,0.00756718814238299,0.00385375102959275,1.38361243811978e-05,0.0151205401603848,0.0495949163105232
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.0132041970367184,0.00673318016997535,7.16390356668949e-06,0.0264012301698701,0.0498892913212442
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,37043,0.0112136578421384,0.0057229380096456,-3.30065676693719e-06,0.0224306163410438,0.0500842812447438
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.00685165723249627,0.00352409333437679,-5.55657028822485e-05,0.0137588801678748,0.0518886490437108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPT,Microtubule-associated protein tau,39489,0.00998030311927116,0.00513977514418387,-9.36561633292279e-05,0.0200542624018715,0.0521819079981579
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRTN,Neurturin,39587,0.00940014409368121,0.00484262652281753,-9.14038910411492e-05,0.0188916920784036,0.052260941539095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0158456090204599,0.0081755101327735,-0.0318696088806959,0.000178390839776194,0.0526220934920771
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL36G,Interleukin-36 gamma,37021,0.0127640317330327,0.00658753897731176,-0.000147544662498372,0.0256756081285637,0.0526931077291591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.0124816212292265,0.00644312786888973,-0.0251101518522504,0.00014690939379737,0.052742435299414
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,37021,0.00748463548029286,0.00387882963818541,-0.000117870610550537,0.0150871415711363,0.0536764227741672
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.00919316308542328,0.00476570914623796,-0.0185339530120497,0.000147626841203124,0.0537456352047725
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0126158993033181,0.00659431897990513,-0.0255407645039321,0.000308965897295985,0.0557509553830816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.011391835101372,0.00597839486751123,-0.023109489041694,0.000325818838949988,0.0567368458239348
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX9,Transcription factor SOX-9,37039,0.00499411248334908,0.00263697360110914,-0.000174355774824836,0.010162580741523,0.0582627713838043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLL1,Delta-like protein 1,39913,0.00524028396390413,0.00277213386439474,-0.000193098410309562,0.0106736663381178,0.0587300908766246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,40052,0.0054065342066418,0.00286014147886169,-0.000199343091927111,0.0110124115052107,0.058735280081152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEF,Thyrotroph embryonic factor,37021,0.00780123104096647,0.00414079038555686,-0.000314718114724975,0.0159171801966579,0.0595875884135856
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NXPE4,NXPE family member 4,37021,-0.00642342423050333,0.00341170461278951,-0.0131103652715708,0.000263516810564117,0.0597548085264379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00675317928221376,0.00359636658757092,-0.0138020577938528,0.000295699229425244,0.0604335892835937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP7,Retinoid-binding protein 7,37382,0.011032792996993,0.00588523307922826,-0.000502263838294372,0.0225678498322804,0.060861474622597
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,39990,0.0073383355253028,0.00392238034257261,-0.000349529946139528,0.0150262009967451,0.0613786551256167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00962630554648862,0.00514580407388243,-0.0197120815312982,0.000459470438320949,0.0614076581677315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REST,RE1-silencing transcription factor,36962,-0.00651257605049891,0.0034855591902108,-0.0133442720633121,0.000319119962314266,0.0617223530821888
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.015385233388394,0.00826242183274419,-0.000809113403784641,0.0315795801805726,0.0626150276297171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,-0.00891829402888322,0.00479346458361515,-0.0183134846127689,0.000476896555002479,0.0628354164877336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00838634423251644,0.00452151817089446,-0.0004758313824367,0.0172485198474696,0.0636524390065268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HCG22,Protein PBMUCL2,37021,-0.0098084954316706,0.00528997701688829,-0.0201768503847716,0.000559859521430449,0.063737772965354
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGM2,Phosphoglucomutase-2,37039,0.0108996279266963,0.0059088016765567,-0.000681623359354809,0.0224808792127474,0.0651119557586907
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTRC,Chymotrypsin-C,39856,0.0110758219075139,0.00602395079759118,-0.000731121655764834,0.0228827654707926,0.0659880248294561
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,39489,0.0102149563502717,0.00556276574632838,-0.000688064512531871,0.0211179772130754,0.0663309640895815
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00897402936751266,0.00488724993970575,-0.000604980514310616,0.0185530392493359,0.066348177977568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00456118983601076,0.00249131004860566,-0.00944415753127785,0.000321777859256327,0.0671463483175069
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,0.00442743199727172,0.00242136517405483,-0.00031844374387574,0.00917330773841918,0.0674985799585877
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.0173014159630655,0.0095084415887843,-0.0359379614770827,0.00133512955095174,0.0688449635970299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,37056,-0.0120842201156293,0.00664179866311964,-0.0251021454953438,0.000933705264085202,0.0688700550712903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAGLN3,Transgelin-3,36962,-0.0106244208543932,0.00584034486013697,-0.0220714967802616,0.000822655071475296,0.0689124732838368
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.00870707872084685,0.00479670676596969,-0.0181086239821474,0.000694466540453751,0.0695087434759493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,39866,0.0109890979886579,0.00605432391301549,-0.000877376880852467,0.0228555728581683,0.0695299242166002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK12,Kallikrein-12,39477,-0.024365961558097,0.0134423723351129,-0.0507130113349184,0.00198108821872432,0.0699090858457975
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0137368536511877,0.00765383826859799,-0.00126466935526433,0.0287383766576398,0.0727100850633998
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCG3,Secretogranin-3,39885,-0.00567415252397388,0.00316210254716613,-0.0118718735164195,0.00052356846847174,0.0727643693826556
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTNNA1,Catenin alpha-1,36991,-0.00614240103056045,0.00342915802411148,-0.012863550757819,0.000578748696698061,0.0732798696802582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,37021,0.00811447121263837,0.0045316589171559,-0.000767580264987189,0.0169965226902639,0.0733775495417802
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNR,Tenascin-R,39749,-0.00731899072469873,0.00409302490639264,-0.0153413195412283,0.000703338091830838,0.0737689578283812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WNT9A,Protein Wnt-9a,39587,0.00490323126282441,0.00274367243069519,-0.000474366701338153,0.010280829226987,0.0739397394935536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPTN,Neuroplastin,39477,0.0146171539254688,0.00819392427712998,-0.00144293765770597,0.0306772455086435,0.0744590805756928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,39667,-0.00660116859449535,0.00371076176784163,-0.0138742616594649,0.000671924470474237,0.075271195369417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB116,Beta-defensin 116,36991,-0.0134350120501504,0.00755583850219716,-0.0282444555144569,0.001374431414156,0.0754110972508648
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00998216193586098,0.00563270418117898,-0.00105793825924982,0.0210222621309718,0.0763879767929573
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0446452668742298,0.0252062285942916,-0.0940494749190414,0.00475894117058182,0.0765505837007654
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JUN,Transcription factor AP-1,39587,0.00894897742749847,0.00506353572040765,-0.000975552584500522,0.0188735074394975,0.0771910838988062
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBX2,Chromobox protein homolog 2,37021,-0.00695035813615432,0.00394929768472959,-0.0146909815982243,0.000790265325915679,0.0784484577577594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,37056,0.0117315840006476,0.00667835111235094,-0.00135798417956022,0.0248211521808555,0.0789991817039568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00461780724751041,0.00262918289278674,-0.00977100571737241,0.0005353912223516,0.0790448489756595
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HLA_A,,37411,0.00550316408270231,0.00315173073105933,-0.000674228150173981,0.0116805563155786,0.0808202581162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,40052,0.00511679575307545,0.00293631640333223,-0.000638384397455729,0.0108719759036066,0.0814242335171029
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF12,Fibroblast growth factor 12,37056,0.00795650523311354,0.0045774066971383,-0.00101521189327753,0.0169282223595046,0.0821967146330961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00851039485610601,0.00489639494716477,-0.00108653924033694,0.018107328952549,0.0822176339782696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00733077474475753,0.00422021641010993,-0.015602398908573,0.000940849419057927,0.0823996789697571
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.0108958572893684,0.00627957897214569,-0.023203832074774,0.00141211749603714,0.0827377899023363
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00791014796867303,0.00455898321673738,-0.00102545913613224,0.0168457550734783,0.0827520901126813
NMR metabolomics,X23495.Concentration of Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,-0.00341533566469973,0.00196908312325548,-0.00727473858628047,0.000444067256881002,0.0828563314951903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0203695532939472,0.0117450870074197,-0.0026508172405955,0.0433899238284899,0.0828838614737731
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GBP6,Guanylate-binding protein 6,37021,-0.00781729792772979,0.00450861627746969,-0.0166541858315704,0.0010195899761108,0.0829667965654191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TAP1,Antigen peptide transporter 1,37169,-0.00992345572746441,0.0057422989316766,-0.0211783616335505,0.00133145017862171,0.0839875948269284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.00826825022171598,0.00479997197890228,-0.0176761953003645,0.00113969485693249,0.0849870269349386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GH2,Growth hormone variant,39477,0.0275788240385421,0.016040028185158,-0.00385963120436759,0.0590172792814519,0.0855659198645685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRG3,Proteoglycan 3,37437,-0.00836948771413484,0.00487693768908755,-0.0179282855847464,0.00118931015647676,0.0861599889654535
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,39489,0.00546740788423622,0.00318719664534022,-0.00077949754063061,0.011714313309103,0.0862865188384323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL19,Interleukin-19,39419,0.0114328491847689,0.00669057985236718,-0.00168068732587073,0.0245463856954086,0.0875083249419784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPM1B,Protein phosphatase 1B,37056,0.0106326236365593,0.00622754003608501,-0.00157335483416731,0.0228386021072859,0.0877795523529107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHPK,Sedoheptulokinase,37169,-0.00696192129605734,0.00408801172016472,-0.0149744242675802,0.00105058167546551,0.0885897079268959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00551623502532366,0.00324661333296963,-0.0118795971579441,0.000847127107296807,0.0893247581211309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00820766519105665,0.00483077195341108,-0.00126064783762906,0.0176759782197424,0.0893319227984248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RELB,Transcription factor RelB,37056,0.00815239774997072,0.00480466492089741,-0.00126474549498821,0.0175695409949297,0.0897642694765515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL1A,Interleukin-1 alpha,39587,0.00882316858931727,0.00520857285818408,-0.00138563421272353,0.0190319713913581,0.0902906963619962
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.00472019653585714,0.00279066988396994,-0.000749516436723953,0.0101899095084382,0.0907757435883383
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN2,Neuroligin-2,36991,-0.00776690076911084,0.00460189297700894,-0.0167866110040484,0.00125280946582668,0.0914806451202509
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB2,Integrin beta-2,39731,-0.00472500840212676,0.00280389136475377,-0.0102206354770442,0.000770618672790633,0.0919771709714145
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,37056,0.00904563927614329,0.00541560110231669,-0.00156893888439742,0.019660217436684,0.0948851721081569
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,37021,0.00546594308469562,0.00327478298224918,-0.000952631560512781,0.011884517729904,0.0951211776431111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00519502773980956,0.00311429654130756,-0.000908993481153248,0.0112990489607724,0.0953113463740241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00519276217644141,0.00311541206470967,-0.000913445470389546,0.0112989698232724,0.0955784538985945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00662492998480012,0.00397491603837741,-0.0144157654200198,0.00116590545041961,0.095601054253327
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEMA6C,Semaphorin-6C,37056,0.00424131071411836,0.00255716879815783,-0.000770740130270981,0.0092533615585077,0.0972209333472696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRR1B,Cornifin-B,37169,0.0141383689810957,0.0085568453350216,-0.00263304787554659,0.0309097858377381,0.0984995358443613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.00687420817809358,0.00416202222156845,-0.00128335537618058,0.0150317717323677,0.0986252532154709
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MUCL3,Mucin-like protein 3,36962,-0.00725338841496499,0.00439245380197943,-0.0158625978668447,0.0013558210369147,0.0986952829119191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,39858,0.00541469885603877,0.00328305635241139,-0.00102009159468755,0.0118494893067651,0.0991086912857494
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00907704365492861,0.00550730898058715,-0.0198713692568794,0.00171728194702221,0.0993393979536937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.00511455245109622,0.00311125057423144,-0.000983498674397398,0.0112126035765898,0.10022220724528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GLI2,Zinc finger protein GLI2,37056,-0.00552246090523104,0.00336042795605004,-0.0121088996990891,0.00106397788862703,0.100328109195332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.004198563057332,0.00256297466540899,-0.000824867286869617,0.00922199340153361,0.101412294717527
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD8,Frizzled-8,36991,0.00680728285871707,0.00415590721667644,-0.00133829528596876,0.0149528610034029,0.101450330052604
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HSP90B1,Endoplasmin,39405,0.0107591464911553,0.00658389149038325,-0.00214528082999583,0.0236635738123065,0.102245050403361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.00761078558330265,0.00466386138433897,-0.016751953896607,0.00153038273000173,0.102732150394259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBLN2,Fibulin-2,37437,-0.00481700148992506,0.0029548233388014,-0.0106084552339758,0.000974452254125687,0.103078963810969
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPLX2,Complexin-2,36962,-0.00477056368477507,0.00292962684169062,-0.0105126322944887,0.000971504924938541,0.103467081885434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00766663357946696,0.00471213014751938,-0.0169024086686049,0.00156914150967102,0.103761102117193
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00474102915014547,0.00293138224115937,-0.0104865383428178,0.0010044800425269,0.105829856979827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINA11,Serpin A11,40052,-0.0064416848908275,0.00399046663041386,-0.0142629994864387,0.00137962970478368,0.106488667967955
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TTN,Titin,37021,-0.0107764269486891,0.00667784291362002,-0.0238649990593843,0.00231214516200615,0.106603754751425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0145803727299384,0.00905366317637736,-0.00316480709576127,0.032325552555638,0.107326130732482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,37056,0.00616673478706558,0.00383846168573151,-0.00135665011696817,0.0136901196910993,0.108173946779167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OPTC,Opticin,39788,-0.00689493256491207,0.00430051721078087,-0.0153239462980426,0.00153408116821842,0.108892712205335
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00738914612436869,0.00461882621221211,-0.0164420455003044,0.00166375325156704,0.109669462677596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FRMD7,FERM domain-containing protein 7,37039,0.00524219011969515,0.00328071225011535,-0.00118800589053093,0.0116723861299212,0.110093277643956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RTKN2,Rhotekin-2,37021,-0.0080777177668392,0.00507371003729243,-0.0180221894399324,0.00186675390625397,0.111392274319304
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TJP3,Tight junction protein ZO-3,36991,-0.00675185436063363,0.00424248809960777,-0.0150671310358649,0.0015634223145976,0.111524636291296
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00822211926024992,0.00516639579377099,-0.00190401649554123,0.0183482550160411,0.111529910407705
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,37169,-0.0062521720991628,0.00393720165976292,-0.0139690873522981,0.00146474315397252,0.112316074818419
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNG,Uracil-DNA glycosylase,37368,0.00537656981964801,0.0033869499855278,-0.00126185215198648,0.0120149917912825,0.112437103977007
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTN4,Alpha-actinin-4,39587,0.0048407605829358,0.00306289526678234,-0.00116251413995759,0.0108440353058292,0.114023379159379
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00753960925700057,0.00477391389069575,-0.0168964804827642,0.00181726196876309,0.114283326620835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.00563686465722325,0.00358078368581156,-0.0126552006814139,0.0013814713669674,0.115465580141228
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL1,Interferon lambda-1,39489,0.0068794765390609,0.00438249657919217,-0.00171021675615575,0.0154691698342776,0.116490737895889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00786772981881269,0.00503818777819144,-0.0177425778640679,0.00200711822644253,0.118401778947344
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BSND,Barttin,36962,-0.00513969414179937,0.00329314052164665,-0.0115942495642268,0.00131486128062806,0.118612271770247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,0.018052354401647,0.0115787484069887,-0.00464199247605087,0.040746701279345,0.118993970663248
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00947736618471967,0.00609895154019675,-0.0214313112035053,0.00247657883406597,0.12022401554716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",36991,0.00984548047705672,0.00636163769993133,-0.00262332941480868,0.0223142903689221,0.121734779225662
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.00497846786447016,0.0032191401008036,-0.0112879824620452,0.00133104673310491,0.121998475455795
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERVV_1,,37021,-0.00726119079032518,0.00469689712239525,-0.0164671091502199,0.00194472756956952,0.122139521010796
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL33,Interleukin-33,39587,0.00588268259501424,0.00381835521230563,-0.0016012936211048,0.0133666588111333,0.12342634315308
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC4A1,Band 3 anion transport protein,37437,-0.00697853276525304,0.00455375099438819,-0.0159038847142539,0.00194681918374782,0.125427304823284
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,37437,0.0043631399201293,0.00284794696583002,-0.00121883613289754,0.00994511597315614,0.125538354327816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,39587,0.00457612311382684,0.00299138626369632,-0.00128699396301796,0.0104392401906716,0.126094597454622
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCA2A,Guanylin,39796,-0.00481192527885778,0.00314771102668787,-0.010981438891166,0.00135758833345044,0.126357148780434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYB5A,Cytochrome b5,36962,0.010697069239702,0.00699917149696191,-0.00302130689434338,0.0244154453737473,0.12645386235315
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,37388,0.00399654749717906,0.0026170027191227,-0.00113277783230144,0.00912587282665956,0.126747874515387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.00381783192259774,0.00250300104383617,-0.00872371396851663,0.00108805012332115,0.127207983461341
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,37064,-0.00501515547630362,0.00331087964345091,-0.0115044795774674,0.00147416862486016,0.129859622244534
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.0037423924319346,0.00247184027187716,-0.00110241450094463,0.00858719936481383,0.130047303386002
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,37021,0.00688497018182462,0.00455534559657432,-0.00204350718746105,0.0158134475511103,0.130709413150005
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,37039,-0.0100012652492153,0.00661734441502411,-0.0229712603026625,0.00296872980423198,0.1307178220426
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PTTG1,Securin,37169,0.00615367214774176,0.00407384012759905,-0.00183105450235238,0.0141383987978359,0.130931078498434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMEM132A,Transmembrane protein 132A,37043,0.00924580573397475,0.00612143184510831,-0.00275220068243754,0.021243812150387,0.13096556107719
NMR metabolomics,X23495.Concentration of Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,0.0053101120107826,0.0035252025683378,-0.00159928502315948,0.0122195090447247,0.132006293295753
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LY96,Lymphocyte antigen 96,39749,-0.00517431898960948,0.00344604197154778,-0.0119285612538431,0.00157992327462418,0.133239635595741
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0094350582230089,0.00629013644752397,-0.0217637256601559,0.00289360921413809,0.133644387854291
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL9,Interleukin-9,37169,-0.00838091229361129,0.00559026326352218,-0.0193378282901148,0.00257600370289219,0.133845955773744
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRXN3,Neurexin-3,37039,0.00512509939291234,0.00342406394062573,-0.00158606593071409,0.0118362647165388,0.134472257181434
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.0101025606240217,0.0067689474090303,-0.0233696975457211,0.0031645762976777,0.135595755804706
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LPO,Lactoperoxidase,39344,-0.00869440439810081,0.00583154066671733,-0.0201242241048668,0.00273541530866516,0.136000898643903
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL20,Interleukin-20,39587,0.0070958091694382,0.00476306602482463,-0.00223980023921808,0.0164314185780945,0.136308292822095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.00785179334310197,0.00530132688445056,-0.0182423940366251,0.00253880735042113,0.138599804236336
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00795552246119321,0.00538591550015423,-0.0185119168414955,0.00260087191910909,0.139673360408241
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLON5,IgLON family member 5,36962,0.0132466896797592,0.00900680891832449,-0.0044066558001568,0.0309000351596752,0.141384992303272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00702929673547916,0.00478130057224366,-0.00234205238611842,0.0164006458570767,0.141541204117181
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,0.00495292420036171,0.00339836856920701,-0.00170787819528402,0.0116137265960074,0.145014110489859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCP11,T-complex protein 11 homolog,37169,-0.00845978350169869,0.0058130511568925,-0.019853363769208,0.00293379676581062,0.145607424789816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.0083104586578206,0.00572461050545931,-0.0195306952485208,0.00290977793287964,0.146602392967848
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00677025175440074,0.00467949262962896,-0.0159420573084735,0.00240155379967202,0.147978985337807
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAMA1,Laminin subunit alpha-1,37021,-0.00762640494847418,0.0052938078622488,-0.0180022683584818,0.00274945846153346,0.149713748304918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.0119458355471486,0.00830129549109986,-0.0282163747097043,0.00432470361540714,0.150165043486184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.0136446553715429,0.00953000073316349,-0.00503414606545757,0.0323234568085433,0.152236210402214
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00606232020432365,0.00424523466688749,-0.00225833974277583,0.0143829801514231,0.153306841340695
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00673373289104501,0.00471653203764081,-0.015978135684821,0.00251066990273097,0.153405577438959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KEL,Kell blood group glycoprotein,39489,0.00494342240447286,0.00346404322945353,-0.00184610232525606,0.0117329471342018,0.153580508710684
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,37056,0.00444164954382593,0.0031202599163874,-0.00167405989229337,0.0105573589799452,0.154618659500307
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UNC5D,Netrin receptor UNC5D,37056,0.00370007774600755,0.00259951890803517,-0.00139497931374138,0.00879513480575648,0.154652508342502
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,0.0047954199001087,0.00337252608368893,-0.00181473122392159,0.011405571024139,0.155072553492436
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENG,Endoglin,40052,-0.00234293885887821,0.00165271409024621,-0.00558225847576077,0.000896380758004354,0.156317744003325
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,37002,0.0114673076752965,0.00812043758232476,-0.00444874998606008,0.027383365336653,0.157928326095553
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHIT1,Chitotriosidase-1,39906,0.0206014037220535,0.0147138424952105,-0.00823772756855917,0.0494405350126661,0.16149146001794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CBLN1,Cerebellin-1,36991,-0.0131328588401833,0.00938774651667139,-0.0315328420128593,0.00526712433249259,0.161855722250197
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.00665522419617808,0.0047703725219692,-0.00269470594688155,0.0160051543392377,0.163004965487252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00773210219723743,0.00554454201621965,-0.00313520015455309,0.0185994045490279,0.163177341063217
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00509715160683615,0.00366692763702913,-0.00209002656174095,0.0122843297754133,0.164542085065162
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,40030,-0.007599910430768,0.00546830318341477,-0.0183177846702609,0.00311796380872495,0.164605270280186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,37368,0.00561217130938274,0.00407679153720918,-0.00237834010354725,0.0136026827223127,0.16865420840723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC8,Histone deacetylase 8,37056,0.0084629252736324,0.00617277136723322,-0.00363570660614472,0.0205615571534095,0.170395457330012
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00876106435994301,0.006435326948815,-0.0213743051796204,0.00385217645973439,0.173410224039616
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.006098709075308,0.00448319593762077,-0.0148857731130447,0.00268835496242871,0.173742889070836
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP13,Collagenase 3,39489,-0.0042435862382789,0.00313251572416266,-0.0103833170576377,0.00189614458107992,0.175536078705345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,39885,0.00314543572948835,0.00232476819641576,-0.00141110993548655,0.00770198139446325,0.176071370118643
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1B,Lithostathine-1-beta,40052,0.00716725760465574,0.00530008736414315,-0.00322091362906483,0.0175554288383763,0.17630129924696
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00352894346062625,0.00261529032712554,-0.00159702558053981,0.00865491250179231,0.177243310486476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDNRB,Endothelin receptor type B,37056,0.0061064509850584,0.00455622683724784,-0.00282375361594737,0.0150366555860642,0.180189440824812
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,0.0114765522823181,0.00857856934750903,-0.0053374436387996,0.0282905482034358,0.180979511377635
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CYTH3,Cytohesin-3,36962,0.00944831906973158,0.0070630004695396,-0.00439516185056603,0.0232917999900292,0.181010851578692
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,-0.0038782190836245,0.00290934363378918,-0.0095805326058513,0.0018240944386023,0.182547595746089
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLHL41,Kelch-like protein 41,37411,0.00663379371347651,0.00498932174590041,-0.00314527690848829,0.0164128643354413,0.183673039483705
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BMP10,Bone morphogenetic protein 10,37124,-0.00364454593643961,0.00276289273970641,-0.00905981570626418,0.00177072383338496,0.18715674578376
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP73,Tumor protein p73,37039,-0.00445647502412671,0.00337846930931474,-0.0110782748703836,0.00216532482213017,0.187164917844865
NMR metabolomics,X23495.Concentration of Large VLDL Particles,APOH,Beta-2-glycoprotein 1,39858,0.00456829294887423,0.00346559056909908,-0.00222426456655997,0.0113608504643084,0.187460265835972
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00326597860503879,0.00248897398123038,-0.00814436760825034,0.00161241039817275,0.189482035627042
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00998518193739504,0.00762544181816232,-0.0049606840262031,0.0249310479009932,0.190402698503902
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF9,Fibroblast growth factor 9,36931,0.00513717401558898,0.00395688336383154,-0.00261831737752085,0.0128926654086988,0.194211309664871
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,39931,0.00344087819886153,0.00265791991743787,-0.00176864483931669,0.00865040123703975,0.195485283408047
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDAN1,Codanin-1,37388,0.00284560079804543,0.00220017620064186,-0.00146674455521262,0.00715794615130347,0.195911661853858
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00406126676920514,0.00314531382448825,-0.0102260818652021,0.00210354832679183,0.196652925396066
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,39794,0.00327038305481027,0.00253668317289619,-0.00170151596406626,0.00824228207368679,0.197334796848829
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,39788,-0.00815559982222775,0.00632915598783168,-0.0205607455583778,0.00424954591392235,0.197564175316475
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRNN,Cornulin,39397,0.00812727514232928,0.006309053738872,-0.00423847018585985,0.0204930204705184,0.197698177083891
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HEBP1,Heme-binding protein 1,39585,-0.00675166608050833,0.00524385646374505,-0.0170296247494486,0.00352629258843196,0.197925674919152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAPPA,Pappalysin-1,39587,0.00594724066721843,0.00462934294814372,-0.00312627151114325,0.0150207528455801,0.198921815349682
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NPHS2,Podocin,37056,-0.0128024370471498,0.00996835602676776,-0.0323404148596146,0.00673554076531507,0.199056837613729
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,39866,0.0056794611268585,0.004486340854444,-0.00311376694785174,0.0144726892015687,0.205551170901259
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00903915305010855,0.00715705553694758,-0.0230669819025258,0.00498867580230871,0.206622054839021
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,0.00577561041099491,0.00457550634153019,-0.00319238201840427,0.0147436028403941,0.20686372033965
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR4,Toll-like receptor 4,37056,0.00339600274555738,0.00269334987953058,-0.00188296301832256,0.00867496850943732,0.207372804979636
NMR metabolomics,X23495.Concentration of Large VLDL Particles,H2AP,Huntingtin-interacting protein M,36962,-0.006141380361801,0.00489280822216473,-0.0157312844772439,0.00344852375364187,0.209433931299952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0178489831809929,0.0142262763644099,-0.0100345184932506,0.0457324848552364,0.209627898438286
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,36991,-0.0104137648359282,0.00832622763821678,-0.0267331710068331,0.00590564133497666,0.21105957608124
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEP350,Centrosome-associated protein 350,36962,-0.00440349113395489,0.00353540018245023,-0.0113328754915573,0.00252589322364757,0.212954681863918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD1,Glutamate decarboxylase 1,36962,-0.00314985480436291,0.00253291694162714,-0.0081143720099521,0.00181466240122628,0.213680798886566
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK1,Kallikrein-1,39720,-0.0152003609239905,0.0122557799484834,-0.0392216896230181,0.00882096777503702,0.214897370541359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.0052558918569479,0.00424991583989771,-0.0135857269031474,0.00307394318925161,0.216218816198828
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0205456627965585,0.0166245445639815,-0.0531297701419623,0.0120384445488453,0.21653088775773
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN1,Transcobalamin-1,37235,0.00412973001863276,0.00334182189158869,-0.00242024088888107,0.0106797009261466,0.216565018547634
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTO1,Protein LTO1 homolog,39587,0.0048623349479045,0.00393628073930513,-0.00285277530113357,0.0125774451969426,0.216751754166175
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00403747938449731,0.0032696966198877,-0.00237112599048259,0.0104460847594772,0.216916794671784
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACHE,Acetylcholinesterase,37124,0.00393852822386054,0.00319495805242127,-0.00232358955888516,0.0102006460066062,0.217697477678342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCC,Netrin receptor DCC,37039,0.00271922173809457,0.00220716989829204,-0.00160683126255783,0.00704527473874696,0.217973023627927
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,36991,0.0126176640217826,0.0102672932913524,-0.00750623082926821,0.0327415588728333,0.219124483736674
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.00816160025754671,0.00666592832011008,-0.0212268197649625,0.00490361924986905,0.220831798442287
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00641614566662094,0.00526391259355742,-0.0167334143499935,0.0039011230167516,0.22290674262242
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASP4,Caspase-4,37169,-0.0196110384408839,0.0160930911930228,-0.0511534971792087,0.0119314202974409,0.22301770757075
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,37056,0.0113798079736208,0.00934515663268581,-0.00693669902644341,0.029696314973685,0.223351198079777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,0.0068278872061552,0.005609569301222,-0.00416686862423992,0.0178226430365503,0.223554824736731
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,39585,0.0071333307576066,0.00586136650952487,-0.00435494760106214,0.0186216091162753,0.22361938283332
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00663333804290656,0.00548627427207914,-0.0173864356161817,0.00411975953036856,0.226654381856184
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0202007920573978,0.0167407931278916,-0.0126111624732697,0.0530127465880652,0.227573222806301
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.0057752345920665,0.00479728573101906,-0.00362744544073086,0.0151779146248639,0.228667475054128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.0032551718737403,0.00271380858634409,-0.00206389295549411,0.00857423670297471,0.230361067323032
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00236239458947038,0.00197046062510478,-0.00622449741467575,0.00149970823573498,0.230582644743338
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MSLNL,Mesothelin-like protein,37039,-0.00422637387483696,0.00354114254467951,-0.0111670132624088,0.00271426551273489,0.232692857955268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB5,Integrin beta-5,39913,0.00440658736885491,0.0037022471935277,-0.00284981713045938,0.0116629918681692,0.233967058761414
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP1B4,Protein ATP1B4,36962,-0.00485706429139213,0.00409037470767301,-0.0128741987184312,0.00316007013564696,0.235076625136157
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RLN2,Prorelaxin H2,37095,0.0164688601914637,0.0138722544234135,-0.0107207584784268,0.0436584788613541,0.235178015193591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00555075657589189,0.00468838355626289,-0.00363847519438338,0.0147399883461672,0.236458344469907
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD82,CD82 antigen,37169,-0.00484755588723121,0.00411385900134816,-0.0129107195298736,0.00321560775541118,0.23867912559685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00396613514957334,0.00337441594883458,-0.0105799904092891,0.00264772011014244,0.239874234666539
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.00957676604131942,0.00815325969533338,-0.0255571550441729,0.00640362296153401,0.240178722708941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00626399920403708,0.00534056299451653,-0.00420350426521532,0.0167315026732895,0.240853215831294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FAM171A2,Protein FAM171A2,37411,0.0179640431841589,0.0153381171114228,-0.0120986663542298,0.0480267527225477,0.241537929720594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,37445,0.0039599337172287,0.00339897975043464,-0.00270206659362319,0.0106219340280806,0.244024884058937
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEZ6,Seizure protein 6 homolog,37039,-0.00353347478889941,0.00303443941277993,-0.00948097603794808,0.00241402646014926,0.244259861412906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DAND5,DAN domain family member 5,37056,-0.00610689709555178,0.00524546601247099,-0.0163880104799949,0.00417421628889136,0.244354319693906
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00569935980748235,0.00489569395818627,-0.0152949199655274,0.00389620035056275,0.244381307769822
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00702400333657386,0.00604022547340137,-0.0188628452644405,0.00481483859129282,0.244902909223546
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00524105035540119,0.00452631723415169,-0.0141126321343385,0.00363053142353611,0.24692341633568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALM3,Paralemmin-3,37021,0.00853351754579653,0.00738716730874195,-0.00594533037933769,0.0230123654709307,0.248037162469896
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A16,Protein S100-A16,39456,-0.00700338995546966,0.00606467918187542,-0.0188901611519455,0.00488338124100617,0.248196889649926
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00615335113829835,0.00533581951097696,-0.00430485510321649,0.0166115573798132,0.248839363756225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CORO6,Coronin-6,36991,-0.00426517770885081,0.00370079952057776,-0.0115187447691832,0.00298838935148159,0.249135955533457
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.00526266276202813,0.00457636681354422,-0.0142323417165748,0.00370701619251853,0.25017904856274
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NECTIN4,Nectin-4,39913,0.00328322504970521,0.00286915716482325,-0.00234032299334835,0.00890677309275878,0.252509296483135
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ISM2,Isthmin-2,37437,-0.00496271947610139,0.00434352711050405,-0.0134760326126893,0.00355059366048654,0.253243463830575
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,37021,0.00466758519597946,0.00408993962684576,-0.00334869647263822,0.0126838668645971,0.253792608067794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.0052057757941743,0.0045657969678455,-0.00374318626280289,0.0141547378511515,0.254236399443293
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00802657033737877,0.00706311969958863,-0.0218702849485725,0.00581714427381493,0.255807222372991
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00328374852746752,0.00290546751592119,-0.00897846485867305,0.00241096780373801,0.258413538010915
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF75D,Zinc finger protein 75D,37169,0.00652582151642053,0.00577879749486431,-0.00480062157351352,0.0178522646063546,0.25880438811499
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00597503356789104,0.00530094623785285,-0.0163648881940826,0.00441482105830055,0.259693675169827
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00556028003390808,0.00496019045824019,-0.0152822533320588,0.00416169326424269,0.262316337171823
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,39587,0.00435955009363269,0.00388913842550227,-0.00326316122035177,0.0119822614076171,0.262324031929859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ESR1,Estrogen receptor,37056,0.00650551547377168,0.00580714807700092,-0.00487649475715012,0.0178875257046935,0.262623387223708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00690569496891679,0.00617259788430712,-0.00519259688432516,0.0190039868221587,0.263260011238594
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00569633068951151,0.00511526264119336,-0.0157222454662505,0.00432958408722747,0.265473134581763
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.0069088004466011,0.00621574391023428,-0.0190916585106603,0.00527405761745809,0.266373418639203
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00697119922859648,0.00630775192509114,-0.00539199454458216,0.0193343930017751,0.269098754472423
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DBH,Dopamine beta-hydroxylase,37430,-0.0117261669806227,0.0106386683052283,-0.0325779568588701,0.00912562289762473,0.270385015087288
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AOC3,Membrane primary amine oxidase,39931,-0.00319497281600984,0.00292995906200148,-0.00893769257753274,0.00254774694551306,0.275531472767428
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA3,Carbonic anhydrase 3,40017,0.00638582893196339,0.00587788433682238,-0.00513482436820848,0.0179064822321353,0.277311092826084
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH22,Cadherin-22,37169,-0.00307249097079919,0.00282947432682609,-0.00861826065137832,0.00247327870977995,0.277548409105523
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.00967017705698273,0.00892575962864509,-0.0271646659291271,0.00782431181516164,0.278650401395954
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1,DNA topoisomerase 1,37382,0.0120330478470128,0.0111130051648158,-0.00974844227602626,0.0338145379700518,0.278921073363843
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGF,Beta-nerve growth factor,39749,0.00129561540168721,0.00119925063965576,-0.00105491585203808,0.0036461466554125,0.280000904141665
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00284901821049262,0.00264797481739082,-0.00803904885257863,0.0023410124315934,0.281977661371285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00896333624244807,0.00836006472452359,-0.0253490631025143,0.00742239061761816,0.283667117203106
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.00343494473634935,0.003204701729171,-0.00284627065282581,0.00971616012552451,0.28380910861226
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00357402273125768,0.00334524577590646,-0.00298265898951898,0.0101307044520343,0.285364597092765
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00301632254523774,0.00283086643359033,-0.00253217566459931,0.0085648207550748,0.286661156051401
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FBN2,Fibrillin-2,37039,0.00624998240939819,0.00586594464296855,-0.00524726909082017,0.0177472339096165,0.286683247727167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0039576682613976,0.00371781280507095,-0.0112445813593367,0.00332924483654146,0.287111463564044
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DEFB118,Beta-defensin 118,36991,0.00602647347815764,0.00567230823085914,-0.00509125065432627,0.0171441976106415,0.288056615881069
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACRV1,Acrosomal protein SP-10,37056,0.00753251075295539,0.00712801684137836,-0.00643840225614619,0.021503423762057,0.290646391924387
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-0.00304610563090919,0.00289055491339368,-0.0087115932611608,0.00261938199934242,0.291987089917755
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,37382,0.008155850770157,0.00774391914569765,-0.00702223075541039,0.0233339322957244,0.292270812786968
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,39587,0.00634304296089908,0.00602772560763762,-0.00547129923007066,0.0181573851518688,0.292672978267505
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17F,Interleukin-17F,39587,-0.0079074122550003,0.00756033108236946,-0.0227256611764445,0.00691083666644385,0.295619493788596
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,36991,0.00740717185848445,0.00708622482274237,-0.00648182879409059,0.0212961725110595,0.295907422884397
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL22,Interleukin-22,37368,-0.00668170046668194,0.00639271358003653,-0.0192114190835535,0.00584801815018966,0.295946627626528
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00442405802660128,0.00423978693728558,-0.012734040423681,0.00388592437047845,0.29675337681333
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.0046956920661009,0.00451096029852834,-0.0135371742512164,0.00414579011901463,0.297917144919119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00596146687729755,0.00574000474340595,-0.0172118761743732,0.00528894241977811,0.299018201359757
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,36962,0.00648021803202456,0.00624391346980834,-0.0057578523687998,0.0187182884328489,0.299361102950342
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.00754136860206565,0.00729668879351466,-0.00676014143322308,0.0218428786373544,0.301373573329253
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00641163878777242,0.00622144585624747,-0.0186056726660175,0.00578239509047262,0.302761282653334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,POF1B,Protein POF1B,37056,0.00452263743182841,0.00441973927276161,-0.00414005154278436,0.0131853264064412,0.306193526371294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,37056,0.0021733449628403,0.0021272681680092,-0.00199610064645772,0.00634279057213833,0.306960541204574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF5,Fibroblast growth factor 5,39587,-0.00328055989392656,0.00323059343773382,-0.00961252303188484,0.00305140324403172,0.309899057914102
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,39866,0.0040390284332731,0.00399595899610366,-0.00379305119909007,0.0118711080656363,0.312137855553097
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",37388,0.00590457262211866,0.00584381633266851,-0.00554930738991162,0.0173584526341489,0.312323349072774
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLINT1,Clathrin interactor 1,36962,-0.00480978958880837,0.00477802202942994,-0.0141747127664911,0.00455513358887431,0.314122220503653
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDSN,Corneodesmosin,39992,0.00414636701183906,0.00412588870576735,-0.00394037485146494,0.0122331088751431,0.314929562498031
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHH,Sonic hedgehog protein,37056,-0.0042634330157994,0.00426350604888642,-0.0126199048716168,0.00409303884001798,0.317337133773925
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,39866,0.00425109487159987,0.00426380017113621,-0.0041059534638271,0.0126081432070269,0.318769780413324
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,39913,-0.00393393088499852,0.00398513429852899,-0.0117447941101153,0.0038769323401183,0.323583303174777
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,39489,0.00452893174137197,0.00459130006499318,-0.00447001638601466,0.0135278798687586,0.323944298061227
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WIF1,Wnt inhibitory factor 1,40030,-0.00318834197009216,0.00326951929549534,-0.00959659978926303,0.00321991584907871,0.329489794554252
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,37056,-0.00880681453771349,0.00909594637367112,-0.0266348694301089,0.0090212403546819,0.332955692814285
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00409969683721166,0.00423655479068146,-0.0124033442269473,0.004203950552524,0.333213985145892
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00458238504080897,0.00474175894352942,-0.0138762325701266,0.00471146248850869,0.333867260303017
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0109639505702001,0.0113751155141375,-0.0113312758375094,0.0332591769779097,0.335136879358311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,39489,0.00492998379455743,0.0051219577668006,-0.00510905342837174,0.0149690210174866,0.335803646593957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TCN2,Transcobalamin-2,40012,0.00274161417911913,0.00285396320461482,-0.00285215370192591,0.00833538206016417,0.336750591054281
NMR metabolomics,X23495.Concentration of Large VLDL Particles,S100A3,Protein S100-A3,37368,0.00423065217926495,0.00440756544094201,-0.0044081760849814,0.0128694804435113,0.337142127631048
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00585079290757138,0.0060958623884595,-0.00609709737380924,0.017798683188952,0.337174820043836
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF7,Fibroblast growth factor 7,36962,-0.00744448885086714,0.00777305404151237,-0.0226796747722314,0.00779069707049711,0.338216479643322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SERPINB5,Serpin B5,39585,0.00454335369446951,0.00474836682037682,-0.00476344527346906,0.0138501526624081,0.338670555011177
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RRP15,RRP15-like protein,36991,0.00844576068679661,0.00882767323842784,-0.00885647886052197,0.0257480002341152,0.338717684302507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00674929040998724,0.00713020098345509,-0.00722590351758474,0.0207244843375592,0.343871113901003
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,37422,-0.00225410602229557,0.00238289537941326,-0.00692458096594557,0.00241636892135443,0.344189628398348
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD5L,CD5 antigen-like,37380,0.00430767742184543,0.00456236551928038,-0.0046345589959441,0.013249913839635,0.345096433175187
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR2,Toll-like receptor 2,37169,-0.00208612022302021,0.00221573589222191,-0.00642896257177515,0.00225672212573473,0.346464649487374
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.00537590286124491,0.00571380965861768,-0.0165749697921356,0.00582316406964574,0.346790350019611
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LAYN,Layilin,39713,0.00295666613609656,0.00314702203925486,-0.00321149706084296,0.00912482933303607,0.347482058225512
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.00704046051017732,0.00749432945070221,-0.0217293462335537,0.00764842521319902,0.347523009871683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",39585,0.0076600163974366,0.00821297482251317,-0.00843741425468921,0.0237574470495624,0.351003367368087
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00343103137230696,0.00368007948017011,-0.00378192440882646,0.0106439871534404,0.351182725336605
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.0115184870166649,0.0123897696013034,-0.0127654614018898,0.0358024354352195,0.352552582945599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00495825013423875,0.0053451665232395,-0.0154347765197882,0.00551827625131068,0.353625033433598
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,39931,0.00269262385460264,0.00292171614522132,-0.00303393979003115,0.00841918749923644,0.356756404970137
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,0.00711815369745327,0.00776129315706848,-0.00809398089040095,0.0223302882853075,0.359086047715691
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL13,Interleukin-13,39587,0.00434506460495487,0.00475537994764902,-0.0049754800924372,0.0136656093023469,0.360880338240264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.00691530005151071,0.00764722597706063,-0.0219038629665495,0.00807326286352812,0.365858704101523
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKAP12,A-kinase anchor protein 12,37124,-0.0018400696978963,0.00206049227750461,-0.00587863456180534,0.00219849516601273,0.371860354882169
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CHRDL2,Chordin-like protein 2,39868,0.00490286463843709,0.00549306173016239,-0.00586353635268119,0.0156692656295554,0.372108462974507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORN4,MORN repeat-containing protein 4,36962,0.00694266897553882,0.0077896149879012,-0.00832497640074754,0.0222103143518252,0.372799409440899
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TG,Thyroglobulin,37368,0.00943757791382721,0.0106116194951707,-0.0113611962967074,0.0302363521243618,0.373824055100436
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRYBB2,Beta-crystallin B2,37388,0.0049209751458292,0.00554307634387409,-0.00594345448816402,0.0157854047798224,0.374680435534118
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,0.00721442950708475,0.00814557672862159,-0.00875090088101357,0.0231797598951831,0.375799647392901
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADA2,Adenosine deaminase 2,39782,-0.00356156736382814,0.00402388156351907,-0.0114483752283255,0.00432524050066923,0.376112072859894
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,0.00610128569543387,0.00693154410110655,-0.00748454074273497,0.0196871121336027,0.378756039189504
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NENF,Neudesin,37368,0.00928320808927796,0.0107222511287338,-0.0117324041230402,0.0302988203015961,0.386621207604819
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00345683805211792,0.00400685035145117,-0.00439658863672637,0.0113102647409622,0.388297606852952
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DLGAP5,Disks large-associated protein 5,37411,-0.00441189799575971,0.00512156354043019,-0.0144501625350029,0.00562636654348347,0.389013328620574
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,36991,0.00631151812926938,0.0073337233676045,-0.00806257967123545,0.0206856159297742,0.389465399742962
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.0033726113114526,0.00393450120213987,-0.00433901104474155,0.0110842336676468,0.391356026242483
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,37021,0.00835856235457082,0.00977829861113101,-0.010806902923246,0.0275240276323876,0.392673321274108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL21R,Interleukin-21 receptor,37056,-0.00453711207955235,0.00531061496591816,-0.0149459174127519,0.00587169325364724,0.392927832732521
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSN,Gelsolin,37383,-0.00154708519864782,0.00182086614962336,-0.00511598285190961,0.00202181245461397,0.395538937969536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL10,Interleukin-10,39587,0.00651298914119248,0.007722338586355,-0.00862279448806332,0.0216487727704483,0.399019859532385
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ABO,Histo-blood group ABO system transferase,37445,0.0118060691422216,0.0140089108912002,-0.0156513962045309,0.039263534488974,0.399380738516769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.0042417683230855,0.00505261482051763,-0.0141448933713,0.00566135672512905,0.401193138599775
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00621438802937581,0.00741692557198074,-0.0207515621504581,0.00832278609170644,0.402121347293054
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,37021,-0.0042117367404365,0.00503451322679417,-0.0140793826649531,0.00565590918408006,0.40284793860587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00488452182178504,0.0058727445324476,-0.00662605746181225,0.0163951011053823,0.40557795018608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NEB,Nebulin,37021,-0.00303853213038737,0.0036656534064701,-0.0102232128070688,0.00414614854629403,0.407164909385721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.0024756860136668,0.00299750158387629,-0.00339941709073072,0.00835078911806432,0.40886376930271
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00464075617243968,0.00562524397736802,-0.00638472202320163,0.015666234368081,0.409393686084587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,36991,0.00738249267982771,0.00895085740654657,-0.0101611878370036,0.024926173196659,0.409511199454204
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,37021,-0.00304092132621004,0.00369827520474554,-0.0102895407275113,0.00420769807509121,0.410947286414497
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.0022409737737741,0.00273741846242236,-0.00760631396012193,0.00312436641257372,0.413001157253507
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.0032556364693337,0.0039826036669524,-0.0110615396565604,0.00455026671789301,0.413677894669769
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,39477,0.0027229377471235,0.00335856364348569,-0.00385984699410847,0.00930572248835546,0.417524639703087
NMR metabolomics,X23495.Concentration of Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00444187381394673,0.00550757688728217,-0.00635297688512633,0.0152367245130198,0.419967880499739
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPRING1,SREBP regulating gene protein,36962,0.00471179815152899,0.00584849790607123,-0.00675125774437061,0.0161748540474286,0.420463665388818
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00504387254763387,0.0063955797669426,-0.0175792088908414,0.00749146379557363,0.430330777481268
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00433290363056759,0.00549576263682713,-0.0151045983987488,0.00643879113761357,0.430472250515143
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA8,Carbonic anhydrase-related protein,37056,0.0020040107153986,0.00254816996423564,-0.00299040241450325,0.00699842384530045,0.431617460750036
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SKIV2L,Helicase SKI2W,37021,0.00306635934800671,0.00393087477858359,-0.00463815521801713,0.0107708739140305,0.435363423490446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CASQ2,Calsequestrin-2,37021,0.00371160008609389,0.00476120210832401,-0.00562035604622116,0.0130435562184089,0.435669197586678
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NMI,N-myc-interactor,37311,0.00548208139596991,0.0070450985660685,-0.00832631179352435,0.0192904745854642,0.436499468072437
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NRN1,Neuritin,37411,-0.00266969584020614,0.00343686680445857,-0.00940595477694493,0.00406656309653266,0.437301030694225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,0.00547391306737664,0.00704828784982431,-0.00834073111827902,0.0192885572530323,0.437390979106872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00314293469975703,0.00406948283152618,-0.0111191210495484,0.00483325165003429,0.439939959033439
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,37437,-0.00163991472447425,0.00212406247156697,-0.00580307716874551,0.00252324771979702,0.440089248212716
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TBR1,T-box brain protein 1,37039,-0.00362283283401255,0.00470474970045673,-0.0128441422469077,0.00559847657888264,0.441291559445923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD177,CD177 antigen,39844,-0.00937306883740458,0.0121830777759415,-0.0332519012782498,0.0145057636034407,0.441696056330476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLNS1A,Methylosome subunit pICln,37039,-0.00252758736757994,0.00328716049294182,-0.00897042193374591,0.00391524719858604,0.441950262616393
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPGN,Epigen,37368,-0.00374537990912944,0.00487361937113977,-0.0132976738765634,0.0058069140583045,0.44220320870519
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00647121726821964,0.00844694168536337,-0.0230272229715318,0.0100847884350926,0.443629316265013
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,-0.00386840789881278,0.00506075231120399,-0.0137874824287726,0.00605066663114704,0.444646282194685
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TEX101,Testis-expressed protein 101,37039,0.00362079806360049,0.00474601360990819,-0.00568138861181957,0.0129229847390205,0.445528613295803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OTOA,Otoancorin,36991,-0.00391412054316281,0.00517305472078878,-0.0140533077959088,0.0062250667095832,0.449281413417196
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MTR,Methionine synthase,37021,0.00474658552306921,0.00628830378792469,-0.00757848990126319,0.0170716609474016,0.450365912286125
NMR metabolomics,X23495.Concentration of Large VLDL Particles,INSL4,Early placenta insulin-like peptide,37368,-0.00393678083441169,0.00522046309508897,-0.0141688885007861,0.0062953268319627,0.450798916411747
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00286262665308377,0.00380790358846104,-0.00460086438029986,0.0103261176864674,0.45220930963584
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SELL,L-selectin,37453,0.00165581201854261,0.00220974814766598,-0.00267529435088271,0.00598691838796794,0.453676358692646
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00298750292401258,0.0040048473117733,-0.0048619978070631,0.0108370036550882,0.455697485843988
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANK2,Ankyrin-2,37021,-0.00512797989193531,0.0069354714743561,-0.0187215039816733,0.00846554419780264,0.459686757520543
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MMP15,Matrix metalloproteinase-15,37437,0.00352829200413614,0.00483551159344941,-0.00594931071902471,0.013005894727297,0.465609029962427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00384711859303586,0.00527360765868056,-0.0141833896040498,0.00648915241797802,0.465706177565182
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,-0.00308475894714781,0.00422974767947796,-0.0113750643989246,0.00520554650462899,0.465830203916573
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,37368,0.0036550029750856,0.00502801249618493,-0.00619990151743687,0.0135099074676081,0.467282671983225
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,37039,0.00429993457029174,0.00594024173833448,-0.00734293923684384,0.0159428083774273,0.469161314186345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL4,Myosin light chain 4,37043,-0.00366399783917085,0.00506758014973965,-0.0135964549326606,0.00626845925431887,0.469676054840947
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00454235641915671,0.00630836107969421,-0.0169067441353574,0.00782203129704393,0.471504946218601
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.00242623165101114,0.00337434747017758,-0.0090399526925592,0.00418748939053692,0.472139841076789
NMR metabolomics,X23495.Concentration of Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,39990,0.00435569649020839,0.00606666715322747,-0.00753497113011745,0.0162463641105342,0.472785016784708
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00535726061206407,0.00748918364086701,-0.0200360605481634,0.00932153932403527,0.474415631631324
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HRAS,GTPase Hras,37161,0.00679562215346366,0.00954048805682375,-0.0119037344379109,0.0254949787448382,0.476295897388638
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,37388,0.00193108486228792,0.00273166766381883,-0.003422983758797,0.00728515348337284,0.479625104219671
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF6,Fibroblast growth factor 6,37056,0.00282745900382504,0.00400376127490826,-0.00501991309499516,0.0106748311026452,0.480075804506931
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DPEP2,Dipeptidase 2,39788,-0.00199679572656823,0.00283524790312061,-0.00755388161668462,0.00356029016354816,0.481271496921996
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00153440867900437,0.00220092958000327,-0.00277941329780203,0.00584823065581078,0.485712501348701
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4,Interleukin-4,39587,0.00613814808995865,0.00880651450334124,-0.0111226203365902,0.0233989165165075,0.485812564455294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,0.00786422606630649,0.0112908968003781,-0.0142659316624345,0.0299943837950475,0.486121247638297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2B,Alpha-amylase 2B,38832,0.00326656036543333,0.00469566884725231,-0.00593695057518119,0.0124700713060479,0.486656397199758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAG,Myelin-associated glycoprotein,37039,-0.00312991120223558,0.00450347848128653,-0.0119567290255572,0.00569690662108602,0.487068436949859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00214188673889789,0.00310618185057614,-0.00394622968823134,0.00823000316602712,0.490483538151361
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,39709,-0.00185234691740796,0.00269710818746939,-0.00713867896484797,0.00343398513003205,0.492225123905754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00455637159064374,0.00663661564392083,-0.0175641382527286,0.00845139507144109,0.492378010413981
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.0037316922243407,0.00548116449684545,-0.0144747746381578,0.00701139018947639,0.495996727158108
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00324323940016263,0.00476512768531823,-0.0125828896633863,0.0060964108630611,0.496124235439497
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,37382,0.00329670225666104,0.00485603550458373,-0.00622112733232307,0.0128145318456451,0.497220706342773
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRTN3,Myeloblastin,39421,0.00305631906043257,0.00451247132941984,-0.00578812474523032,0.0119007628660955,0.498222575015476
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,37039,0.00239283935241224,0.00354663685534127,-0.00455856888405666,0.00934424758888113,0.499891932395963
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,37039,0.00680710500411725,0.0100939920822798,-0.0129771194771512,0.0265913294853857,0.500086707412032
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,37382,-0.00305964423826759,0.00454285859773578,-0.0119636470898297,0.00584435861329453,0.500636703994889
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.00314451348580054,0.0047050070089219,-0.0123663272232875,0.00607730025168638,0.50393252425614
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00234606299601192,0.00354143802021636,-0.00928728151563597,0.00459515552361214,0.507685813915587
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00488482177907263,0.0075045100257272,-0.00982401787135268,0.0195936614294979,0.515110673091148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.00311548543988189,0.00479452731374153,-0.00628178809505152,0.0125127589748153,0.515832545481862
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STEAP4,Metalloreductase STEAP4,36991,-0.00475999387574571,0.00733764389810581,-0.0191417759160331,0.00962178816454168,0.5165379855482
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00487814964034611,0.00754388308006764,-0.0196641604772787,0.00990786119658646,0.51787822490584
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SOX2,Transcription factor SOX-2,37391,0.00149615577424779,0.00231959899955962,-0.00305025826488907,0.00604256981338464,0.518934092819086
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOS,Proto-oncogene c-Fos,36931,-0.00221385677492363,0.00345142187969208,-0.00897864365912011,0.00455093010927284,0.521252478880694
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RUVBL1,RuvB-like 1,39477,0.00635440456546113,0.00991264229716814,-0.0130743743369884,0.0257831834679107,0.52150581671525
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2BP,LRP2-binding protein,37039,-0.00497874129587215,0.00778260825550458,-0.0202326534766611,0.0102751708849168,0.522361497623908
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,0.00167066465759081,0.00261260942376398,-0.00345004981298659,0.0067913791281682,0.522531571819209
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00300839875004436,0.00473937897447057,-0.00628078403991797,0.0122975815400067,0.525591809325495
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,39732,0.00242694970294185,0.00383393453301667,-0.00508756198177082,0.00994146138765453,0.526730985952538
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FZD10,Frizzled-10,37039,0.00368614797672969,0.00584542642485537,-0.00777088781598683,0.0151431837694462,0.528310563704588
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PCDH17,Protocadherin-17,39868,0.00213667861763114,0.00341054829784753,-0.00454799604615001,0.0088213532814123,0.531001717106641
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REN,Renin,39868,-0.00401985099833896,0.00642919036988725,-0.016621064123318,0.00858136212664005,0.531815931740863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVPL,Envoplakin,37169,-0.00199590957964953,0.00321342378601836,-0.00829422020024552,0.00430240104094646,0.534533806416921
NMR metabolomics,X23495.Concentration of Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,39246,0.00282695664741615,0.00459108133057942,-0.00617156276051952,0.0118254760553518,0.538068881892794
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MB,Myoglobin,40052,0.00310380706462302,0.00505813179636992,-0.00681013125626203,0.0130177453855081,0.539470349596515
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UBQLN3,Ubiquilin-3,37021,-0.00279646568999923,0.00458826591792752,-0.0117894668891372,0.0061965355091387,0.542215492319388
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EXOSC10,Exosome component 10,37021,-0.00362693404339325,0.00595226022247343,-0.0152933640794412,0.00803949599265467,0.542311420990509
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSD1,Tryptase delta,37411,0.00216704476493483,0.00357091592352518,-0.00483195044517452,0.00916603997504418,0.543954229202085
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,37388,0.00409217556709698,0.00680288522990065,-0.0092414794835083,0.0174258306177023,0.54749359143195
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.00366832658314917,0.00611066959131656,-0.0156452389821296,0.00830858581583128,0.548306687405613
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00185234562421892,0.00309221596552898,-0.00420839766821787,0.00791308891665571,0.549159848552795
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,36962,0.00230901943326052,0.00387845038405123,-0.00529274331947989,0.00991078218600092,0.551622580251896
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PDCL2,Phosducin-like protein 2,36962,-0.00308582109871664,0.00518756937036753,-0.013253457064637,0.00708181486720371,0.551954599653897
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,36991,0.0055384700331354,0.00937692908748659,-0.0128403109783383,0.0239172510446091,0.554766059780359
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00293149598038088,0.00496857841326472,-0.0126699096703797,0.00680691770961797,0.555195981698795
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.0022082970528461,0.00374492735166828,-0.00954835466211592,0.00513176055642373,0.555417411369341
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FOLR3,Folate receptor gamma,39858,-0.0107996626690488,0.0184506890684638,-0.0469630132432379,0.0253636879051403,0.558336986839344
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,37368,0.00317586695815524,0.00544946269831982,-0.00750507993055161,0.0138568138468621,0.560047544798663
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,37039,0.00208270440951063,0.00359399882854547,-0.00496153329443848,0.00912694211345975,0.562265113730835
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GJA8,Gap junction alpha-8 protein,36962,0.00327405158622095,0.00583449708693274,-0.00816156270416723,0.0147096658766091,0.574702131098737
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,40052,-0.00170604017147891,0.00305491086206278,-0.00769366546112195,0.00428158511816413,0.57653922872487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BRD2,Bromodomain-containing protein 2,36991,-0.0018432915837052,0.00330548068083996,-0.00832203371815153,0.00463545055074112,0.577094920673257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HBZ,Hemoglobin subunit zeta,37437,-0.00568336267250728,0.0102978307114718,-0.0258671108669919,0.0145003855219774,0.581026623935477
NMR metabolomics,X23495.Concentration of Large VLDL Particles,REG1A,Lithostathine-1-alpha,39804,-0.00249734535919777,0.00453275463791825,-0.0113815444495175,0.006386853731122,0.581672011694572
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,39477,-0.00264537914514234,0.00483257225142518,-0.0121172207579357,0.00682646246765102,0.584107642489945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00271348510972421,0.00498324651293572,-0.0124806482750782,0.00705367805562979,0.586091836716585
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",37021,0.00208459354551542,0.0038635003371486,-0.00548786711529583,0.00965705420632668,0.589509046524224
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNPO1,Transportin-1,37169,-0.00186060362520945,0.00345706265947973,-0.00863644643778973,0.00491523918737082,0.590445483897459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,37161,-0.00517816382497216,0.00965296166328798,-0.0240979686850166,0.0137416410350723,0.591668541201186
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00204245653513788,0.00388752586660683,-0.00966200723368727,0.0055770941634115,0.599322884263758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00226878100151543,0.0043362431429081,-0.00623025555858444,0.0107678175616153,0.600834262156869
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTN5,Contactin-5,39897,-0.00183635448727617,0.00351207691578825,-0.00872002524222114,0.00504731626766879,0.601072970526956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,39822,-0.00241107034437614,0.00461970704344434,-0.0114656961495271,0.00664355546077477,0.601740381820119
NMR metabolomics,X23495.Concentration of Large VLDL Particles,YY1,Transcriptional repressor protein YY1,37056,-0.00139490358034468,0.00271242347495107,-0.00671125359124877,0.0039214464305594,0.607075566597907
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAV,Integrin alpha-V,40030,-0.000812281072166455,0.00161326828627843,-0.00397428691327218,0.00234972476893927,0.614619425576721
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00182095682784076,0.00364343946862006,-0.00532018453065456,0.00896209818633607,0.617230879832322
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,39788,-0.00223594373571095,0.00450794049173701,-0.0110715070995155,0.0065996196280936,0.619900432821309
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,36991,0.00206712755857207,0.00423985650094332,-0.00624299118327684,0.010377246300421,0.62587917751273
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL25,Interleukin-25,36903,-0.00162655748970555,0.00335283193116148,-0.00819810807478205,0.00494499309537094,0.627592675050625
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",36991,0.00391652506709319,0.00807616567900218,-0.0119127596637511,0.0197458097979375,0.62772091150533
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBM25,RNA-binding protein 25,36962,-0.00214661242809776,0.0044608421372822,-0.0108898630171709,0.00659663816097535,0.630373604480255
NMR metabolomics,X23495.Concentration of Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00153522654172271,0.00319646323230186,-0.00472984139358894,0.00780029447703437,0.631029800332378
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.00620965586159549,0.0131301528679968,-0.0319447554828691,0.0195254437596781,0.636270035250957
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,0.00310923426382845,0.0066328844020165,-0.00989121916412389,0.0161096876917808,0.639248508687928
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,37169,0.00381393647160074,0.00817800168327994,-0.0122149468276279,0.0198428197708294,0.64096165492699
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,37124,0.00180216386330199,0.00386603950079986,-0.00577527355826573,0.00937960128486971,0.641114022771051
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00309844017651546,0.00664898207385531,-0.00993356468824096,0.0161304450412719,0.641221637778752
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00159713667839087,0.00343472201954726,-0.00513491847992176,0.00832919183670351,0.64194102823317
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DKKL1,Dickkopf-like protein 1,39788,-0.00378935153600384,0.0082054260355806,-0.0198719865657418,0.0122932834937341,0.644223559326073
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCIN,Adseverin,36991,0.00326306791791237,0.00721826017347545,-0.0108847220220995,0.0174108578579242,0.651235099733104
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00269236691021775,0.00597845474655053,-0.00902540439302129,0.0144101382134568,0.652468959054951
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.00220434072463353,0.00496035405312002,-0.0119266346687488,0.0075179532194817,0.656766639420046
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,-0.00145218327416224,0.00328107199896094,-0.00788308439212569,0.00497871784380121,0.658066622826816
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RBP1,Retinol-binding protein 1,37039,0.0030210144252122,0.00685532149564058,-0.0104154157062433,0.0164574445566677,0.659450707082599
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,37368,-0.00197312912554433,0.00450662025221553,-0.0108061048198868,0.00685984656879812,0.661517233451034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NLGN1,Neuroligin-1,37039,-0.0028569433835686,0.00656641573895945,-0.0157271182319291,0.0100132314647919,0.66350847519363
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LMOD2,Leiomodin-2,36991,-0.0026932534118608,0.00626242914795467,-0.0149676145418519,0.00958110771813035,0.667155205151448
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,0.00244410460124292,0.0057477642712917,-0.00882151337048881,0.0137097225729747,0.670678150165191
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,37169,-0.00305741122952955,0.00724366225194752,-0.0172549892433467,0.0111401667842876,0.672972811957376
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPT1,Translationally-controlled tumor protein,39587,0.00267442439978687,0.00636512299056436,-0.00980121666171928,0.015150065461293,0.674368079403591
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00143621004214391,0.00345997016738829,-0.00534533148593712,0.00821775157022495,0.678080435490334
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,37056,-0.00490091587540475,0.0118166858644268,-0.0280616201696813,0.0182597884188718,0.678335049738272
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN4,Prefoldin subunit 4,36962,0.00219820210527002,0.00531442189121016,-0.00821806480150189,0.0126144690120419,0.679152175262411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TSPAN7,Tetraspanin-7,36991,0.00379998854061915,0.00920018493800293,-0.0142323739378666,0.0218323510191049,0.679588499030148
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,-0.00102817428711735,0.00250579342649132,-0.00593952940304033,0.00388318082880563,0.68157855023247
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OSTN,Osteocrin,37039,-0.00166563787404074,0.00408191033624179,-0.00966618213307464,0.00633490638499317,0.683241013042386
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0018013240877402,0.00442893807132011,-0.00687939453204722,0.0104820427075276,0.684221328042128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.0025903701332136,0.00640552633149127,-0.0151452017429365,0.00996446147650928,0.685927935447311
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAD2,Glutamate decarboxylase 2,37056,-0.00183540789754479,0.00455097290278322,-0.0107553147869999,0.00708449899191032,0.686733990934152
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,37043,-0.00161464822817363,0.00403174117600494,-0.00951686093314331,0.00628756447679605,0.688806483305441
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",39585,0.00165889708859504,0.004216307987533,-0.00660506656696964,0.00992286074415972,0.693994107531276
NMR metabolomics,X23495.Concentration of Large VLDL Particles,STC2,Stanniocalcin-2,39831,0.00100420870811934,0.00258317020867537,-0.00405880490088438,0.00606722231712306,0.697465904214825
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD27,CD27 antigen,39913,0.00145149304648964,0.00379603227995076,-0.00598873022221386,0.00889171631519314,0.702191183985702
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD2,T-cell surface antigen CD2,37021,0.00142351988892837,0.00374756850259848,-0.00592171437616465,0.00876875415402138,0.704061706504551
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,36962,-0.00146438919122354,0.00385590012375689,-0.00902195343378704,0.00609317505133996,0.704115762680891
NMR metabolomics,X23495.Concentration of Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00425944625936658,0.0113110252457547,-0.0264290557410458,0.0179101632223126,0.706495742025598
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,37039,0.00148022341500831,0.00395671087538462,-0.00627492990074555,0.00923537673076217,0.708332575886722
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TPSG1,Tryptase gamma,37056,0.000982983864485336,0.00262802014237819,-0.00416793561457592,0.00613390334354659,0.708380789894451
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00208735465494842,0.00559733207579471,-0.00888341621360921,0.013058125523506,0.709214159627961
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,37382,0.00156108761851739,0.00422221211900629,-0.00671444813473494,0.00983662337176972,0.711587854963168
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GPA33,Cell surface A33 antigen,39788,0.00472727237242471,0.0128016781440925,-0.0203640167899967,0.0298185615348461,0.711931586081803
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL2,Interleukin-2,39587,0.00109885107708126,0.00303991557843869,-0.00485938345665857,0.00705708561082109,0.717749838079959
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF20,Fibroblast growth factor 20,37056,-0.00151587892625181,0.0041981788985352,-0.00974430956738079,0.00671255171487718,0.71804533691349
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNW1,Interferon omega-1,37021,-0.00124336446916462,0.00345766647002856,-0.00802039075042059,0.00553366181209135,0.719154733880608
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PITHD1,PITH domain-containing protein 1,36931,-0.00274297660815528,0.00772446376056801,-0.0178829255788686,0.012396972362558,0.72251851238123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,0.00256489365256246,0.0072845670375038,-0.011712857740945,0.0168426450460699,0.724768266547312
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,36942,-0.00161577279496199,0.00463921240896785,-0.010708629116539,0.00747708352661499,0.727631001099178
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL3,Interleukin-3,36962,-0.00198132961234958,0.00582370901821132,-0.0133957992880438,0.00943314006334461,0.733697950156658
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HMCN2,Hemicentin-2,37100,0.00183431963875108,0.00555044243682939,-0.00904454753743452,0.0127131868149367,0.741041248932987
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00096042083008408,0.00291316787212068,-0.00667022985944062,0.00474938819927246,0.741644869929411
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSCA,Prostate stem cell antigen,37382,0.00816840998938378,0.0247766774604819,-0.0403938778331607,0.0567306978119283,0.74164580758472
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF830,Zinc finger protein 830,37368,-0.00256437473913065,0.00787012418839468,-0.0179898181483842,0.0128610686701229,0.744553010684956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PMCH,Pro-MCH,37021,-0.0025737403653327,0.0080921915086779,-0.0184344357223414,0.013286954991676,0.750450288724425
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,36962,0.00266560143691501,0.00847232977470759,-0.0139401649215119,0.0192713677953419,0.75305188178509
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,37169,0.00137000741830103,0.00437254021484202,-0.00720017140278933,0.0099401862393914,0.754041924908859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BCAN,Brevican core protein,39749,0.00100940474010853,0.00324814895019846,-0.00535696720228044,0.0073757766824975,0.755984822662993
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,37056,-0.00232337001068124,0.00750645655167428,-0.0170360248519628,0.0123892848306003,0.756933767516246
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HDAC9,Histone deacetylase 9,36991,-0.00192196312771401,0.0062714947771893,-0.014214092891005,0.010370166635577,0.759259188154683
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,39962,0.000883544119052652,0.00290471977100246,-0.00480970663211217,0.00657679487021748,0.760998243000034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,OMP,Olfactory marker protein,36991,0.00143656338624923,0.00474675389124965,-0.00786707424060008,0.0107402010130985,0.762168091835918
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MLLT1,Protein ENL,36962,-0.00208869617116493,0.00697139995867578,-0.0157526400901695,0.0115752477478396,0.764479952050536
NMR metabolomics,X23495.Concentration of Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,37437,-0.000675869792905916,0.00227024230977457,-0.00512554472006408,0.00377380513425225,0.765930425582788
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IFNL2,Interferon lambda-2,36991,-0.00179093420295143,0.0060500495668567,-0.0136490313539906,0.0100671629480877,0.767219674395732
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FGF3,Fibroblast growth factor 3,37056,0.000887518602604533,0.00300708619193747,-0.0050063703335929,0.00678140753880197,0.767889752712337
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,36962,0.00182146839309298,0.00621446700301518,-0.0103588869328168,0.0140018237190027,0.769449360623498
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.00118633893550877,0.00404801749335011,-0.00912045322247498,0.00674777535145745,0.769475813990446
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RSPO1,R-spondin-1,39749,0.00100768339749938,0.00344214602198431,-0.00573892280558987,0.00775428960058864,0.76971814870128
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HK2,Hexokinase-2,39585,-0.000766139112864062,0.0026685670580523,-0.00599653054664656,0.00446425232091844,0.774041396967645
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.00140381195697331,0.00491909591602253,-0.00823761603843085,0.0110452399523775,0.77535745060862
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.00123052123672992,0.00434522991036478,-0.0097471718610449,0.00728612938758505,0.777035603479693
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,0.00230621003787162,0.00819282224940638,-0.0137517215709649,0.0183641416467081,0.778337846113294
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EFNB2,Ephrin-B2,37039,-0.00164282141749293,0.00587928316737641,-0.0131662164255507,0.00988057359056484,0.779922717668909
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",39489,-0.00145848683591831,0.00526966628017664,-0.0117870327450645,0.00887005907322791,0.781960188824289
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,0.00153575484735275,0.00557941672334556,-0.00939990193040455,0.0124714116251101,0.783124917921711
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,39477,0.000821950483572704,0.0030618835875608,-0.00517934134804647,0.00682324231519188,0.788359560648912
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,37382,0.0013559768377946,0.00524141929667169,-0.00891720498368192,0.0116291586592711,0.795867467671851
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,37039,0.00157184067208432,0.00626827796996259,-0.0107139841490424,0.013857665493211,0.802002679135099
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,36962,0.000785962015605088,0.00321250945285425,-0.00551055651198924,0.00708248054319942,0.80672607583923
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,39477,0.00110078463620849,0.00453599952823784,-0.00778977443913767,0.00999134371155466,0.808258492300508
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.000835690139123222,0.00348711002748742,-0.00767042579299856,0.00599904551475212,0.81060372985398
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IKZF2,Zinc finger protein Helios,39477,0.00219217097355242,0.00917824934060783,-0.0157971977340389,0.0201815396811438,0.811229583979487
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PKLR,Pyruvate kinase PKLR,39881,0.00148758029530295,0.00623789965506329,-0.0107387030286211,0.013713863619227,0.81151610441318
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,37056,0.00106419699829528,0.00446341725962439,-0.00768410083056853,0.00981249482715908,0.811554010634019
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.0021101296427002,0.00888781284921051,-0.0153099835417524,0.0195302428271528,0.812335960243754
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,37169,0.000910356994056107,0.00384019885218917,-0.00661643275623467,0.00843714674434688,0.812614002205402
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000768845314455335,0.00326871648911644,-0.00563783900421288,0.00717552963312355,0.814046803760043
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CGN,Cingulin,37039,0.000881564575315482,0.00379350490869975,-0.00655370504573603,0.00831683419636699,0.816240367690491
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.00319732864056842,0.0140630936917253,-0.03076099227635,0.0243663349952131,0.820150483603516
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,36991,0.00130444951702477,0.00578965836151788,-0.0100432808715503,0.0126521799055998,0.821744100286099
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CD70,CD70 antigen,39866,-0.000892762183403263,0.00412051515203185,-0.0089689718813857,0.00718344751457917,0.828473933468956
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,39587,0.00135730885088184,0.00641734760678677,-0.0112206924584202,0.0139353101601839,0.832495029936026
NMR metabolomics,X23495.Concentration of Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.00137604305939448,0.00689480143714713,-0.0148898538762029,0.0121377677574139,0.841814016377582
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PI16,Peptidase inhibitor 16,37445,-0.000463895610886711,0.00233142345147362,-0.005033485575775,0.00410569435400158,0.842285067122107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,37169,0.00147360159730312,0.00748970857040609,-0.0132062272006928,0.0161534303952991,0.844026034596583
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCRL6,Fc receptor-like protein 6,39866,0.00124935394179844,0.00643299934536694,-0.0113593247751208,0.0138580326587176,0.846013779102039
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PGR,Progesterone receptor,37056,0.00194072122591034,0.0102612803090251,-0.0181713881797789,0.0220528306315996,0.849993434471763
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTSV,Cathepsin L2,39967,-0.000738350251501337,0.00399594792136034,-0.0085704081773676,0.00709370767436493,0.853408044962088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,-0.000698846319916569,0.00398815206241524,-0.00851562436225043,0.00711793172241729,0.860901124850219
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,-0.000593256259672445,0.00340477578473835,-0.00726661679775961,0.00608010427841472,0.861677233605303
NMR metabolomics,X23495.Concentration of Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,39913,0.000483107690002179,0.00278911464130502,-0.00498355700695566,0.00594977238696002,0.862487098075414
NMR metabolomics,X23495.Concentration of Large VLDL Particles,UPK3A,Uroplakin-3a,36991,-0.00078742382130133,0.00466059344899008,-0.00992218698132189,0.00834733933871923,0.865835777966723
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,-0.000686527474001365,0.00408445860443674,-0.00869206633869737,0.00731901139069464,0.866520674311941
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TLR1,Toll-like receptor 1,37056,0.000414582410054436,0.00254932615751932,-0.00458209685868344,0.00541126167879231,0.870816734415264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,0.00113544908422071,0.00709818634589074,-0.0127769961537251,0.0150478943221666,0.872912031933453
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.00121625513818997,0.00760587067752088,-0.0161237616661309,0.013691251389751,0.872954384594409
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,0.00125249379389824,0.007952725218377,-0.0143348476341207,0.0168398352219172,0.874859222716609
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,36991,-0.000884908321884704,0.00588125467298444,-0.0124121674809342,0.0106423508371648,0.880402040163459
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,0.000700354059967302,0.00482500603932526,-0.00875665777711021,0.0101573658970448,0.88459355764107
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,37039,-0.000711219073653454,0.00501024159453079,-0.0105312925989338,0.0091088544516269,0.887119260848429
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZNF174,Zinc finger protein 174,37056,0.000528474480986709,0.00373046764632955,-0.00678324210581921,0.00784019106779263,0.887347254244164
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PALLD,Palladin,37056,0.000549272980143658,0.00397936537337927,-0.0072502831516797,0.00834882911196702,0.890218580057447
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MYL6B,Myosin light chain 6B,37039,-0.00121482469939025,0.00902423396638975,-0.0189023232735142,0.0164726738747337,0.892915932388995
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CAPN3,Calpain-3,37368,-0.000483761584878665,0.00367650834502797,-0.00768971794113349,0.00672219477137616,0.895317041666523
NMR metabolomics,X23495.Concentration of Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,0.000295554562991908,0.00233168175599462,-0.00427454167875754,0.00486565080474136,0.899135432741793
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,37039,-0.000519117605315914,0.00417588273096941,-0.00870384775801595,0.00766561254738412,0.901069142848863
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.000606622894314671,0.00494705638025202,-0.0103028533996086,0.00908960761097929,0.902407496779362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGB7,Integrin beta-7,40030,-0.000539858350362678,0.00443825350487136,-0.00923883521991054,0.00815911851918518,0.903187573064513
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SHC1,SHC-transforming protein 1,36962,-0.00134699314837436,0.0112893302660057,-0.0234740804697456,0.0207800941729969,0.905027158692362
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,0.000443249791527319,0.00380156564374845,-0.00700781887021964,0.00789431845327428,0.90718146344345
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CNTF,Ciliary neurotrophic factor,36991,0.000384003715904062,0.00331339147164744,-0.00611024356852493,0.00687825100033305,0.907737958487095
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,39720,-0.000359395426568706,0.00322172389684544,-0.00667397426438577,0.00595518341124836,0.911178645910758
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.000631515777472273,0.00573442373008205,-0.0106079547334885,0.0118709862884331,0.912310214620853
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ITGAX,Integrin alpha-X,37169,0.000545700040778525,0.00516144985509392,-0.00957074167520556,0.0106621417567626,0.91580125308323
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,-0.000464295506742891,0.00576414124038731,-0.011762012337902,0.0108334213244162,0.935801687948167
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SEPTIN7,Septin-7,37169,0.000402977157848392,0.00500984643488995,-0.0094163218545359,0.0102222761702327,0.935890887667568
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PFDN6,Prefoldin subunit 6,37039,0.000509287896956315,0.00644126225466423,-0.0121155861221856,0.0131341619160982,0.93698095000612
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,36962,-0.000418017395963934,0.00530936305233892,-0.0108243689785482,0.00998833418662034,0.937246900994111
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GAGE2A,G antigen 2A,36962,0.000465108513767347,0.00595789817497203,-0.0112123719091778,0.0121425889367125,0.937776846962348
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL5,Interleukin-5,39587,0.00109772328352501,0.0140759341475749,-0.0264911076457219,0.0286865542127719,0.937840323799328
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KHDC3L,KH domain-containing protein 3,36962,0.000502871992457451,0.00649357711484615,-0.012224539152641,0.0132302831375559,0.938273554239859
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,-0.000394475892636736,0.00547563625980888,-0.0111267229618621,0.0103377711765887,0.942569565407945
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,36962,0.0004379924404133,0.00619933861373652,-0.0117127112425103,0.0125886961233369,0.943676216911543
NMR metabolomics,X23495.Concentration of Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00017040129825234,0.00253073135143386,-0.00478983215055803,0.00513063474706271,0.946317766195563
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TFRC,Transferrin receptor protein 1,39918,0.000252076260323621,0.00380977390488093,-0.007215080593243,0.00771923311389024,0.947246748293257
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,37021,-0.000467301025309127,0.00740130371818501,-0.0149738563129518,0.0140392542623335,0.949657841617353
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL17A,Interleukin-17A,39558,0.0002514791341094,0.00413041066158006,-0.00784412576258752,0.00834708403080632,0.951451747823103
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.000204452989022905,0.00349464741155696,-0.00664505593762873,0.00705396191567454,0.953347576371417
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,39585,-0.000162776378093098,0.00312723280472634,-0.00629215267535673,0.00596659991917053,0.958488517891034
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,36962,0.000199960511908194,0.00407035351793941,-0.00777793238325305,0.00817785340706943,0.960819568599456
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRR5,Proline-rich protein 5,37056,0.000224781682750545,0.00465096936439237,-0.0088911182714585,0.0093406816369596,0.961453920220351
NMR metabolomics,X23495.Concentration of Large VLDL Particles,TP53BP1,TP53-binding protein 1,37056,0.000396141274375291,0.00859348293775667,-0.0164470852836278,0.0172393678323784,0.963232939851493
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CRX,Cone-rod homeobox protein,39585,0.000456517807865042,0.0105600281247366,-0.0202411373166187,0.0211541729323488,0.965518151588885
NMR metabolomics,X23495.Concentration of Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,0.000173097411790937,0.00405159513441505,-0.00776802905166257,0.00811422387524444,0.965922766900872
NMR metabolomics,X23495.Concentration of Large VLDL Particles,LCN15,Lipocalin-15,37411,0.000257984014260063,0.00605232645291355,-0.0116045758334505,0.0121205438619706,0.966000620437123
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,39858,0.000107765587539271,0.00279233608760385,-0.00536521314416427,0.00558074431924281,0.969215090516029
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,36962,-8.86596887057469e-05,0.0031441855373718,-0.00625126334195448,0.00607394396454299,0.977504675797297
NMR metabolomics,X23495.Concentration of Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",37368,-0.0001052832939039,0.00428332244796237,-0.00850059529191015,0.00829002870410235,0.980390478979392
NMR metabolomics,X23495.Concentration of Large VLDL Particles,IL24,Interleukin-24,39587,-9.44625788228505e-05,0.00460634432771854,-0.00912289746115119,0.00893397230350549,0.983639140465933
NMR metabolomics,X23495.Concentration of Large VLDL Particles,EVI2B,Protein EVI2B,36962,8.2444300170838e-05,0.00402759728884335,-0.00781164638596213,0.00797653498630381,0.98366887736975
NMR metabolomics,X23495.Concentration of Large VLDL Particles,KLK3,Prostate-specific antigen,37437,-0.000138831441501759,0.00768341998453093,-0.0151983346111824,0.0149206717281789,0.985584102305977
NMR metabolomics,X23495.Concentration of Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,37021,0.000121853725573792,0.00699299161887262,-0.0135844098474166,0.0138281172985641,0.986097732620264
NMR metabolomics,X23495.Concentration of Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,36991,7.27975002663125e-05,0.00434313019415402,-0.00843973768027557,0.0085853326808082,0.986627116095427
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,5.53666073107485e-05,0.00540711121880854,-0.010542571381554,0.0106533045961755,0.991830286197151
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,3.18306565787573e-05,0.00351931303204975,-0.00686602288623875,0.00692968419939626,0.992783712506299
NMR metabolomics,X23495.Concentration of Large VLDL Particles,DUOX2,Dual oxidase 2,39585,-5.92798971757752e-05,0.00695890946900086,-0.0136987424564175,0.0135801826620659,0.993203361688873
NMR metabolomics,X23495.Concentration of Large VLDL Particles,NCLN,Nicalin,39587,4.2807524642198e-05,0.00514240239513862,-0.0100363011698295,0.0101219162191139,0.993358254965766
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,39585,3.79134342859237e-05,0.00478764384585311,-0.00934586850358617,0.00942169537215802,0.993681704879088
NMR metabolomics,X23495.Concentration of Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-3.2403292638655e-05,0.00628989998765522,-0.0123606072684429,0.0122958006831656,0.995889683223171
NMR metabolomics,X23495.Concentration of Large VLDL Particles,CDH4,Cadherin-4,36991,-2.28482429734006e-05,0.00457002407386901,-0.00898009542775667,0.00893439894180987,0.996010997538916
NMR metabolomics,X23495.Concentration of Large VLDL Particles,PRND,Prion-like protein doppel,37388,-1.91614830198571e-05,0.00495856602646313,-0.00973795089488759,0.00969962792884787,0.996916783845443
